<SEC-DOCUMENT>0001104659-20-075229.txt : 20200619
<SEC-HEADER>0001104659-20-075229.hdr.sgml : 20200619
<ACCEPTANCE-DATETIME>20200619161542
ACCESSION NUMBER:		0001104659-20-075229
CONFORMED SUBMISSION TYPE:	S-3ASR
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20200619
DATE AS OF CHANGE:		20200619
EFFECTIVENESS DATE:		20200619

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PTC THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001070081
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				043416587
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-239308
		FILM NUMBER:		20975808

	BUSINESS ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449
		BUSINESS PHONE:		9082227000

	MAIL ADDRESS:	
		STREET 1:		100 CORPORATE COURT
		CITY:			SOUTH PLAINFIELD
		STATE:			NJ
		ZIP:			07080-2449

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PTC THERAPEUTICS INC
		DATE OF NAME CHANGE:	19980909
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3ASR
<SEQUENCE>1
<FILENAME>tm2022875-1_s3asr.htm
<DESCRIPTION>DOCUMENT S-3ASR
<TEXT>
<html>
  <head>
    <title>tm2022875-1_s3asr - none - 3.8468274s</title>
  </head>
  <body style="width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:27pt;width:541.31pt;">
        <div style="text-align:center; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">As filed with the Securities and Exchange Commission on June&#160;19, 2020</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="margin-top:0.05pt; text-align:right; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">Registration No. 333-&#8199;&#8199;&#8199;&#8199;&#8199;</font>&#8203;</div>
        <div style="margin-top:0.883pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.04pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:5.55pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">UNITED STATES </font>
          <br >
          <font style="letter-spacing:-0.24pt;">SECURITIES AND EXCHANGE COMMISSION </font>
        </div>
        <div style="margin-top:0.05pt; text-align:center; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">Washington, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:541.31pt; line-height:12pt;font-weight:bold;font-size:12pt;">
          <font style="letter-spacing:-0.24pt;">FORM S-3</font><font style="font-weight:normal;letter-spacing:0.24pt;"> </font>
        </div>
        <div style="margin-top:0.05pt; text-align:center; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">REGISTRATION STATEMENT </font>
          <br >
          <font style="letter-spacing:-0.17pt;">UNDER </font>
          <br >
          <font style="letter-spacing:-0.17pt;">THE SECURITIES ACT OF 1933</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:541.31pt; line-height:14pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">PTC THERAPEUTICS, INC.</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:-1.95pt; text-align:center; width:541.31pt; line-height:8pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Exact name of registrant as specified in its charter) </font>
        </div>
        <table style="width:349.31pt;height:25.5pt;margin-left:96pt;margin-top:6.05000000000001pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:168.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.17pt;">Delaware </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:168.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.17pt;">04-3416587 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:168.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">(State or other jurisdiction of </font>
                <br >
                <font style="letter-spacing:0.16pt;">incorporation or organization) </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:1.5pt 0pt 0.5pt 0pt; width:168.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">(I.R.S. Employer </font>
                <br >
                <font style="letter-spacing:0.16pt;">Identification Number)</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:10pt; text-align:center; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">100 Corporate Court </font>
          <br >
          <font style="letter-spacing:-0.17pt;">South Plainfield, NJ 07080 </font>
          <br >
          <font style="letter-spacing:-0.17pt;">(908) 222-7000</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="margin-top:0.05pt; text-align:center; width:541.31pt; line-height:8pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices) </font>
        </div>
        <div style="margin-top:4pt; text-align:center; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">Stuart W. Peltz, Ph.D. </font>
          <br >
          <font style="letter-spacing:-0.17pt;">Chief Executive Officer </font>
          <br >
          <font style="letter-spacing:-0.17pt;">PTC Therapeutics, Inc. </font>
          <br >
          <font style="letter-spacing:-0.17pt;">100 Corporate Court </font>
          <br >
          <font style="letter-spacing:-0.17pt;">South Plainfield, New Jersey 07080 </font>
          <br >
          <font style="letter-spacing:-0.17pt;">(908) 222-7000 </font>
        </div>
        <div style="text-align:center; width:541.31pt; line-height:8pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) </font>
        </div>
        <table style="width:541.31pt;margin-top:3.54999999999995pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
          <tr style="line-height:8.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1.5pt 0pt; width:0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.17pt;">Copies to: </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9.5pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8.5pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:2.833pt 0pt 1.5pt 0pt; width:264.66pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.17pt;">Richard Aldridge </font>
                <br >
                <font style="letter-spacing:-0.17pt;">Morgan, Lewis &amp; Bockius LLP </font>
                <br >
                <font style="letter-spacing:-0.17pt;">1701 Market Street </font>
                <br >
                <font style="letter-spacing:-0.17pt;">Philadelphia, Pennsylvania 19103 </font>
                <br >
                <font style="letter-spacing:-0.17pt;">Telephone: (215) 963-5000 </font>
                <br >
                <font style="letter-spacing:-0.17pt;">Fax: (215) 963-5001 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.833pt 0pt 1.5pt 0pt; width:264.65pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.17pt;">Mark E. Boulding </font>
                <br >
                <font style="letter-spacing:-0.17pt;">Executive Vice President and Chief Legal Officer</font>
                <br >
                <font style="letter-spacing:-0.17pt;">PTC Therapeutics, Inc.</font>
                <br >
                <font style="letter-spacing:-0.17pt;">100 Corporate Court</font>
                <br >
                <font style="letter-spacing:-0.17pt;">South Plainfield, New Jersey 07080-2449</font>
                <br >
                <font style="letter-spacing:-0.17pt;">Telephone: (908) 222-7000</font>
                <br >
                <font style="letter-spacing:-0.17pt;">Fax: (908) 222-1128</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:8pt; text-align:center; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">Approximate date of commencement of proposed sale to the public: From time to time after this registration statement becomes effective.</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">If this Form is filed to register additional securities for an offering pursuant to Rule&#160;462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">If this Form is a post-effective amendment filed pursuant to Rule&#160;462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">If this Form is a registration statement pursuant to General Instruction I.D or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule&#160;462(e) under the Securities Act, check the following box. &#9746; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D filed to register additional securities or additional classes of securities pursuant to Rule&#160;413(b) under the Securities Act, check the following box. &#9744; </font>
        </div>
        <div style="text-indent:20pt; margin-top:3.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </font>
        </div>
        <table style="width:501.31pt;height:21pt;margin-left:20pt;margin-top:7.04999999999995pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:116.33pt;">
              <font style="letter-spacing:0.18pt;">Large accelerated filer &#9746; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:116.33pt;">
              <font style="letter-spacing:0.18pt;">Accelerated filer &#9744; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:116.33pt;">
              <font style="letter-spacing:0.18pt;">Non-accelerated filer &#9744; </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:116.33pt;white-space:normal;">
              <div style=" float:left; line-height:9pt; text-align:left; width:106pt;white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Smaller reporting company</font>
                <br >
              </div>
              <div style=" line-height:9pt; text-align:left; margin-left:106pt;">
                <font style="letter-spacing:0.18pt;">&#9744; </font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:9pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:116.33pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:116.33pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:116.33pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; width:116.33pt;white-space:normal;">
              <div style=" float:left; line-height:9pt; text-align:left; width:106pt;white-space:nowrap;">
                <font style="letter-spacing:0.18pt;">Emerging growth company</font>
                <br >
              </div>
              <div style=" line-height:9pt; text-align:left; margin-left:106pt;">
                <font style="letter-spacing:0.18pt;">&#9744;</font>
              </div>
              <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:11.5pt; width:541.31pt; line-height:8.5pt;">
          <font style="letter-spacing:0.17pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;7(a)(2)(B) of the Securities Act. &#9744; </font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:541.31pt; line-height:8.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.17pt;">CALCULATION OF REGISTRATION FEE</font><font style="font-weight:normal;letter-spacing:0.17pt;"> </font>
        </div>
        <table style="width:541.31pt;height:43.5pt;margin-top:-5.94999999999993pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;">
            <td style="border-bottom:3px double #000000;padding:0pt 0pt 1pt 0pt; width:0pt;" colspan="22">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0.083pt 0pt 0.667pt 0pt; width:259.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Title of Each Class of Securities to be Registered</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.083pt 0pt 0.667pt 0pt; width:44.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount to be </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Registered</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.083pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Proposed Maximum </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Offering Price Per </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Unit</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.083pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Proposed Maximum </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Aggregate Offering </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Price</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0.083pt 0pt 0.667pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Amount of </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Registration Fee </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #000000; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:3px double #000000;padding:1.25pt 0pt 1pt 0pt; width:259.36pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.16pt;">Common Stock, par value $0.001 per share </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="border-bottom:3px double #000000;padding:1.25pt 0pt 1pt 0pt; width:44.74pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.16pt;">760,365 </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:22.715pt;width:0pt;border-bottom:3px double #000000;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3px double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3px double #000000; min-width:15pt; text-align:right; white-space:nowrap;">48.45 </td>
            <td style="padding:0pt;padding-left:22.715pt;width:0pt;border-bottom:3px double #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:8.55pt;width:0pt;border-bottom:3px double #000000;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3px double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3px double #000000; min-width:36pt; text-align:right; white-space:nowrap;">36,839,684.25 </td>
            <td style="padding:0pt;padding-left:8.55pt;width:0pt;border-bottom:3px double #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:10.83pt;width:0pt;border-bottom:3px double #000000;">&#8203;</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3px double #000000; min-width:3pt; text-align:right; ">$</td>
            <td style="padding:1.25pt 0pt 1pt 0pt;border-bottom:3px double #000000; min-width:21pt; text-align:right; white-space:nowrap;">4,781.80</td>
            <td style="padding:0pt;padding-left:10.83pt;width:0pt;border-bottom:3px double #000000;">&#8203;</td>
            <td style="padding:0pt;border-bottom:3px double #000000; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8.55pt; margin-top:8.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.17pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:8.4pt; margin-bottom:0pt; line-height:8.55pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.17pt;">The shares of common stock will be offered for resale by the selling stockholders. Pursuant to Rule&#160;416 under the Securities Act, this Registration Statement also relates to an indeterminate number of additional shares of common stock to be issued as a result of stock splits, stock dividends or similar transactions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:8.55pt; margin-top:3.5pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.17pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.5pt; margin-bottom:0pt; line-height:8.55pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.17pt;">Estimated solely for purposes of calculating the registration fee pursuant to Rule&#160;457(c) under the Securities Act, based on the average of the high and low price per share of the common stock as reported on The Nasdaq Global Select Market on June 15, 2020. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:6.883pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:1.05pt; width:541.31pt;">
          <div style="margin-left: 0pt; width: 541.31pt; margin-top: 0pt; font-size: 2pt; line-height: 0pt; border-bottom: 2pt solid #000000; ">&#8203;</div>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">760,365 Shares</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="position:relative;z-index:-1;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_ptctherapeutic-bw.jpg" alt="[MISSING IMAGE: lg_ptctherapeutic-bw.jpg]" height="83" width="160" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:20pt;font-weight:bold;font-size:18pt;">
          <font style="letter-spacing:-0.36pt;">PTC Therapeutics, Inc.</font><font style="font-weight:normal;letter-spacing:0.36pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus relates to resales of shares of common stock previously issued by PTC Therapeutics, Inc. to certain former securityholders of Censa Pharmaceuticals Inc., or Censa, in connection with our acquisition of Censa. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will not receive any proceeds from the sale of the shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The selling stockholders identified in this prospectus, or their pledgees, assignees, donees, transferees or other successors-in-interest, may offer the shares from time to time through public or private transactions at prevailing market prices, at prices related to prevailing market prices or at privately negotiated prices. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our common stock is traded on The Nasdaq Global Select Market under the symbol &#8220;PTCT.&#8221; On June&#160;18, 2020, the closing sale price of the common stock on The Nasdaq Global Select Market was $50.36 per share. You are urged to obtain current market quotations for the common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Investing in our common stock involves significant risks. See the information contained in this prospectus under the heading &#8220;Risk Factors&#8221; beginning on page </font><a href="#tRIFA">
            <font style="letter-spacing:-0.2pt;">7</font></a><font style="letter-spacing:-0.2pt;"> of this prospectus and in the documents incorporated by reference in this prospectus for a discussion of the factors you should carefully consider before deciding to purchase our common stock.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">The date of this prospectus is June&#160;19, 2020.</font>
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:416pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TABLE OF CONTENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:175pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tATP">
                  <font style="letter-spacing:0.2pt;">ABOUT THIS PROSPECTUS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tATP">1 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSNRF">
                  <font style="letter-spacing:0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tSNRF">1 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPRSU">
                  <font style="letter-spacing:0.2pt;">PROSPECTUS SUMMARY </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tPRSU">5 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tRIFA">
                  <font style="letter-spacing:0.2pt;">RISK FACTORS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tRIFA">7 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tUOP">
                  <font style="letter-spacing:0.2pt;">USE OF PROCEEDS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tUOP">7 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSEST">
                  <font style="letter-spacing:0.2pt;">SELLING STOCKHOLDERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tSEST">7 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tDOCS">
                  <font style="letter-spacing:0.2pt;">DESCRIPTION OF CAPITAL STOCK </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tDOCS">13 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPOD">
                  <font style="letter-spacing:0.2pt;">PLAN OF DISTRIBUTION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tPOD">17 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tLEMA">
                  <font style="letter-spacing:0.2pt;">LEGAL MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tLEMA">19 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tEXP">
                  <font style="letter-spacing:0.2pt;">EXPERTS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tEXP">19 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tWYCF">
                  <font style="letter-spacing:0.2pt;">WHERE YOU CAN FIND MORE INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tWYCF">19 </a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:434pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tIBR">
                  <font style="letter-spacing:0.2pt;">INCORPORATION BY REFERENCE </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:9.75pt; text-align:right; white-space:nowrap;">
              <a href="#tIBR">19</a>
            </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tATP">&#8203;</a><a name="tSNRF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ABOUT THIS PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC. The selling stockholders may from time to time sell shares of common stock described in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus provides you with a description of the common stock selling stockholders may offer. You should read both this prospectus together with the additional information described under the heading &#8220;Where You Can Find More Information&#8221; beginning on page </font><a href="#tWYCF">
            <font style="letter-spacing:0.2pt;">19</font></a><font style="letter-spacing:0.2pt;"> of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have not authorized anyone to provide you with information different from that contained in this prospectus, any accompanying prospectus supplement or in any related free writing prospectus filed by us with the SEC. We do not take any responsibility for, and cannot provide any assurance as to the reliability of, any information other than the information in this prospectus, any accompanying prospectus supplement or in any related free writing prospectus filed by us with the SEC. This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securities described herein or an offer to sell or the solicitation of an offer to buy such securities in any circumstances in which such offer or solicitation is unlawful. The selling stockholders are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted. You should assume that the information appearing in this prospectus, any prospectus supplement, the documents incorporated by reference and any related free writing prospectus is accurate only as of the respective dates of such documents. Our business, financial condition, results of operations and prospects may have changed materially since those dates. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Unless the context otherwise indicates, references in this prospectus to &#8220;PTC,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us&#8221; and &#8220;the Company&#8221; refer, collectively, to PTC Therapeutics, Inc., a Delaware corporation, and its consolidated subsidiaries. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus and the information incorporated by reference in this prospectus include &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. All statements contained or incorporated by reference herein, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth, other than statements of historical facts, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;potential,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The forward-looking statements in this prospectus and the information incorporated by reference herein and therein include, among other things, statements about: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">expectations with respect to our gene therapy platform, including any potential regulatory submissions and potential approvals, including those related to our gene therapy for the treatment of Aromatic L-Amino Acid Decarboxylase, or AADC deficiency, or PTC-AADC, our manufacturing capabilities and the potential financial impact and benefits of our leased biologics manufacturing facility and the potential achievement of development, regulatory and sales milestones and contingent payments that we may be obligated to make; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.81pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.81pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to negotiate, secure and maintain adequate pricing, coverage and reimbursement terms and processes on a timely basis, or at all, with third-party payors for our products or product candidates that we commercialize or may commercialize in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to maintain our marketing authorization of Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy, or nmDMD, in the European Economic Area, or EEA, which is subject to the specific obligation to conduct and submit the results of Study 041 to the European Medicines Agency, or EMA, and annual review and renewal by the European Commission following reassessment of the benefit-risk balance of the authorization by the EMA; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to enroll, fund, and complete Study 041, a multicenter, randomized, double-blind, 18-month, placebo-controlled clinical trial of Translarna for the treatment of nmDMD followed by an 18-month open label extension, according to the protocol agreed with the EMA, and by the EMA&#8217;s deadline; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the anticipated period of market exclusivity for Emflaza for the treatment of DMD in the United States under the Orphan Drug Act of 1983, the Drug Price Competition and Patent Term Restoration Act of 1984, or the Hatch-Waxman Act; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to complete any dystrophin study necessary in order to resolve the matters set forth in the United States Food and Drug Administration&#8217;s, or the FDA, denial of our appeal to the Complete Response Letter we received from the FDA in connection with our New Drug Application, or NDA, for Translarna for the treatment of nmDMD, and our ability to perform additional clinical trials, non-clinical studies or CMC assessments or analyses at significant cost; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing and scope of our commercialization of our products and product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our expectations with respect to the novel coronavirus (COVID-19) pandemic and related response measures and their effects on our business, operations, clinical trials, potential regulatory submissions and approvals, our collaborators, contract research organizations, suppliers and manufacturers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to obtain additional and maintain existing reimbursed named patient and cohort early access programs for our products on adequate terms, or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our expectations with respect to the development, regulatory and commercial status of our product candidates and program directed against spinal muscular atrophy in collaboration with F. Hoffmann La Roche Ltd and Hoffmann La Roche Inc., which we refer to collectively as Roche, and the Spinal Muscular Atrophy Foundation, or the SMA Foundation, and our estimates regarding future revenues from achievement of milestones in that program; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our expectations and the potential financial impact and benefits related to our Collaboration and Licensing Agreement with Akcea Therapeutics, Inc., or Akcea, including with respect to the timing of regulatory approval of TegsediTM (inotersen) and WaylivraTM (volanesorsen) in countries in which we are licensed to commercialize them, the commercialization of Tegsedi and Waylivra, and our expectations with respect to contingent payments to Akcea based on the potential achievement of certain regulatory milestones and royalty payments by us to Akcea based on our potential achievement of certain net sales thresholds; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our estimates regarding the potential market opportunity for our products or product candidates, including the size of eligible patient populations and our ability to identify such patients; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our estimates regarding expenses, future revenues, third-party discounts and rebates, capital requirements and needs for additional financing, including our ability to maintain the level of our expenses consistent with our internal budgets and forecasts and to secure additional funds on favorable terms or at all; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing and conduct of our ongoing, planned and potential future clinical trials and studies in our gene therapy, splicing, Bio-e and oncology programs as well as studies in our products for maintaining authorizations, label extensions and additional indications, including the timing of initiation, enrollment and completion of the trials and the period during which the results of the trials will become available; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to realize the anticipated benefits of our acquisitions or other strategic transactions, including the possibility that the expected impact of benefits from the acquisitions or strategic transactions will not be realized or will not be realized within the expected time period, significant transaction costs, the integration of operations and employees into our business, our ability to obtain marketing approval of our product candidates we acquired from the acquisitions or other strategic transactions and unknown liabilities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the rate and degree of market acceptance and clinical utility of any of our products or product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability and willingness of patients and healthcare professionals to access our products and product candidates through alternative means if pricing and reimbursement negotiations in the applicable territory do not have a positive outcome; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to complete the FDA post-marketing requirements to the marketing authorization of Emflaza and any other post-marketing requirements for our products; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the timing of, and our ability to obtain additional marketing authorizations for our products and product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the ability of our products and our product candidates to meet existing or future regulatory standards; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to maintain the current labeling under the marketing authorization in the EEA or expand the approved product label of Translarna for the treatment of nmDMD; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential receipt of revenues from future sales of our products or product candidates; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential impact that enrollment, funding and completion of Study 041 may have on our revenue growth; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our sales, marketing and distribution capabilities and strategy, including the ability of our third-party manufacturers to manufacture and deliver our products and product candidates in clinically and commercially sufficient quantities and the ability of distributors to process orders in a timely manner and satisfy their other obligations to us; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to establish and maintain arrangements for the manufacture of our products and product candidates that are sufficient to meet clinical trial and commercial launch requirements; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to establish and grow our manufacturing capabilities for our gene therapy platform; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our expectations with respect to the potential financial impact and benefits of our leased biologics manufacturing facility and our ability to satisfy our obligations under the terms of the lease agreement for such facility; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to satisfy our obligations under the terms of the credit and security agreement with MidCap Financial Trust, or MidCap Financial, as administrative agent and MidCap Financial and certain other financial institutions as lenders thereunder; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our ability to satisfy our obligations under the indenture governing our 3.00% convertible senior notes due August&#160;15, 2022 and under the indenture governing our 1.50% convertible senior notes due September&#160;15, 2026; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our regulatory submissions, including with respect to timing and outcome of regulatory review; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our plans to advance our earlier stage programs and pursue research and development of other product candidates, including our splicing, gene therapy, Bio-e and oncology programs; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">whether we may pursue business development opportunities, including potential collaborations, alliances, and acquisition or licensing of assets and our ability to successfully develop or commercialize any assets to which we may gain rights pursuant to such business development opportunities; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the potential advantages of our products and any product candidate; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our intellectual property position; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the impact of government laws and regulations; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">the impact of litigation that has been or may be brought against us or of litigation that we are pursuing against others; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">our competitive position. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We may not actually achieve the plans, intentions or expectations expressed or implied in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We have included important factors in the cautionary statements included in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:520pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">this prospectus and the information incorporated by reference herein, particularly the factors set forth under the caption &#8220;Risk Factors&#8221; of this prospectus, under the caption &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000064/ptct1231201910-k.htm">
            <font style="letter-spacing:0.2pt;">Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2019</font></a><font style="letter-spacing:0.2pt;">, and under the caption &#8220;Risk Factors&#8221; in Part&#160;II, Item&#160;1A of our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000096/ptct0331202010-q.htm">
            <font style="letter-spacing:0.2pt;">Quarterly Report on Form 10-Q for the fiscal quarter ended </font><font style="letter-spacing:0.2pt;">March&#160;31, 2020</font></a><font style="letter-spacing:0.2pt;">, that we believe could cause actual results or events to differ materially from the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we make. We do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPRSU">&#8203;</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-bottom:120pt; margin-left:12pt;width:456pt;">
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PROSPECTUS SUMMARY</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">This summary highlights selected information contained elsewhere in this prospectus and in the documents we incorporate by reference. This summary does not contain all of the information you should consider before making an investment decision. You should read this entire prospectus carefully, especially the risks of investing in our common stock discussed under &#8220;Risk Factors&#8221; beginning on page </font><a href="#tRIFA">
              <font style="letter-spacing:0.2pt;">7</font></a><font style="letter-spacing:0.2pt;"> of this prospectus, under the caption &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000064/ptct1231201910-k.htm">
              <font style="letter-spacing:0.2pt;">Annual Report on Form 10-K for </font><font style="letter-spacing:0.2pt;">the fiscal year ended December&#160;31, 2019</font></a><font style="letter-spacing:0.2pt;">, and under the caption &#8220;Risk Factors&#8221; in Part&#160;II, Item&#160;1A of our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000096/ptct0331202010-q.htm">
              <font style="letter-spacing:0.2pt;">Quarterly Report on Form 10-Q for the fiscal quarter ended March&#160;31, 2020</font></a><font style="letter-spacing:0.2pt;">, along with our consolidated financial statements and notes to those consolidated financial statements and the other information incorporated by reference in this prospectus. </font>
          </div>
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">PTC Therapeutics, Inc.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We are a science-driven global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Our ability to commercialize products is the foundation that drives our continued investment in a robust diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. Our strategy is to bring best-in-class therapies with differentiated clinical benefit to patients affected by rare disorders and to leverage its our commercial infrastructure to maximize value for our patients and other stakeholders. We have a portfolio pipeline that includes commercial products as well as product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. </font>
          </div>
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Acquisition of Censa Pharmaceuticals Inc.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">On May&#160;29, 2020, we acquired Censa, which prior to the acquisition was a privately-held biopharmaceutical company focused on the development and commercialization of PTC923 (formerly CNSA-001), a clinical-stage investigational therapy for orphan metabolic diseases, including phenylketonuria and other diseases associated with defects in the tetrahydrobiopterin biochemical pathways diagnosed at birth. The acquisition was effected pursuant to an Agreement and Plan of Merger, or the Merger Agreement, by and among us, Hydro Merger Sub, Inc., a Delaware corporation and a wholly owned, indirect subsidiary of the Company, Censa, and, solely in its capacity as the representative, agent and attorney-in-fact of the securityholders of Censa, Shareholder Representative Services LLC, a Colorado limited liability company and resulted in Censa becoming our wholly owned, indirect subsidiary. </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">The above descriptions of the Merger Agreement is a summary only and is qualified in their entirety by reference to the terms of the Merger Agreement, included as Exhibit&#160;2.1 hereto. </font>
          </div>
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">Company Information</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We were incorporated under the laws of the State of Delaware on March&#160;31, 1998, under the name PTC Therapeutics, Inc. Our principal executive offices are located at 100 Corporate Court, South Plainfield, New Jersey 07080. Our telephone number is (908) 222-7000. We maintain a website at </font><font style="font-style:italic;letter-spacing:0.2pt;">www.ptcbio.com</font><font style="letter-spacing:0.2pt;">. The information contained on, or that can be accessed through, our website is not a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. </font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="border:1pt #000 solid;margin-top:3.85pt;min-height:694pt;margin-left:57.66pt;width:480pt;">
        <div style="margin-top:10pt;margin-bottom:508pt; margin-left:12pt;width:456pt;">
          <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
            <font style="letter-spacing:-0.2pt;">The Offering</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Common Stock Offered by the Selling Stockholders </font>
            </div>
          </div>
          <div style="margin-left:204pt; margin-top:-12pt; width:252pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">760,365 shares </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Use of Proceeds </font>
            </div>
          </div>
          <div style="margin-left:204pt; margin-top:-12pt; width:252pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">We will not receive any proceeds from the sale of shares in this offering. See &#8220;Use of Proceeds&#8221; for more information </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Risk Factors </font>
            </div>
          </div>
          <div style="margin-left:204pt; margin-top:-12pt; width:252pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">You should read the &#8220;Risk Factors&#8221; section of this prospectus, as well as those risk factors incorporated by reference in this prospectus, for a discussion of factors to consider carefully before deciding to purchase shares of our common stock. </font>
          </div>
          <div style="width:180pt;">
            <div style="margin-left:10pt; text-indent:-10pt; margin-top:6pt; line-height:12pt;">
              <font style="letter-spacing:0.2pt;">Nasdaq Global Select Market Symbol</font>
            </div>
          </div>
          <div style="margin-left:204pt; margin-top:-12pt; width:252pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#8220;PTCT&#8221;</font>
          </div>
        </div>
        <div style="margin-top:2pt;margin-left:12pt;width:456pt;">
          <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
            <font style="letter-spacing:0.2pt;">&#160;</font>
            <br >
          </div>
        </div>
      </div>
      <div style="margin-top:2.1316282072803E-14pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tRIFA">&#8203;</a><a name="tUOP">&#8203;</a><a name="tSEST">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RISK FACTORS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Investing in our common stock involves significant risks. In deciding whether to invest, and in consultation with your own financial and legal advisors, you should carefully consider the risk factors and the risks described under the caption &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000064/ptct1231201910-k.htm">
            <font style="letter-spacing:0.2pt;">Annual Report on Form 10-K </font><font style="letter-spacing:0.2pt;">for the fiscal year ended December&#160;31, 2019</font></a><font style="letter-spacing:0.2pt;">, and under the caption &#8220;Risk Factors&#8221; in Part&#160;II, Item&#160;1A of our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000096/ptct0331202010-q.htm">
            <font style="letter-spacing:0.2pt;">Quarterly Report on Form 10-Q for the fiscal quarter ended March&#160;31, 2020</font></a><font style="letter-spacing:0.2pt;">, as well as the other information contained in this prospectus and in our filings with the SEC that we have incorporated by reference in this prospectus. Any of these risks could have a material adverse effect on our business, financial condition, results of operations and prospects and cause the value of our stock to decline, which could cause you to lose all or part of your investment. The risks and uncertainties we have described are not the only ones facing us. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business operations. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">USE OF PROCEEDS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We will not receive any proceeds from the sale of shares by the selling stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The selling stockholders will pay any underwriting discounts and commissions and expenses incurred by the selling stockholders for brokerage, accounting, tax, or legal services or any other expenses incurred by the selling stockholders in disposing of the shares. We will bear all other costs, fees and expenses incurred in effecting the registration of the shares covered by this prospectus, including, without limitation, all registration and filing fees, The Nasdaq Global Select Market listing fees, and fees and expenses of our counsel and our accountants. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SELLING STOCKHOLDERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This prospectus relates to the resale of shares of our common stock held by the selling stockholders listed in the table below. The selling stockholders acquired these shares from us in a private offering pursuant to an exemption from registration afforded by Section&#160;4(a)(2) of the Securities Act and/or Regulation&#160;D promulgated thereunder as partial consideration for our acquisition of Censa on May&#160;29, 2020. Under the Merger Agreement, we agreed to file a registration statement on Form S-3 with the SEC for the purposes of registering for resale the shares of our common stock issued to the selling stockholders and to maintain the effectiveness of the registration statement until the six month anniversary date of the closing of the acquisition or such earlier time as all shares of common stock covered by the registration statement have been sold, subject to certain exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth, to our knowledge, certain information about the selling stockholders as of June&#160;19, 2020. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to shares. Unless otherwise indicated below, to our knowledge, all persons named in the table have sole voting and investment power with respect to their shares of common stock, except to the extent authority is shared by spouses under applicable law. The inclusion of any shares in this table does not constitute an admission of beneficial ownership for the person named below. </font>
        </div>
        <table style="width:456pt;height:130pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:27.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:186.55pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Name of Selling Stockholders </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially Owned Prior </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Being </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Offered </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Common Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to be Beneficially Owned </font>
                <br >
                <font style="letter-spacing:-0.16pt;">After Offering</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 0.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;font-size:7.5pt;">
                <font style="font-size:10pt;letter-spacing:0.2pt;">Christopher Schelling</font><font style=" position:relative; bottom:4.25pt;letter-spacing:0.15pt;">&#8224; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">144,743<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(4)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">144,743</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;font-size:7.5pt;">
                <font style="font-size:10pt;letter-spacing:0.2pt;">Joseph Baron</font><font style=" position:relative; bottom:4.25pt;letter-spacing:0.15pt;">&#8224; </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,665<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(5)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">71,665</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;font-size:7.5pt;">
                <font style="font-size:10pt;letter-spacing:0.2pt;">Jonathan Reis</font><font style=" position:relative; bottom:4.25pt;letter-spacing:0.15pt;">&#8224;# </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">68,700<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(6)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">68,700</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jefferson Davis</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;"># </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">42,451<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(7)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">42,451</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Harry Palmin </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,250<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(8)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,250</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Benjamin Dewees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,622<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(9)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">29,622</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:547pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;height:27.25pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:186.55pt;text-align:left;" rowspan="2">
              <div style="white-space:nowrap; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Name of Selling Stockholders </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially Owned Prior </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to Offering </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4" rowspan="2">
              <div style="text-align:center; line-height:9pt; padding-bottom:0pt;">
                <font style="letter-spacing:-0.16pt;">Number of Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Being </font>
                <br >
                <font style="letter-spacing:-0.16pt;">Offered </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;" rowspan="2">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:0pt;" colspan="10">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares of Common Stock </font>
                <br >
                <font style="letter-spacing:-0.16pt;">to be Beneficially Owned </font>
                <br >
                <font style="letter-spacing:-0.16pt;">After Offering</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:8pt;height:13.5pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:7.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage</font><font style=" position:relative; bottom:3.25pt;font-size:6pt;letter-spacing:-0.12pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:3.25pt 0pt 2.5pt 0pt;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Baron Family Investments, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">23,519<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(10)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">23,519</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">InClin, Inc. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">47,870<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(11)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">47,870</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Daniel Levy </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,500<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(12)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,500</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Keith Hyland </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">534<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(13)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">534</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Neil Smith</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">#(3)</font> </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">9,144<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(14)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">9,144</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">The Reis Family Irrevocable Trust&#8201;&#8211;&#8201;2018 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">16,874<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(15)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">16,874</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Michelle Skupien </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,242<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(16)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,242</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Andrew R Schelling Irrevocable Trust </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">17,999<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(17)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">17,999</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Lauren E Schelling Irrevocable Trust </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">17,999<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(18)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">17,999</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Robert Steiner </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,738<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(19)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,738</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stuart Swiedler </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">514<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(20)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">514</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Scott Reynolds </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">317<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(21)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">317</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Stephen J. Aselage </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,727<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(22)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">5,727</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Helge Reisch</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">#(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,072<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(23)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,072</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">MNT Investments (Cyprus) LTD </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,889<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(24)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">25,889</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Jacque K. Davis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,127<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(25)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,127</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Boden Family Investments, LLC </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,300<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(26)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,300</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Daniel Gressel </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">14,474<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(27)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">14,474</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Robert Fischetti </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,915<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(28)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,915</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Reis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,300<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(29)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">6,300</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Timothy D. Miller </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">12,944<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(30)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">12,944</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:186.55pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Millennium Trust Co., LLC </font>
                <br >
                <font style="letter-spacing:0.2pt;">CUSTODIAN FBO </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.5pt 0pt 0.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Robert T. Davis IRA xxxx44969 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,875<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(31)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,875</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Agha Shahid Khan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,499<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(32)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">7,499</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Rizwan Kirmani </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,749<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(33)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,749</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Arkin Bio Ventures LP </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">144,690<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(34)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">144,690</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Arnold Wong </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,825<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(35)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,825</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Darryl Phelps </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,825<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(36)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,825</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Sandra Suoka Chen </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,274<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(37)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,274</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Taylor Kilfoil </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,825<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(39)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">3,825</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Amir Caspari </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,550<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(40)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,550</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Dove </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,550<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(41)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">2,550</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:186.55pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Laurens Cook </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,274<font style="position:absolute;"><font style=" position:relative; bottom:3.75pt;font-size:7.5pt;">(42)</font> </font></td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt; width:7.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.285pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:24.75pt; text-align:right; white-space:nowrap;">1,274</td>
            <td style="padding:0pt;padding-left:18.21pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:14.845pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt; width:3pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:19.675pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.7pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Less than 1%. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">#</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Employee or former employee of us or Censa. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Former member of the board of directors of Censa. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">We do not know when or in what amounts a selling stockholder may offer shares for sale. The selling stockholders might not sell any or all of the shares offered by this prospectus. Because the selling stockholders may offer all or some of the shares pursuant to this offering, and because there are currently no agreements, arrangements or understandings with respect to the sale of any of the shares, we </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">cannot estimate the number of the shares that will be held by the selling stockholders after completion of the offering. However, for purposes of this table, we have assumed that, after completion of the offering, none of the shares covered by this prospectus will be held by the selling stockholders and that the number of shares otherwise held by the selling stockholders and not covered by this prospectus remains the same after completion of the offering. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Based on 65,479,703 shares of our common stock outstanding on May&#160;29, 2020. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Received an inducement grant for non-statutory stock options and restricted stock&#160;units from us pursuant to the Nasdaq inducement grant exception and our 2020 Inducement Stock Incentive Plan on June&#160;10, 2020. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:3.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 144,743 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The selling stockholder is a former member of the board of directors of Censa. The address of the selling stockholder is 3068 NW Duffy Drive, Bend, OR 97703. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 71,665 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The selling stockholder is a former member of the board of directors of Censa. The address of the selling stockholder is 31 Shirley Rd, Wellesley, MA, 02482. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(6)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 68,700 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The selling stockholder is a former member of the board of directors of Censa and prior to the acquisition served as the President and Chief Executive Officer of Censa. The address of the selling stockholder is 146 Winthrop Road, Brookline, MA, 02445. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(7)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 42,451 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. Prior to the acquisition the selling stockholder served as Vice President, Corporate Development of Censa. The address of the selling stockholder is 513 Strawberry Hill Road, Concord, MA, 01742. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(8)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 2,250 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 51 Helene Road, Waban, MA, 02468. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(9)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 29,622 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 1225 Pickett St., Sonoma, CA, 95476. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(10)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 23,519 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 31 Shirley Rd, Wellesley, MA, 02482. Voting and investment control over the shares is held by Joseph Baron, as the managing member of the selling stockholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(11)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 47,870 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 2655 Campus Drive, San Mateo, CA, 94403. Arnold Wong is the Chief Financial Officer of the selling stockholder. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(12)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 2,500 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 490 Summerfield Way, San Mateo, CA, 94402. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(13)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 534 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 37 Lakewood Circle, Venice, FL, 34292. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(14)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 9,144 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. Prior to the acquisition the selling stockholder served as Vice President, Research and Development and Head of Operations of Censa and currently serves as our Vice President, Product Owner. The address of the selling stockholder is 6709 Millory Springs Ln, Cary, NC, 27519. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(15)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 16,874 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is Fidelity Personal Trust Company, FSB, 2 Contra Way, Merrimack, NH, 03054. Voting and investment control over the shares is held by Fidelity Personal Trust Company, FSB, trustee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(16)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 3,242 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 71 Marlborough Street #2, Boston, MA, 02116. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(17)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 17,999 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 3068 NW Duffy Drive, Bend, OR, 97703. Voting and investment control over the shares is held by Aaron Schelling, trustee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(18)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 17,999 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 3068 NW Duffy Drive, Bend, OR, 97703. Voting and investment control over the shares is held by Aaron Schelling, trustee. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(19)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 2,738 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 205500 Fox Fire Lane, Marshfield, WI, 54449. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(20)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 514 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 6012 Auburn Ave, Oakland, CA, 94618. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(21)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 317 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 21 Mount Airy Road, Pipersville, PA, 18947. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(22)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 5,727 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is PO Box 3141, RSF, CA, 92067. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(23)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 2,072 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. Prior to the acquisition the selling stockholder served as Vice President of CMC of Censa and currently serves as our Vice President, Technical Operations. The address of the selling stockholder is 36 Wells St., Westerly, RI, 02891. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(24)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 25,889 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is Agias Fylaxeos 95, 3087, Limassol, Cyprus </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(25)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 3,127 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 2100 Bradford Mill CT, Apex,</font>
          <br >
          <font style="letter-spacing:0.2pt;">NC, 27539. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(26)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 6,300 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 2842 Cravey Drive, Atlanta,</font>
          <br >
          <font style="letter-spacing:0.2pt;">GA, 30345. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(27)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 14,474 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 88 Cedar Cliff Road, Riverside,</font>
          <br >
          <font style="letter-spacing:0.2pt;">CT, 06878. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(28)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 3,915 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 7 Lockwood Drive, Old Greenwich, CT, 06870. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(29)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 6,300 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 15 Yitzchak Elhanan Street, Apt. 261, Tel-Aviv 6525015, Israel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(30)</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 12,944 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 10730 Graeloch Rd., Laurel, MD, 20723. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(31)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 1,875 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 2001 Spring Road, Suite 700, Oak Brook, IL, 60523. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(32)</font>
          <br >
        </div>
        <div style=" margin-top:3.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 7,499 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 2411 W. Belvedere Ave, S-402, Balto, MD, 21215. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(33)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 3,749 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 3623 Chesapeake St., NW, Washington, DC, 20008. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(34)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 144,690 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is Hachoshlim, 6 Herzliya, Israel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(35)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 3,825 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 13163 Diericx Drive, Moutnain View, CA, 94040. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(36)</font>
          <br >
        </div>
        <div style=" margin-top:3.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 3,825 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 8 Shackwell Ct, Danville, CA, 94506. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(37)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 1,274 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 1549 Tobias Drive, San Jose, CA, 95118. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(38)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 3,825 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 21 Ryries Parade, Cremorne, NSW 2090, Australia. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(39)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 2,550 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 31 Ahad Haam Street, Tel Aviv 6520204, Israel. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(40)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 2,550 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 7241 E. Ventana Canyon Drive, Tuscon, AZ, 85750. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:3.9pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(41)</font>
          <br >
        </div>
        <div style=" margin-top:3.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Consists of 1,274 shares of common stock issued to the selling stockholder pursuant to the Merger Agreement and registered hereby. The address of the selling stockholder is 70 Chestnut St, Boston, MA, 02108. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Relationships with Selling Stockholders</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">None of the selling stockholders has had a material relationship with us or any of our subsidiaries within the past three&#160;years except as set forth below or in the table above or the notes thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">None of the selling stockholders has held any position or office with us or any of our subsidiaries within the past three&#160;years, except that the selling stockholders indicated below or in the table above or the notes thereto have been employed by us and/or Censa. In connection with our acquisition of Censa, Helge Reisch, formerly Vice President of CMC of Censa, and Neil Smith, formerly Vice President R&amp;D and Head of Operations of Censa, entered into employment arrangements with the Company. Under their respective employment agreement, Mr.&#160;Smith will serve as Global Project Leader and Mr.&#160;Reisch will serve as Vice President, Technical Operations. Each of Mr.&#160;Smith and Mr.&#160;Reisch will receive an annual base salary and will be eligible to receive an annual discretionary bonus and an annual equity grant commensurate with and on the same terms as other comparable employees. Pursuant to their respective employment agreement, each of Mr.&#160;Smith and Mr.&#160;Reisch also received inducement grants of options to purchase 24,700 shares of our common stock and 1,740 restricted stock&#160;units. The employment agreements with Mr.&#160;Smith and Mr.&#160;Reisch also include certain other customary terms. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition to the shares of common stock being registered hereby, each of the selling stockholders received its pro&#160;rata portion of the cash consideration in connection with the closing of the acquisition. Under the Merger Agreement, each selling stockholder will also be entitled to receive its pro&#160;rata portion of contingent payments from the Company based on (i)&#160;the achievement of certain development and regulatory milestones up to an aggregate maximum amount of $217.5&#160;million for PTC923&#8217;s two most advanced programs and receipt of a priority review voucher from the U.S. Food and Drug Administration as set forth in the Merger Agreement, (ii)&#160;$109&#160;million in development and regulatory milestones for each additional indication of PTC923, (iii)&#160;the achievement of certain net sales milestones up to an aggregate </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:104pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">maximum amount of $160.0&#160;million, (iv)&#160;a&#160;percentage of annual net sales during specified terms, ranging from single to low double digits of the applicable net sales threshold amount, and (v)&#160;any sublicense fees paid to the Company in consideration of any sublicense of Censa&#8217;s intellectual property to commercialize PTC923, on a country-by-country basis, which contingent payment shall equal to a mid-double digit&#160;percentage of any such sublicense fees. Pursuant to the Merger Agreement, the Company has the option to pay the initial $30&#160;million development milestone, for the completion of enrollment of a Phase&#160;3 clinical trial for the PTC923 for phenylketonuria, if achieved, in cash or shares of the Company&#8217;s common stock, or the Initial Milestone. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">To the extent that we choose to pay the Initial Milestone with shares of our common stock, we will issue such shares to the selling stockholders in a private offering pursuant to an exemption from registration afforded by Section&#160;4(a)(2) of the Securities Act and/or Regulation&#160;D promulgated thereunder, and have agreed to file another registration statement on Form S-3 with the SEC for the purposes of registering for resale of such shares within 30&#160;days of the date of the milestone notice for the Initial Milestone and to maintain the effectiveness of such registration statement until the six month anniversary date of the date of the milestone notice for the Initial Milestone or such earlier time as all shares of common stock covered by such registration statement have been sold, subject to certain exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the Merger Agreement, we will indemnify each selling stockholder against any damages to which a selling stockholder may become subject by reason of any material misstatement or omission in this registration statement, except to the extent that such damages arise out of or are based upon information furnished to us by or on behalf of Censa or a Censa Securityholder for use in this registration statement. Each selling stockholder will indemnify us and certain related persons against any damages to which such indemnified parties may become subject by reason of any material misstatement or omission in this registration statement or any violation or alleged violation of the Securities Act, the Exchange Act, or any state securities law, or any rule promulgated under any of the foregoing, in each case to the extent based upon any action or omission made in reliance upon information provided by such selling stockholder for use in this registration statement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each selling stockholder also entered into a Joinder Agreement, under which such selling stockholder has agreed that, without our prior written consent and during the period (i)&#160;commencing at the merger effective time and ending on August&#160;27, 2020 for the shares of our common stock received at merger closing, and (ii)&#160;within 60&#160;days after the issuance of Initial Milestone shares to the extent we choose to pay the Initial Milestone using shares of our common stock, such selling stockholder will not, directly or indirectly, transfer any such shares of our common stock or enter into any contract, option or other arrangement or understanding with respect to any transfer (whether by actual disposition or effective economic disposition due to hedging, cash settlement or otherwise) of such shares of our common stock, except certain permitted transfers subject to certain conditions, and provided that the lock-up provisions described above will lapse (i)&#160;(A)&#160;with respect to one-third of the shares of our common stock received at merger closing, on June&#160;28, 2020 and (B)&#160;with respect to an additional one-third of the shares of our common stock received at merger closing, on July&#160;28, 2020, and (ii)&#160;with respect to fifty&#160;percent of the shares of our common stock received as Initial Milestone payment, if any, on the date that is 30&#160;days after the date such shares are issued. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The foregoing description of the Merger Agreement is a summary only and is qualified in its entirety by reference to the terms of the Merger Agreement, included as Exhibit&#160;2.1 hereto. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDOCS">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DESCRIPTION OF CAPITAL STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following description of our capital stock is intended as a summary only. This description is based upon, and is qualified by reference to, our restated certificate of incorporation, our amended and restated bylaws and applicable provisions of Delaware corporate law. This summary is not complete. You should read our restated certificate of incorporation and amended and restated bylaws, which are filed as exhibits to the registration statement of which this prospectus forms a part, for the provisions that are important to you. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our authorized capital stock consists of 125,000,000 shares of common stock and 5,000,000 shares of preferred stock. As of May&#160;29, 2020, there were 65,479,703 shares of common stock outstanding and no shares of preferred stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Common Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Voting Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. Each election of directors by our stockholders will be determined by a plurality of the votes cast by the stockholders entitled to vote on the election. In general, except (1)&#160;for the election of directors, (2)&#160;as described below under &#8220;&#8212;&#160;Provisions of Our Certificate of Incorporation and Bylaws and Delaware Law That May Have Anti-Takeover Effects&#8201;&#8212;&#8201;Super-Majority Voting,&#8221; (3)&#160;in the future to the extent that we have two or more classes or series of stock outstanding with separate voting rights and (4)&#160;as otherwise required by law, any matter to be voted on by our stockholders at any meeting is decided by the vote of the holders of a majority in voting power of the votes cast by the holders of shares of our stock present or represented at the meeting and voting affirmatively or negatively on such matter. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Dividends.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Holders of common stock are entitled to receive proportionately any dividends as may be declared by our board of directors, subject to any preferential dividend rights of outstanding preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Liquidation and Dissolution.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;In the event of our liquidation or dissolution, the holders of our common stock are entitled to receive proportionately all assets available for distribution to stockholders after the payment of all debts and other liabilities and subject to the prior rights of any of our outstanding preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Rights.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Holders of our common stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of our common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of our preferred stock that we may designate and issue in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Transfer Agent and Registrar.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;American Stock Transfer &amp; Trust Company, LLC is the transfer agent and registrar for our common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Nasdaq Global Select Market.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our common stock is listed on The Nasdaq Global Select Market under the symbol &#8220;PTCT.&#8221; </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Preferred Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the terms of our certificate of incorporation, our board of directors is authorized to issue shares of preferred stock in one or more series without stockholder approval, subject to any limitations imposed by the Nasdaq Marketplace Rules. Our board of directors has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions, future financings and other corporate purposes, could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from seeking to acquire, a majority of our outstanding voting stock. Currently, we have no shares of preferred stock outstanding. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stock Options and Warrants</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of March&#160;31, 2020, we had (i)&#160;issued and outstanding options to purchase 12,670,068 shares of our common stock at a weighted average exercise price of $34.95 per share and (ii)&#160;927,151 shares of our common stock issuable upon the vesting of outstanding restricted stock awards and restricted stock&#160;units. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Convertible Notes</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In August&#160;2015, we issued, at par value, $150.0&#160;million aggregate principal amount of 3.0% convertible senior notes due 2022, or the 2022 Convertible Notes. The 2022 Convertible Notes bear cash interest at a rate of 3.0% per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, beginning on February&#160;15, 2016. The 2022 Convertible Notes will mature on August&#160;15, 2022, unless earlier repurchased or converted. The conversion rate for the 2022 Convertible Notes was initially, and remains, 17.7487 shares of our common stock per $1,000 principal amount of the 2022 Convertible Notes, which is equivalent to an initial conversion price of approximately $56.34 per share of our common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In September&#160;2019, we issued, at par value, $287.5&#160;million aggregate principal amount of 1.5% convertible senior notes due 2026, or the 2026 Convertible Notes. The 2026 Convertible Notes bear cash interest at a rate of 1.50% per year, payable semi-annually on March&#160;15 and September&#160;15 of each year, beginning on March&#160;15, 2020. The 2026 Convertible Notes will mature on September&#160;15, 2026, unless earlier repurchased or converted. The conversion rate for the 2026 Convertible Notes was initially, and remains, 19.0404 shares of our common stock per $1,000 principal amount of the 2026 Convertible Notes, which is equivalent to an initial conversion price of approximately $52.52 per share of our common stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Effects of Authorized but Unissued Stock</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have shares of common stock and preferred stock available for future issuance without stockholder approval, subject to any limitations imposed by the listing standards of the Nasdaq Global Select Market. We may utilize these additional shares for a variety of corporate purposes, including for future public offerings to raise additional capital or facilitate corporate acquisitions or for payment as a dividend on our capital stock. The existence of unissued and unreserved common stock and preferred stock may enable our board of directors to issue shares to persons friendly to current management or to issue preferred stock with terms that could have the effect of making it more difficult for a third party to acquire, or could discourage a third party from seeking to acquire, a controlling interest in our company by means of a merger, tender offer, proxy contest or otherwise. In addition, if we issue preferred stock, the issuance could adversely affect the voting power of holders of common stock and the likelihood that such holders will receive dividend payments and payments upon liquidation. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Provisions of Our Certificate of Incorporation and Bylaws and Delaware Law That May Have Anti-Takeover Effects</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Delaware Law.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;We are subject to Section&#160;203 of the Delaware General Corporation Law. Subject to certain exceptions, Section&#160;203 prevents a publicly held Delaware corporation from engaging in a &#8220;business combination&#8221; with any &#8220;interested stockholder&#8221; for three&#160;years following the date that the person became an interested stockholder, unless either the interested stockholder attained such status with the approval of our board of directors, the business combination is approved by our board of directors and stockholders in a prescribed manner or the interested stockholder acquired at least 85% of our outstanding voting stock in the transaction in which it became an interested stockholder. A &#8220;business combination&#8221; includes, among other things, a merger or consolidation involving us and the &#8220;interested stockholder&#8221; and the sale of more than 10% of our assets. In general, an &#8220;interested stockholder&#8221; is any entity or person beneficially owning 15% or more of our outstanding voting stock and any entity or person affiliated with or controlling or controlled by such entity or person. The restrictions contained in Section&#160;203 are not applicable to any of our existing stockholders that owned 15% or more of our outstanding voting stock upon the closing of our initial public offering. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Staggered Board; Removal of Directors.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our certificate of incorporation and our bylaws divide our board of directors into three classes with staggered three-year terms. In addition, our certificate of incorporation and our bylaws provide that directors may be removed only for cause and only by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">affirmative vote of the holders of 75% of our shares of capital stock present in person or by proxy and entitled to vote. Under our certificate of incorporation and bylaws, any vacancy on our board of directors, including a vacancy resulting from an enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office. Furthermore, our certificate of incorporation provides that the authorized number of directors may be changed only by the resolution of our board of directors. The classification of our board of directors and the limitations on the ability of our stockholders to remove directors, change the authorized number of directors and fill vacancies could make it more difficult for a third party to acquire, or discourage a third party from seeking to acquire, control of our company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stockholder Action; Special Meeting of Stockholders; Advance Notice Requirements for Stockholder Proposals and Director Nominations.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;Our certificate of incorporation and our bylaws provide that any action required or permitted to be taken by our stockholders at an annual meeting or special meeting of stockholders may only be taken if it is properly brought before such meeting and may not be taken by written action in lieu of a meeting. Our certificate of incorporation and our bylaws also provide that, except as otherwise required by law, special meetings of the stockholders can only be called by our chairman of the board, our president or chief executive officer or our board of directors. In addition, our bylaws establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of stockholders, including proposed nominations of candidates for election to our board of directors. Stockholders at an annual meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of our board of directors, or by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered timely written notice in proper form to our secretary of the stockholder&#8217;s intention to bring such business before the meeting. These provisions could have the effect of delaying until the next stockholder meeting stockholder actions that are favored by the holders of a majority of our outstanding voting securities. These provisions also could discourage a third party from making a tender offer for our common stock, because even if it acquired a majority of our outstanding voting stock, it would be able to take action as a stockholder, such as electing new directors or approving a merger, only at a duly called stockholders meeting and not by written consent. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Super-Majority Voting.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;The Delaware General Corporation Law provides generally that the affirmative vote of a majority of the shares entitled to vote on any matter is required to amend a corporation&#8217;s certificate of incorporation or bylaws, unless a corporation&#8217;s certificate of incorporation or bylaws, as the case may be, requires a greater&#160;percentage. Our bylaws may be amended or repealed by a majority vote of our board of directors or the affirmative vote of the holders of at least 75% of the votes that all our stockholders would be entitled to cast in any annual election of directors. In addition, the affirmative vote of the holders of at least 75% of the votes that all our stockholders would be entitled to cast in any election of directors is required to amend or repeal or to adopt any provisions inconsistent with any of the provisions of our certificate of incorporation described above. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Directors&#8217; Liability</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our certificate of incorporation limits the personal liability of directors for breach of fiduciary duty to the maximum extent permitted by the Delaware General Corporation Law and provides that no director will have personal liability to us or to our stockholders for monetary damages for breach of fiduciary duty or other duty as a director. However, these provisions do not eliminate or limit the liability of any of our directors: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for any breach of the director&#8217;s duty of loyalty to us or our stockholders; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for voting or assenting to unlawful payments of dividends, stock repurchases or other distributions; or </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">for any transaction from which the director derived an improper personal benefit. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any amendment to or repeal of these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to such amendment or repeal. If the Delaware General Corporation Law is amended to provide for further limitations on the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:436pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">personal liability of directors of corporations, then the personal liability of our directors will be further limited to the greatest extent permitted by the Delaware General Corporation Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, our certificate of incorporation provides that we must indemnify our directors and officers and we must advance expenses, including attorneys&#8217; fees, to our directors and officers in connection with legal proceedings, subject to very limited exceptions. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We maintain a general liability insurance policy that covers certain liabilities of our directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers. In addition, we have entered into indemnification agreements with our directors. These indemnification agreements may require us, among other things, to indemnify each such director for some expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by him in any action or proceeding arising out of his service as one of our directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Certain of our non-employee directors may, through their relationships with their employers, be insured and/or indemnified against certain liabilities incurred in their capacity as members of our board of directors. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PLAN OF DISTRIBUTION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The shares covered by this prospectus may be offered and sold from time to time by the selling stockholders. The term &#8220;selling stockholders&#8221; includes donees, pledgees, assignees, transferees or other successors-in-interest selling shares received after the date of this prospectus from a selling stockholder as a gift, pledge, partnership distribution or other non-sale related transfer. The selling stockholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges in any market or trading facility on which the shares are traded, or in the over-the-counter market or otherwise, at fixed prices, at prices and under terms then prevailing or at prices related to the then current market price or in negotiated transactions. The selling stockholders may sell their shares by one or more of, or a combination of, the following methods: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">purchases by a broker-dealer as principal and resale by such broker-dealer for its own account pursuant to this prospectus; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">ordinary brokerage transactions and transactions in which the broker solicits purchasers; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">block trades in which the broker-dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">an over-the-counter distribution in accordance with the rules of The Nasdaq Global Select Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">through one or more underwritten offerings on a firm commitment or best efforts basis; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in privately negotiated transactions; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">in options transactions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In addition, any shares that qualify for sale pursuant to Rule&#160;144 may be sold under Rule&#160;144 rather than pursuant to this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent required, this prospectus may be amended or supplemented from time to time to describe a specific plan of distribution. In connection with distributions of the shares or otherwise, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions. In connection with such transactions, broker-dealers or other financial institutions may engage in short sales of the common stock in the course of hedging the positions they assume with selling stockholders. The selling stockholders may also sell the common stock short and redeliver the shares to close out such short positions. The selling stockholders may also enter into option or other transactions with broker-dealers or other financial institutions which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial institution may resell pursuant to this prospectus. The selling stockholders may also pledge or grant a security interest in shares to a broker-dealer, other financial institution or other person, and, upon a default such pledgee or secured parties may effect sales of the pledged shares pursuant to this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In effecting sales, broker-dealers or agents engaged by the selling stockholders may arrange for other broker-dealers to participate. Broker-dealers or agents may receive commissions, discounts or concessions from the selling stockholders in amounts to be negotiated immediately prior to the sale. Except as set forth in this prospectus under the heading &#8220;Selling Stockholders,&#8221; each selling stockholder has informed us that it is not a registered broker-dealer or an affiliate of a registered broker-dealer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In offering the shares covered by this prospectus, the selling stockholders and any broker-dealers who execute sales for the selling stockholders may be deemed to be &#8220;underwriters&#8221; within the meaning of the Securities Act in connection with such sales. Any profits realized by the selling stockholders and the compensation of any broker-dealer may be deemed to be underwriting discounts and commissions. Any selling stockholder who is an &#8220;underwriter&#8221; within the meaning of the Securities Act will be subject to the prospectus delivery requirements of the Securities Act and the provisions of the Exchange Act and the rules thereunder relating to stock manipulation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to comply with the securities laws of certain states, if applicable, the shares must be sold in such jurisdictions only through registered or licensed brokers or dealers. In addition, in certain states the shares may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:400pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have advised the selling stockholders that the anti-manipulation rules of Regulation&#160;M under the Exchange Act may apply to sales of shares in the market and to the activities of the selling stockholders and their affiliates. In addition, we will make copies of this prospectus available to the selling stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">At the time a particular offer of shares is made, if required, a prospectus supplement will be distributed that will set forth the number of shares being offered and the terms of the offering, including the name of any underwriter, dealer or agent, the purchase price paid by any underwriter, any discount, commission and other item constituting compensation, any discount, commission or concession allowed or reallowed or paid to any dealer, and the proposed selling price to the public. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have agreed to indemnify the selling stockholders against certain liabilities, including certain liabilities under the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have agreed with the selling stockholders to keep the Registration Statement of which this prospectus constitutes a part effective until the earlier of (i)&#160;such time as all of the shares covered by this prospectus have been disposed of pursuant to and in accordance with the Registration Statement or (ii)&#160;November&#160;29, 2020. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tLEMA">&#8203;</a><a name="tEXP">&#8203;</a><a name="tWYCF">&#8203;</a><a name="tIBR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">LEGAL MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The validity of the shares offered by this prospectus has been passed upon by Morgan, Lewis &amp; Bockius LLP, Philadelphia, Pennsylvania. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXPERTS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Ernst &amp; Young LLP, independent registered public accounting firm, has audited our consolidated financial statements included in our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000064/ptct1231201910-k.htm">
            <font style="letter-spacing:0.2pt;">Annual Report on Form 10-K for the year ended December&#160;31, 2019</font></a><font style="letter-spacing:0.2pt;">, and the effectiveness of our internal control over financial reporting as of December&#160;31, 2019, as set forth in their reports, which are incorporated by reference in this prospectus and elsewhere in the registration statement. Our financial statements are incorporated by reference in reliance on Ernst &amp; Young LLP&#8217;s reports, given on their authority as experts in accounting and auditing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The financial statements of Agilis Biotherapeutics, Inc. as of and for the&#160;years ended December&#160;31, 2017 and 2016, incorporated in this prospectus by reference from our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008118000066/form8-k082418.htm">
            <font style="letter-spacing:0.2pt;">Current Report on Form 8-K filed </font><font style="letter-spacing:0.2pt;">August&#160;24, 2018</font></a><font style="letter-spacing:0.2pt;"> have been audited by BDO USA, LLP, independent auditors, as stated in their report, which is incorporated herein by reference. Such financial statements have been so incorporated in reliance upon the report of such firm given upon their authority as experts in accounting and auditing. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WHERE YOU CAN FIND MORE INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC&#8217;s website at http://www.sec.gov. Copies of certain information filed by us with the SEC are also available on our website at http://www.ptcbio.com. Our website is not a part of this prospectus and is not incorporated by reference in this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">This prospectus is part of a registration statement we filed with the SEC. This prospectus omits some information contained in the registration statement in accordance with SEC rules and regulations. You should review the information and exhibits in the registration statement for further information on us and our consolidated subsidiaries and the securities we are offering. Statements in this prospectus concerning any document we filed as an exhibit to the registration statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings. You should review the complete document to evaluate these statements. You can obtain a copy of the registration statement from the SEC at the address listed above or from the SEC&#8217;s website. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">INCORPORATION BY REFERENCE</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The SEC allows us to incorporate by reference in this prospectus much of the information we file with the SEC, which means that we can disclose important information to you by referring you to those publicly available documents. The information that we incorporate by reference in this prospectus is considered to be part of this prospectus. Because we are incorporating by reference future filings with the SEC, this prospectus is continually updated and those future filings may modify or supersede some of the information included or incorporated in this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or in any document previously incorporated by reference have been modified or superseded. This prospectus incorporates by reference the documents listed below (File No. 001-35969) and any future filings we make with the SEC under Sections&#160;13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act (in each case, other than those documents or the portions of those documents not deemed to be filed) until the offering of the securities under the registration statement is terminated or completed: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000064/ptct1231201910-k.htm">
            <font style="letter-spacing:0.2pt;">Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2019</font></a><font style="letter-spacing:0.2pt;">, including the information specifically incorporated by reference into the Annual Report on Form 10-K from our </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008120000086/ptct2020proxy.htm">
            <font style="letter-spacing:0.2pt;">definitive </font><font style="letter-spacing:0.2pt;">proxy statement for the 2020 Annual Meeting of Stockholders, filed on April&#160;27, 2020</font></a><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000096/ptct0331202010-q.htm">
            <font style="letter-spacing:0.2pt;">Quarterly Report on Form 10-Q for the fiscal quarter ended March&#160;31, 2020</font></a><font style="letter-spacing:0.2pt;">; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.8pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <font style="letter-spacing:0.2pt;">Current Reports on Form 8-K filed on </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008118000066/form8-k082418.htm">
            <font style="letter-spacing:0.2pt;">August&#160;24, 2018</font></a><font style="letter-spacing:0.2pt;">, </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000110465920005099/tm203487d1_8k.htm">
            <font style="letter-spacing:0.2pt;">January&#160;17, 2020</font></a><font style="letter-spacing:0.2pt;"> (solely with respect to Item&#160;9.01 and Exhibits&#160;99.3 and 99.4), </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000066/a8k31620.htm">
            <font style="letter-spacing:0.2pt;">March&#160;16, 2020</font></a><font style="letter-spacing:0.2pt;"> (excluding Item&#160;7.01 and Exhibit&#160;99.1), </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:406pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:30pt; width:426pt; line-height:12pt;">
          <a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000095/a8k43020pluto.htm">
            <font style="letter-spacing:0.2pt;">April&#160;30, 2020</font></a><font style="letter-spacing:0.2pt;"> (Film #20835722), </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000110465920057485/tm2018807d1_8k.htm">
            <font style="letter-spacing:0.2pt;">May&#160;6, 2020</font></a><font style="letter-spacing:0.2pt;"> (excluding Item&#160;7.01 and Exhibit&#160;99.1), </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000106/a8k6120.htm">
            <font style="letter-spacing:0.2pt;">June&#160;4, 2020</font></a><font style="letter-spacing:0.2pt;"> and </font><a style="-sec-extract:exhibit" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/1070081/000107008120000108/a8k61020.htm">
            <font style="letter-spacing:0.2pt;">June&#160;10, 2020</font></a><font style="letter-spacing:0.2pt;">; and </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000110465913049330/a13-6876_78a12b.htm">
            <font style="letter-spacing:0.2pt;">The description of the securities contained in our registration statement on Form 8-A filed under the </font><font style="letter-spacing:0.2pt;">Exchange Act on June&#160;14, 2013, including any amendment or report filed for the purpose of </font><font style="letter-spacing:0.2pt;">updating such description.</font></a><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A statement contained in a document incorporated by reference into this prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus, any prospectus supplement or in any other subsequently filed document which is also incorporated in this prospectus modifies or replaces such statement. Any statements so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may request a copy of these filings, at no cost, by writing or telephoning us at the following address or phone number: </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PTC Therapeutics, Inc.</font>
          <br >
          <font style="letter-spacing:0.2pt;">100 Corporate Court</font>
          <br >
          <font style="letter-spacing:0.2pt;">South Plainfield, New Jersey 07080</font>
          <br >
          <font style="letter-spacing:0.2pt;">(908) 222-7000</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PART II.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">INFORMATION NOT REQUIRED IN PROSPECTUS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:12.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;14.</font>
          <br >
        </div>
        <div style=" margin-top:12.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Other Expenses of Issuance and Distribution.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The following table sets forth the various expenses to be incurred in connection with the sale and distribution of the securities being registered hereby, all of which will be borne by the Registrant (except any underwriting discounts and commissions and expenses incurred by the selling stockholders for brokerage, accounting, tax or legal services or any other expenses incurred by the selling stockholders in disposing of the shares). All amounts shown are estimates except the SEC registration fee. </font>
        </div>
        <table style="width:456pt;height:70.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">SEC registration fee </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:0pt 0pt 1pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">4,781.80 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Legal fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">18,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Accounting fees and expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">46,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #FFFFFF;padding:3.5pt 0pt 2.5pt 0pt; width:398.59pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Miscellaneous expenses </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.5pt 0pt 2.5pt 0pt;border-bottom:1px solid #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">6,000 </td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;border-bottom:1px solid #FFFFFF;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 3.25pt 0pt; width:398.59pt;text-align:left;">
              <div style="margin-left:10pt;">
                <font style="letter-spacing:0.2pt;">Total expenses </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3px double #000000; min-width:3.75pt; text-align:right; ">$</td>
            <td style="padding:3.25pt 0pt 2.5pt 0pt;border-bottom:3px double #000000; min-width:30.75pt; text-align:right; white-space:nowrap;">74,781.80</td>
            <td style="padding:0pt;padding-left:0pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:17.2pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;15.</font>
          <br >
        </div>
        <div style=" margin-top:17.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Indemnification of Directors and Officers.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;102 of the Delaware General Corporation Law permits a corporation to eliminate the personal liability of its directors or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his or her duty of loyalty, failed to act in good faith, engaged in intentional misconduct or knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. The Registrant&#8217;s certificate of incorporation provides that no director shall be personally liable to it or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability, except to the extent that the Delaware General Corporation Law prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;145 of the Delaware General Corporation Law provides that a corporation has the power to indemnify a director, officer, employee or agent of the corporation and certain other persons serving at the request of the corporation in related capacities against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlements actually and reasonably incurred by the person in connection with an action, suit or proceeding to which he or she is or is threatened to be made a party by reason of such position, if such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, and, in any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, such person is fairly and reasonably entitled to indemnify for such expenses which the Court of Chancery or such other court shall deem proper. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Registrant&#8217;s certificate of incorporation provides that it will indemnify each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding whether civil, criminal, administrative or investigative (other than an action by or in the right of us) by reason of the fact that he or she is or was, or has agreed to become, the Registrant&#8217;s director or officer, or is or was serving, or has agreed to serve, at the Registrant&#8217;s request as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (all such persons being referred to as an &#8220;Indemnitee&#8221;), or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding and any appeal therefrom, if such Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the Registrant&#8217;s best interests, and, with respect to any criminal action or proceeding, he or she had no reasonable cause to believe his or her conduct was unlawful. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Registrant&#8217;s certificate of incorporation also provides that the Registrant will indemnify any Indemnitee who was or is a party to an action or suit by or in the right of the Registrant to procure a judgment in its favor by reason of the fact that the Indemnitee is or was, or has agreed to become, the Registrant&#8217;s director or officer, or is or was serving, or has agreed to serve, at the Registrant&#8217;s request as a director, officer, partner, employee or trustee or, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise, or by reason of any action alleged to have been taken or omitted in such capacity, against all expenses (including attorneys&#8217; fees) and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred in connection with such action, suit or proceeding, and any appeal therefrom, if the Indemnitee acted in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the Registrant&#8217;s best interests, except that no indemnification shall be made with respect to any claim, issue or matter as to which such person shall have been adjudged to be liable to the Registrant, unless a court determines that, despite such adjudication but in view of all of the circumstances, he or she is entitled to indemnification of such expenses. Notwithstanding the foregoing, to the extent that any Indemnitee has been successful, on the merits or otherwise, he or she will be indemnified by the Registrant against all expenses (including attorneys&#8217; fees) actually and reasonably incurred by him or her or on his or her behalf in connection therewith. If the Registrant does not assume the defense, expenses must be advanced to an Indemnitee under certain circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Registrant has entered into indemnification agreements with its directors and executive officers. In general, these agreements provide that the Registrant will indemnify the director or executive officer to the fullest extent permitted by law for claims arising in his or her capacity as a director or officer of the Registrant or in connection with their service at the Registrant&#8217;s request for another corporation or entity. The indemnification agreements also provide for procedures that will apply in the event that a director or executive officer makes a claim for indemnification and establish certain presumptions that are favorable to the director or executive officer. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Registrant maintains a general liability insurance policy which covers certain liabilities of its directors and officers arising out of claims based on acts or omissions in their capacities as directors or officers. </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:11.51pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;16.</font>
          <br >
        </div>
        <div style=" margin-top:11.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exhibits.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <table style="width:456pt;height:221.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:36pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">EXHIBIT </font>
                <br >
                <font style="letter-spacing:-0.16pt;">NUMBER </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:408pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">DESCRIPTION </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000110465920057485/tm2018807d1_ex2-1.htm">&#8203;</a>
            </td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:36pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000110465920057485/tm2018807d1_ex2-1.htm">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">2.1</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">&#8224;</font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000110465920057485/tm2018807d1_ex2-1.htm">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000110465920057485/tm2018807d1_ex2-1.htm">&#8203;</a>
            </td>
            <td style="padding:1.917pt 0pt 0.833pt 0pt; width:408pt;white-space:normal;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000110465920057485/tm2018807d1_ex2-1.htm">
                <font style="letter-spacing:0.2pt;">Agreement and Plan of Merger, dated May&#160;5, 2020, by and among PTC Therapeutics, Inc., Hydro Merger Sub, Inc., Censa Pharmaceuticals Inc. and, solely in its capacity as securityholder representative, Shareholder Representative Services LLC (incorporated by reference to Exhibit&#160;2.1 to the Current Report on Form 8-K filed by the Registrant on May&#160;6, 2020) </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000110465920057485/tm2018807d1_ex2-1.htm">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000104746913006241/a2215112zex-3_3.htm">&#8203;</a>
            </td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000104746913006241/a2215112zex-3_3.htm">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.1 </font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000104746913006241/a2215112zex-3_3.htm">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000104746913006241/a2215112zex-3_3.htm">&#8203;</a>
            </td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:408pt;white-space:normal;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000104746913006241/a2215112zex-3_3.htm">
                <font style="letter-spacing:0.2pt;">Restated Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit&#160;3.3 to the Registration Statement on Form S-1, as amended (File No. 333-188657), of the Registrant) </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000104746913006241/a2215112zex-3_3.htm">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008117000074/bylawsexhibit31of421178-k.htm">&#8203;</a>
            </td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008117000074/bylawsexhibit31of421178-k.htm">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">4.2 </font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008117000074/bylawsexhibit31of421178-k.htm">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008117000074/bylawsexhibit31of421178-k.htm">&#8203;</a>
            </td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:408pt;white-space:normal;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008117000074/bylawsexhibit31of421178-k.htm">
                <font style="letter-spacing:0.2pt;">Amended and Restated Bylaws of the Registrant (incorporated by reference to Exhibit&#160;3.1 to the Current Report on Form 8-K filed by the Registrant on April&#160;21, 2017) </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="http://www.sec.gov/Archives/edgar/data/1070081/000107008117000074/bylawsexhibit31of421178-k.htm">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">
                <font style="margin-left:5pt;letter-spacing:0.2pt;">5.1* </font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">
                <font style="letter-spacing:0.2pt;">Opinion of Morgan, Lewis &amp; Bockius LLP </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x1.htm">&#8203;</a>
            </td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:36pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x1.htm">
                <font style="letter-spacing:0.2pt;">23.1* </font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x1.htm">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x1.htm">&#8203;</a>
            </td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:408pt;white-space:normal;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x1.htm">
                <font style="letter-spacing:0.2pt;">Consent of Ernst &amp; Young LLP, independent registered public accounting firm for the Registrant </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x1.htm">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x2.htm">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x2.htm">
                <font style="letter-spacing:0.2pt;">23.2* </font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x2.htm">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x2.htm">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x2.htm">
                <font style="letter-spacing:0.2pt;">Consent of BDO USA, LLP </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex23x2.htm">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">
                <font style="letter-spacing:0.2pt;">23.3* </font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">
                <font style="letter-spacing:0.2pt;">Consent of Morgan, Lewis &amp; Bockius LLP (included in Exhibit&#160;5.1 filed herewith) </font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a style="-sec-extract:exhibit" href="tm2022875-1_ex5x1.htm">&#8203;</a>
            </td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">
              <a href="#tPOA">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:36pt;">
              <a href="#tPOA">
                <font style="letter-spacing:0.2pt;">24.1* </font></a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tPOA">&#8203;</a>
            </td>
            <td style="padding:0pt; width:6pt;">
              <a href="#tPOA">&#8203;</a>
            </td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408pt;">
              <a href="#tPOA">
                <font style="letter-spacing:0.2pt;">Power of Attorney (included on the signature page of this registration statement)</font></a>
            </td>
            <td style="padding:0pt; width:0pt;">
              <a href="#tPOA">&#8203;</a>
            </td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:6.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8224;</font>
          <br >
        </div>
        <div style=" margin-top:6.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Portions of this exhibit have been omitted pursuant to Item&#160;601(b)(10)(iv) of Regulation&#160;S-K. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:2.61pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:2.61pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style="letter-spacing:0.2pt;">Filed herewith. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8.12pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Item&#160;17.</font>
          <br >
        </div>
        <div style=" margin-top:8.12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:48pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Undertakings.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned Registrant hereby undertakes: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">to include any prospectus required by Section&#160;10(a)(3) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;); </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">to reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Securities and Exchange Commission pursuant to Rule&#160;424(b) if, in the aggregate, the changes in volume and price represent no more than a 20&#160;percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(iii)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">to include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">provided</font><font style="letter-spacing:0.2pt;">, </font><font style="font-style:italic;letter-spacing:0.2pt;">however</font><font style="letter-spacing:0.2pt;">, that paragraphs (1)(i), (1)(ii) and (1)(iii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the Registrant pursuant to Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), that are incorporated by reference in this registration statement, or is contained in a form of prospectus filed pursuant to Rule&#160;424(b) that is part of this registration statement. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for the purpose of determining liability under the Securities Act to any purchaser: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.1pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(i)</font>
          <br >
        </div>
        <div style=" margin-top:8.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">each prospectus filed by the Registrant pursuant to Rule&#160;424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:40pt; line-height:12pt; margin-top:8.2pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(ii)</font>
          <br >
        </div>
        <div style=" margin-top:8.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:60pt;">
          <font style="letter-spacing:0.2pt;">each prospectus required to be filed pursuant to Rule&#160;424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule&#160;430B relating to an offering made pursuant to Rule&#160;415(a)(1)(i), (vii)&#160;or (x)&#160;for the purpose of providing the information required by Section&#160;10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule&#160;430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font><font style="font-style:italic;letter-spacing:0.2pt;">Provided, however</font><font style="letter-spacing:0.2pt;"> , that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference in the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:328pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date. </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <font style="letter-spacing:0.2pt;">That, for purposes of determining any liability under the Securities Act, each filing of the Registrant&#8217;s annual report pursuant to Section&#160;13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section&#160;15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial </font><font style="font-style:italic;letter-spacing:0.2pt;">bona fide</font><font style="letter-spacing:0.2pt;"> offering thereof. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">EXHIBIT INDEX</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A list of exhibits filed herewith is contained in &#8220;Item&#160;16. Exhibits&#8221; and is incorporated herein by reference.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">II-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPOA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Borough of South Plainfield, State of New Jersey, on this 19th day of June, 2020. </font>
        </div>
        <table style="width:456pt;height:66pt;margin-top:14pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:224pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:0pt;" colspan="4">
              <font style="letter-spacing:-0.2pt;">PTC THERAPEUTICS, INC. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:224pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:16.5pt 0pt 0.5pt 0pt; width:18pt;">
              <font style="letter-spacing:0.2pt;">By:</font>
            </td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:16.5pt 0pt 0.5pt 0pt; width:201pt;white-space:normal;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ STUART W. PELTZ, PH.D.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 201pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:224pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:18pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:0pt; width:0.5pt;">&#8203;</td>
            <td style="padding:5.167pt 0pt 0.5pt 0pt; width:201pt;text-align:center;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">Stuart W. Peltz, Ph.D.</font>
                <br >
                <font style="font-style:italic;letter-spacing:0.2pt;">Chief Executive Officer</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.3pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">POWER OF ATTORNEY AND SIGNATURES</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We, the undersigned officers and directors of PTC Therapeutics, Inc., hereby severally constitute and appoint Stuart W. Peltz, Emily Hill and Mark E. Boulding, and each of them singly, our true and lawful attorneys with full power to any of them, and to each of them singly, to sign for us and in our names in the capacities indicated below the Registration Statement on Form S-3 filed herewith and any and all amendments (including post-effective amendments) to said Registration Statement, and to file or cause to be filed the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, and generally to do all such things in our name and on our behalf in our capacities as officers and directors to enable PTC Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming all that said attorneys, and each of them, or their substitute or substitutes, shall do or cause to be done by virtue hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated. </font>
        </div>
        <table style="width:456pt;height:295.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:168pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:72pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:normal;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 2.833pt 0pt; width:192pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ STUART W. PELTZ, PH.D.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Stuart W. Peltz, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Chief Executive Officer and Director (Principal Executive Officer) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 2.833pt 0pt; width:72pt;white-space:nowrap;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ EMILY HILL</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Emily Hill </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Chief Financial Officer </font>
              <br >
              <font style="letter-spacing:0.2pt;">(Principal Financial Officer) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ CHRISTINE UTTER</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Christine Utter </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Chief Accounting Officer </font>
              <br >
              <font style="letter-spacing:0.2pt;">(Principal Accounting Officer) </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ MICHAEL SCHMERTZLER</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Michael Schmertzler </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Chairman of the Board and Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ ALLAN JACOBSON, PH.D.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Allan Jacobson, Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ STEPHANIE S. OKEY, M.S.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Stephanie S. Okey, M.S. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ EMMA REEVE</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Emma Reeve </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:172.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:192pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Signature </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:168pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Title </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt; width:72pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Date </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ DAVID P. SOUTHWELL</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">David P. Southwell </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:13.917pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ GLENN D. STEELE, JR., M.D., PH.D.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Glenn D. Steele, Jr., M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ DAWN SVORONOS</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Dawn Svoronos </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:192pt;white-space:normal;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">/s/ JEROME B. ZELDIS, M.D., PH.D.</font>
              </div>
              <div style="margin-top:2.5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center;">
                <font style="letter-spacing:0.2pt;">Jerome B. Zeldis, M.D., Ph.D. </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:168pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Director </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:14.167pt 0pt 2.833pt 0pt; width:72pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">June&#160;19, 2020</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>tm2022875-1_ex5x1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title>tm2022875-1_s3asr_DIV_08-ex5x1 - none - 0.717801s</title>
  </head>
  <body style="width:595.31pt;">
    <div style=" width:595.3pt;min-height:663.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exhibit&#160;5.1</font>&#8203;</div>
        <div style="position:relative;z-index:-1;margin-top:9.7pt; width:456pt;">
          <img src="lg_morganlewis-bw.jpg" alt="[MISSING IMAGE: lg_morganlewis-bw.jpg]" height="35" width="220" >
        </div>
        <div style="margin-top:12.41pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">June&#160;19, 2020 </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">PTC Therapeutics, Inc.</font> <br ><font style="letter-spacing:0.2pt;">100 Corporate Court </font> <br ><font style="letter-spacing:0.2pt;">South Plainfield, New Jersey 07080 </font></div>
        <div style=" float:left; line-height:12pt; margin-top:7.8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Re:</font>
          <br >
        </div>
        <div style=" margin-top:7.8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <font style=" text-decoration:underline;letter-spacing:0.2pt;">PTC Therapeutics, Inc. Registration Statement on Form S-3</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Ladies and Gentlemen: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have acted as counsel to PTC Therapeutics, Inc., a Delaware corporation (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Company</font><font style="letter-spacing:0.2pt;">&#8221;), in connection with the preparation of a Registration Statement on Form S-3 (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Registration Statement</font><font style="letter-spacing:0.2pt;">&#8221;) for filing with the Securities and Exchange Commission (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">SEC</font><font style="letter-spacing:0.2pt;">&#8221;) pursuant to the Securities Act of 1933, as amended (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Act</font><font style="letter-spacing:0.2pt;">&#8221;), for the registration by the Company of 760,365 shares (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Shares</font><font style="letter-spacing:0.2pt;">&#8221;) of common stock, par value $0.001 per share, of the Company (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221;), which are held by former securityholders (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Selling Stockholders</font><font style="letter-spacing:0.2pt;">&#8221;) of Censa Pharmaceuticals Inc., a Delaware corporation (&#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Censa</font><font style="letter-spacing:0.2pt;">&#8221;), pursuant to the registration rights the Company provided to the Selling Stockholders in Section&#160;5.11 of the Agreement and Plan of Merger (the &#8220;</font><font style=" text-decoration:underline;letter-spacing:0.2pt;">Merger Agreement</font><font style="letter-spacing:0.2pt;">&#8221;), dated May&#160;5, 2020, by and among the Company, Hydro Merger Sub, Inc., a Delaware corporation, Censa and, solely in its capacity as the Securityholders&#8217; Representative, Shareholder Representative Services LLC, a Colorado limited liability company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have examined the Registration Statement, the Merger Agreement, the Restated Certificate of Incorporation of the Company, the Amended and Restated Bylaws of the Company, and such certificates, records, statutes and other documents as we have deemed relevant in rendering this opinion. As to matters of fact, we have relied on representations of officers of the Company. In our examination, we have assumed the genuineness of documents submitted to us as originals and the genuineness of, and conformity with, the original of all documents submitted to us as copies thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We assume that the appropriate action will be taken, prior to the offer and sale of the Shares by the Selling Stockholders, to register and qualify the Shares for sale under all appropriate state securities or &#8220;blue sky&#8221; laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Based upon the foregoing, we are of the opinion that the Shares have been duly authorized by the Company and are validly issued, fully paid and non-assessable. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">It is understood that this opinion is to be used solely in connection with the offer and sale of the Shares while the Registration Statement is in effect. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The opinion set forth above is limited to the laws of the Delaware General Corporation Law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We hereby consent to the use of this opinion as Exhibit&#160;5.1 to the Registration Statement and to the reference to us under the caption &#8220;Legal Matters&#8221; in the prospectus included in the Registration Statement. In giving such consent, we do not thereby admit that we are acting within the category of persons whose consent is required under Section&#160;7 of the Act or the rules or regulations of the SEC thereunder. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Very truly yours, </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ Morgan, Lewis &amp; Bockius LLP </font>
        </div>
        <div style="position:relative;z-index:-1;margin-top:9.8pt; text-align:right; width:456pt;">
          <img src="lh_morganlewis-bw.jpg" alt="[MISSING IMAGE: lh_morganlewis-bw.jpg]" height="61" width="277" >
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>tm2022875-1_ex23x1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
<html>
  <head>
    <title>tm2022875-1_s3asr_DIV_09-ex23x1 - none - 0.6904562s</title>
  </head>
  <body style="width:595.31pt;">
    <div style=" width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Exhibit&#160;23.1</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">Consent of Independent Registered Public Accounting Firm</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">We consent to the reference to our firm under the caption &#8220;Experts&#8221; in the Registration Statement (Form S-3) and related Prospectus of PTC Therapeutics, Inc. for the registration of common stock and to the incorporation by reference therein of our reports dated March&#160;2, 2020, with respect to the consolidated financial statements of PTC Therapeutics, Inc. and the effectiveness of internal control over financial reporting of PTC Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December&#160;31, 2019, filed with the Securities and Exchange Commission. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">/s/ Ernst &amp; Young LLP </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Iselin, New Jersey</font> <br ><font style="letter-spacing:0.2pt;">June&#160;19, 2020</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>4
<FILENAME>tm2022875-1_ex23x2.htm
<DESCRIPTION>EXHIBIT 23.2
<TEXT>
<html>
  <head>
    <title>tm2022875-1_s3asr_DIV_10-ex23x2 - none - 0.6572518s</title>
  </head>
  <body style="width:595.31pt;">
    <div style=" width:595.3pt;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">&#8203;</div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Exhibit&#160;23.2</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Consent of Independent Certified Public Accounting Firm</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">PTC Therapeutics, Inc.</font> <br ><font style="letter-spacing:0.2pt;">South Plainfield, New Jersey </font></div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of PTC Therapeutics, Inc. of our report dated August&#160;21, 2018, relating to the consolidated financial statements of Agilis Biotherapeutics, Inc. (&#8220;the Company&#8221;) as of and for the&#160;years ended December&#160;31, 2017 and 2016 appearing in PTC Therapeutics, Inc.&#8217;s Form 8-K filed on August&#160;24, 2018. Our report contains an explanatory paragraph regarding the Company&#8217;s ability to continue as a going concern. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We also consent to the reference to us under the caption &#8220;Experts&#8221; in the Prospectus. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">/s/ BDO USA, LLP</font> <br ><font style="letter-spacing:0.2pt;">Boston, Massachusetts </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">June&#160;19, 2020</font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>lg_ptctherapeutic-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_ptctherapeutic-bw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"; 2P P$1  (1 0,1 ?_$ ,T  0 " @(# 0$
M       *"P@)!@<"! 4# 0$! 0$! 0                (# 000   & 0(#
M! ('#PT,!P,("P ! @,$!081!R$2"#$3"0I!%%$B%=9WMSAA<3)"(W.T=;46
M=I:V-QJQ4C.S-%0U53875Y<Y@:'1<B1TE-0EE1@9D<%#U296)V)31K*3TT1%
M9H9'6(*29(2%9Z?7*)@1 0 " 0(& @,!  ,! 0$    ! A$Q$B%!47$R V&!
M(A,S0E)R(T/!8O_:  P# 0 "$0,1 #\ G\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MC56Z'>4=]N2RV^T9FVZDE(,RT/0_9+T"'7[
M
M
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MDESG[LS7%>=3HYW:N7CQY3T[#',3&KN8?5'
M
M
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MW/6>^[CE[QAO]E]77I_BF(FMHUA68EVL)=
M
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M#V1G,37A*HG+G(XZ
M
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MJ>V
M
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M22T<4F:>TN)%V"%/W
M
M               '\,S(C,NTB,R^?H Z;SB/F]PXJ%2E%CQM9#:GV["1$D<C
MA1S:47(X2367=J]'#7YHJ,1Q3.<X=8N]-SF1$F3DV59,ZZI)*]7]U(\V.@U_
M53)"949[0FW5J)/L$*WXT<VS]NUZ39#;BE:;2G%<>FO-NFZF5,QVB=D$KG2M
M!$Z5<E1$V:>'L"9M:><N[8=GQ*Z! :0Q"A1(C+:22AJ-&98;2DM3(DH:0A*2
M+F/L+TB5/=
M   >*DI61I4E*B,C(R41*(R/@9&1ZD9&0#IC<SIXV7W=KY-?GNV.W^2E):E-
M+D7N#XI>R"]=.,<E:5W-1.+G>]3;YM?HN0M=="T[%IAS$(VG79Y8[IRZ@4SK
M[;5Z=A5Y+LRE'"QFEVGQ.O0U+N[*TEI0MG ^](FT32;27-Q;023UT&FZMO+A
MV3.:Z<4';KN\#/JDZ*ER;>\:QB;B46 B6N8[G--96G.S265Y.24:NK(232W%
MK%\G#4SX>D<FG#=&CNZ,XYM)#S2V'5M.:<Z#Y5:'J6O;P/TC-3\P
M   =M;9;Z;N;/6!V.W.XV=8<ZI#Z%HQ?,LFQMMPY#+;#CB_<*TKU*6IEE*#,
MSXI21'P(AW,QH8B=4M?PW_-,[K[2V51A?4+6UU]1V=TQ%5<27=TLUO&RN<FI
MR>[M5AG+[)>K5A/&UJ@R)6B3U(S(7NBVO!.)C1/-Z-/$0V-ZT\6B7VVDF_5)
M5"H94UFRQJ=2L-+R%=VF EGUR3)6I)E0O<VIF:="U[1R:3''D[$\N;/HN/$0
MZ
M
M
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M@3;)O/)3S&>G,HB/B9")K,*B<NXA+H
M
M
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MRN-J(R^88A3]P
M
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M(]B]";BN2U5Z;J!7R'TQRFM<_M-4<Z=2+F+7.8F)Q*HG+JL<=
M 2SO!X\Q#FG2OE-)M_O!7HL\;RB]A4DRRHL=P^MB5T;)LUQU4V=.LK[(ZI,2
M'#K6G5.N<>[TYNPC,M-T6C;9.)CQ62W37U4;2=4. TF>;:Y9CMQ"N*NMLTQJ
M_)\8NY3+=JY8MQ$/%CUO:,)6Z=8[RZ+,E<I\IGH>DVK-78F)9*"70
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M"GM@       @9^:R:;.B6LTD:BB[VF2O21Z[._X!M_CZ3&LJ],8J
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M2X[L23&N9<%UMZ,_$?@.LK)F"R9H7#DN-G_[*S$S>TZR[B(8D"70
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MN)"FVU4S4'80ZO(K2@:G-PFK2V[EN4]5J,D]ZKD/VNIZ<QQ-9C5V)RQ<''0
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M]G'TBXISMHG/17V>(5YD7J:ZJW)V+[=O-8%ATJK3'*VQ#(]V,1O"DS*&TI;
MB93G2XY):]T>];/DXNH29ZZ!OQ&*N17G*.3E^X6?;A2V[#/LXR_.)[+DAUJ;
ME^2W62RVG9A,%+<;DW4V:\AR445KO#)1&ONT\VO*6D9F=5XPX@
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M+@I,==-85<5,6LL(E?SH.PES'5.J>F)U+FTTXD%J;>,:$3GA.K/@0H
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M-8_P Y_FF]OZNSHV_P ?28UE7H#%0
M       ,J>CC\]4+\';_ /:&1=/(78?2S^::']O+K]N;"_DY71D8(=     '
M3.]._6V.PF(7&8;C9=C6/0:FLM+'U>YR7'J&1,.KJ9MPN+$]W;.N9=DOQ8"^
M[3S%KIKV$9EV(F7)G""3XNOF>YE@>2[,=-4%*JZ5]^F/3KFTJ-O\MJWVC^\]
M^DD1K&FRV>XEDC*82U\FKAZ::\IZ:9BFGDYC=KH@V[J[JY3O!E]OFF7.0W;:
MWL;2Q?5!AH@L][;6DRVD<K#:UI01R9J]"(S(BT+T#.9S.95HZU'
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M-='3,53TZ142LBJ*IV='C^Z[)+4E.J#6GF(N9.LVKMGX5$Y8HB70
M   &X#PG_$XS7H,W=QONFXLC#+2]QZ!+2FGII4J&B;G6-V]I,E3[BRKF(\1N
M-7+]N:OJ?:?#4RNML<)T3:,K9'H8ZW]L>LW:3'LWQ3(J23;2:*AL;6$Q?XM,
MD=_?O7C<1M$*AN;3N%FFC=]J9ES:>UUT5HM7'&-'8G.K.<0Z
M                            KF?-\_RYPK[=X5\7^8C6W\X[HCS^D&T9
M+                                =G[5;Q;B;+9$G*MM\HM<5NTQI<0
MI]0^U'DDQ.;0U);YW8\A/*ZVV1&7+V$.Q::Z.3$3JM(/ A\<3$^N'$I6W.[M
MO!QS=."_>6;"+W<->5W5DQ+RN@QZAKDQ6,"QEEE,ARW+NE]ZKB7*:>/,6EHB
MT;JN1PX2E$C)0  (&WFL?X <_P TWM_5V=&W^/I,:RKT!BH
M                         &5/1Q^>J%^#M_\ M#(NGD+L/I9_--#^WEU^
MW-A?R<KHR,$.@   ,!NM?Q#-C.B7#BR3<+(L;58N2JMEFAM<CD8XZ]'L;"77
M'*3,:Q[(")+$F&M/+W7MC(RU+M%UIGC/"$S;&G&57OXJWC<[]]<&1-T&/Y;D
M^-8&S'K'GH,7/(V65DYQ5!;4=K$4E6#XRXV<IBS5SJU5H7#3CJ7;6C2O B.O
M&6@Y]]Z4\Y(D.*=>=5S..*^B6KLU/33CP&:GX@
M   #S;;6\M+;:36XL]$I+M,_8(!8*>5L\*J#"A674_N?CK3]BZ[8UF/O7.(&
MATL?S+;G#KB.46X9RM9'%-Z<LR2<35PS,]4ZZ%KXT^43^4_"?",E@
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M>:9M$:K)E!+(R5HG7E*;5Q+L3ED2)=
M        !7,^;Y_ESA7V[PKXO\Q&MOYQW1'G](-HR6
M               ,J.D'JDSCI/WCQ/<K$+2?";K\@Q:3<M1;2^@)=J*?*Z;(
M9;9M4=E6ORN\]RBU;-1I7[&NAE5;;9^')C*WO\(GK\H>O/IGQ?,H)RE7=/A^
M&6%^Y)@6\8W9&62LO1&,I%Q86,J7HG&'-34LU)])GJ6G;Q_J-)(GDVPB'0!
MV\UC_ #G^:;V_J[.C;_'TF-95Z Q4
M       #*GHX_/5"_!V__:&1=/(78?2S^::']O+K]N;"_DY71D8(=  !JF\3
MOQ+-N^@K9S),JO4SG[IK'\KFP&D4=M8Q_6,9?QA#Y*=JI\!]M!IR)'$ED:O0
M9:'KI2N>,Z)F>4*I?Q"_$QWMZY=TK_(\@R:\K\5;N+YO'Z>ORC."KG*=S+KV
M]IGY%3=Y%9L1Y;4>T2DDI)*6DI))$6@Y:TSPY.Q&./-K($.@
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MVU/4QK'YQM_TB?QX\E9[=TD['YRJZQ2TF2EIMXR9<)U'(Z1FCVY$7'@,EOD
M           _J5*0HE(4:5%Q)23-*B/V2,M#(!+R\O%XS5[TUYC)V9W.M[NZ
MQF9%OKBNB2Y&:9)'C1JC#L<H:QEF%]\2:R,VQ[EGRH)GZG]+H6A#6L[HVRBW
M#C"SHQW(JW**U%M4K>7#6\ZPE3[1LN=XR9)7[11F>FI\#](RF,*B<ON@Z
M                                  *YGS?/\N<*^W>%?%_F(UM_..Z(
M\_I!M&2P                                  2,O+S^(U8=)/53C&W=
MTVVK%MVLUVRJI,Q,*D0W70L.A[CNJ<G65O:5Y1"<7E!<JT<^NA\VG#72LY_&
M>:;1SZ+9S!\IK\UQ#&<KK)#,B'D./TMVPMAZ.^CNK>LBV37U2*Z\PK5J41ZI
M4:3+B1F6AB)C$X=CC#E0XZ@;>:Q_@!S_ #3>W]79T;?X^DQK*O0&*@
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MS7;^:5=F>.6..S32TLHU@AM#AI?0IQD]&W'"T<0@S+CZ!R8F-77#1P
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M[)92UF#>35SLZ+1VM/.93KB>.K0XMFQ42CXD1<-#UU*[VB>%='*UQW:0QFH
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M88^E^PPO<O,ZIYY9Q;]J!(6MF(@N\[K51%H6A$1#69BM<1K*(C,Y0A!DL
M          9/]-W29NIU06\BJVWC4S[D4YJ'CM;J/4:.08D:8Z25/LNDI/<R
MDZ'IQ/@*K6;:.3.$^CPV?*QX=MZ;>2]25A(GO0I+LFN8CO;99FP[-@Y!4SXC
M;R;+"93B&G(<9U*C29&1'RD9:B\UK'#C+F)GXA+<V9Z2-@MC,:I<=PO:_;]A
M5'#B1(]TG <+@7+QPUREL2'I=5103]83ZXLB4DBT(^&FIZQ-IGX=B(ADDVVA
MI"&FD(;:;0EMMMM)(0VA!$E"$(21)2A*2T(BX$0EUY@
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MH&)1]M6H+LRRET<:M@(>7D[Q$OO30X:3(S]J6MVC,;H<B>.)1FQFH
M   &Z;P%]SGML.O:BNN9I,;^;/<IE?>(CF?>2:N"TG14EUELBT1V:ZC3U1FZ
M;YV\%Q_46+=K#3+;^A4XXCM2?%!Z'] I1")C$J?3'              5D7FV
MOS\8S]<V]_(G*1K?QCNBNJ'(,E@          ML?+!_V=FV'P3[5?=/<X7;Q
MJBOE*2.(6             - 'CX>(CC_ $=]+644%;:5<K+<]PK<:+#K42L9
MFS&IV)R]OE=R[66-Q#F]XM&3:DAMM:CTXD6A:Z4C'Y3R3/'@J2-T]P;/=#/<
MJS>V[LI.1Y'D%X:6V&X_)[MW,ZW6E332W&TJ2Y-/@DS(NPC,A$SF<J=>C@
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M2-;^,=T5U0Y!DL          %MCY8/\ L[-L/@GVJ^Z>YPNWC5%?*4D<0L
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MIRP<A+<B.6%D;),'9O<J2=5ISGQ/7A%K3;LJ*Q'=D&)=
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M-='?0A0             K(O-M?GXQGZYM[^1.4C6_C'=%=4.09+
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MUY08'0PVH[U2A162\?N+*0HX%7 @H;(T03]N9<?2-?9&?RC1RL\$?$9*
M        ?TC-)ZI,R/V2,R/^\ LZ_+ >('=;Z;1V6#[@//G:Q9&8V$9+#F0V
M+'>2LTQFLB:OVUM.0G5,X]3(B-/LZ:C6WY5SSRB.%L)A@R6
M                    *YGS?/\ +G"OMWA7Q?YB-;?SCNB//Z0;1DL
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MXQW175#D&2P          6V/E@_[.S;#X)]JONGN<+MXU17RE)'$+
M   !Z\F2S$:-Y]:4-DI*34I24%JK@1:K-*=0CB*J?S/W6O$Z@NIFNVGJFS=J
ML4K-O<T:GM(IW8KLB1BF05;K")U;8S'''&_='BA2227LZZ$-+_C&Q%>/Y2BS
MC-8          .V-DMH\FWPW,Q+;7%8<B19Y5<1ZAEYN%938\5Z2S(=:5*35
MQ)LI"7"C*TY4*4>AZ%P,=B,SAR9Q&5O3X*_0+6](/3EA<RP*2>5WN+X9;RE'
M+N?5TN66V>(0;!)0K>N@.MGZU#7H1),D%P[=2&EYQ&V-'(X\9;MQDH
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MD:W\8[HKJAR#)8          +;'RP?\ 9V;8?!/M5]T]SA=O&J*^4I(XA8
M        ,5.L'=^!LUM)*RB9):CFF[HXJ3<FG!X39+S1?5BAS>!FWV<G'V2%
M^NNZV$WG$*1_J!WNO>H+<23N+D3$F/92:FKJ5-R[--L]W-6TXTTHYB:ZK(TF
M3G!/=%R^R8F9F9S*M'20X           F)^5^\.U_=C=J;O;G./*F8[17FRV
M1XY+LL:*9%*):,;O1[%R)/;R*(MMM2JYCG4;"N;0N!:<=*_C&[FBW&<+-2HK
M(U+4U=/#0AN)4UT*LBMMI-#;<:!&:BL(0@U+-"$M-$1%J>A>DQG/&<KC@^B
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MVR0U!D7ONR^E_()FXQNM)4FDJ":414B=?HN?_P!G3C=^,1;JF-9A(/&:@
M                            %<SYOG^7.%?;O"OB_P Q&MOYQW1'G](-
MHR6          "U_\K'\@O'O@QV;^Z.[0TOX5^T5\I2>1FL       !XK42$
MJ6KZ%"34>GL)(S/^\0"$#YIOQ*ZW ]O"Z8J&?<5E]G55O5AIS*]C((#C<JI<
MV?EM.)L8-K'BI-*;)6BUMJ26IZ$6IZZ^%>Z,9MV5QC[[\I]Z5*>=DR9+KC\B
M0^XMY]]]Y9N.O/.N&IQUUUQ1J4I1F:C/4^(R6_(          2/O+4=-ECN_
MUM1\R6EA=!2X3N902DN2(//Z\O'Z><R:8DN-([Q)(EE[<N!"Z3MG=R3;$QB5
MMHPPW';)MLB2DC,]")*2U/MX)(B$*?L              *R+S;7Y^,9^N;>_
MD3E(UOXQW175#D&2P          6V/E@_P"SLVP^"?:K[I[G"[>-45\I21Q"
MP          1=/,]]54OIZZ3&4TZG"LIF1;<R4E_M1M'=/Y1?0W=7:V;#61_
MY-V:\?G#2N8KNCJG,3;"J2&:@          <XVQQ?[]]R=O<+YE(^^_.,3Q?
MG2IM*D>[]] J>9*GD.-)4GUO4C4E22])&7 =B,S@7$'@B=)E+TP]'^WU4Q$B
M.V%G@6#,2)RX],N8X[13<U-#KDJNKX:G'-+H_;*U^9IQUOV<(BO1%8XS;JW0
M#-8                                               #T[&(B?7SX
M+B4K;FPY41:5$E25(DL+94E25DI*DF2]#(R,C 5:GFKNFR%M!U.X1F]56UD(
MMS<RWYLI[L-BKC/2?O?B;*-LJD>H0HKSRF_=I?+WRG#+F/ETU/72_&L3S176
M8Y0B?#-8             F/>5<ZP+_%][+C:B[D/MX\[D6QU)7-QI%W()R)'
MC[RO2"?BE8E 1RJ>1HDFB2>I\. UIQK,2F>$Q*S0A2FYT.)-9U[J9%8E-:D:
M3[N0TAY&J3XI/E67#T#.>$X4]H<                               5S
M/F^?Y<X5]N\*^+_,1K;^<=T1Y_2#:,E@          M?_*Q_(+Q[X,=F_NCN
MT-+^%?M%?*4GD9K      !^+\F/%1WDF0S';(R(W'W6V4:GP(N9Q24ZF?8 T
M"^+1XS&R/2#MAD^.8YEF-9'FUMCM]"3"I\HV[NW>ZM\&R277G[ER<KC3O;S(
MK:",FSYU*)*=3,:5KC\I3,YX1HJINK;J9R;JJWARK<[(6VF&[J_M+FOBE7Q:
M^3'*U8K&9*)3<.1)CFL_<MO0DK41<>/$3:TVG+L1B,,8!+H          +(#
MRE'1K;;?[59ENUDI*2=_E\FPJTH1<Q>:KR?:S YD=7)-KH\9[BZ?MT+4D_I3
M,:^-<=4ZVRF\#)0              *R+S;7Y^,9^N;>_D3E(UOXQW175#D&2
MP          6V/E@_P"SLVP^"?:K[I[G"[>-45\I21Q"P          5S?FX
M]^8%AD^,[/(F0W)<NCK+KU=#U<J1RTVZ&<1%GW:):INB#C\=&^7V3(QK/"F)
M3$<<H-8R4          #<'X)/3E"ZC.M7"JN;'FOIP2^VVSIGU-R>V:'JS=C
M"(R5NG!BR5*:(I7$EDE'LF+I$3,_$)M.([KCW;;'TXK@F,8ZA*TIJ:QN(E*S
M6:R)+CBM%&XE#FOMO21&)F<SEV(Q&'.!QT
M                       1)/-3;!/9KTHR-QF67WE8)A&]5L1LE8+2@[69
ML^T7>ICQ78_'W.X<ZDEP/0SXC6O&LHS,65<BT*;6MM9&2D*4A1&1D9*29I,C
M(]#(R,ADMX@            ,\?#?WHO=F>K':*SK'8C=;/SBE>NRDQH[RULU
MD*Z*,3#LEUEI@R.Q7J9J(CU+V!?KG%OA-HS"Z!Z5]Q:O<W87:O(:QYI[FVZP
M IAM/Q'DHF2<,HYSJ#*&_(;:,O6?H3,C+YPY>,6=K.89#"70
M                  5S/F^?Y<X5]N\*^+_,1K;^<=T1Y_2#:,E@
M  M4?*]9_AM#T(X]%N,@KZ^0C;/9]"FY"UDOF;L=US<29);5Q03B=?GC6T3-
M*X9UG%I24SWNVG(U)/.J,E(4:5%WKW!23T,C^H]I&(VVZ+S!_/?M/_YZH_\
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M7=?-[S-KGN8C!3[M]E^034%IQB*GF9CQTZ,LNJ2GAV&(F9G5V(B-'48XZ
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MK%/,I'J_!/<%R]NIZ:#6O"N>J9UPLI!DH
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M2S_]6-T>U1ZG_P#%P;Y,0?\ ,_ZP_P"F7<_^MC='WW!OL8@_YG_6'_3-N?\
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MK)WKIS-/):;I[MVK))7'4265;IYA%0G2,RRA!$4?Z'0S(=OKDC1KO$.@
M        "P0\HQU+V.66>0[96JEML5T[(FXK3*[-QI<>AVWPN*RMQ+\UV*3O
MU+Z5!$7HT&N<^O[3C\OC"?0,E                               KF?-
M\_RYPK[=X5\7^8C6W\X[HCS^D&T9+
M  &WOPE/#AW)ZW^H#"6ZRDM6</QW*L-OK6X<ILN*N5!K]P\6K+=EJWI:*RB-
M2&8T]2E&M:4MD1J49:"Z1F<SI#EIQ"WWZ7=@Z+INV8P?:JB4ZXQBN/0:1;RY
MDF:AU,%^<\TIMZ6S'?41>O*U-2$F?L<!RTYGX(CA\LAA+H
M "LB\VU^?C&?KFWOY$Y2-;^,=T5U0Y!DL          %MCY8/^SLVP^"?:K[
MI[G"[>-45\I21Q"P        !T3U-SCK=A-T9R322HV,2'$FKETU*1&+B2C(
MC+B+IQO";>,J0[K$MI-QU6]2DF2I"C+?W>5+9H02"[M6Y&2N%KRF9&?M^T3;
M6>[L:0QN''0          6Q/E@]NV,!Z+4Q6C4:EY=N9KJX\LM'LEI'?^V;;
M/M0-+\(PF/+/PDWC-0
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MEWBTZ06M/_-FX?W?J1I=,:I"(S4
M                   K4?-T[0O8_OE@><)>4W'?P)M*XQ5_=H<<M-V,_>)X
MY?KSAF9$O33NO;:>@:6XUB4QJA:C-0             SW\-W+Y>%=3%9=1'E
MLN(P_+8_,V\3!Z2(D=)_5#9?TU)/9R\1?KG%G+:+LK;[+8V:XXU>15H6RY+E
M1B4A\Y">:.M*5%WALL:GQ[.7@)F,3@B<N;CCH
M      KF?-\_RYPK[=X5\7^8C6W\X[HCS^D&T9+
M         !O.\+;P8-U^O7),=LGY4.JPNWEXD]!DUV3T,2R>K\B1E1.+DP[B
MILFD.M.4">5)IT(E'KKPTTK3ANG1,VY1JLZO#T\,39#H6VYI<>QO%Z"3DB*J
MG1=6LG%L&3/D6;6)T=!:NN6=%C=6[+5)>JC6MQ1FIU2C,S,C'+7SPC0BO.=6
MT 0H                  %9%YMK\_&,_7-O?R)RD:W\8[HKJAR#)8
M    +;'RP?\ 9V;8?!/M5]T]SA=O&J*^4I(XA8         QBZR:]%ATT[O(
M69D2</F%PY?IY4'7Z)*OU@NGG'=-_%2,]4;9-=3/44T78UOKNXV79V(W R!)
M=G#T";>4]W8TAT4..@          MI?+/Y]7YUT9HF0.?E3EVY1'SLN,G]1R
M.E;/@XM9GQ6-+3$QF.J8U24QFH
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M9K_6Z>P-,?\ G'='^_I-4&:P
M               $+[S:M J;LOCD\B/E:;P-C7ZIIJK.<J7VD@TZ^V]D:QC]
M<]V?^_I6D#)H              "Y6\"W/H^7]%55&01D_'S[<.0OC'+ZF5K
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MNQ\FH?8?AE;MR8RI[6\=FGFD%+;,U=S[7NRX'KP[NK6>$9.,_"23LMTF]/\
ML!#A,[6[8XMB4V-!9B2+"EAR8KDQQ,"+7R9*VGILLFU2FHJ=4\RM"(BU/341
M-K3PY.[8UYLCA+H                      *R+S;7Y^,9^N;>_D3E(UOXQ
MW175#D&2P          6V/E@_P"SLVP^"?:K[I[G"[>-45\I21Q"P
M !UQN]$*=MIF,0T\Y/T[K?+IS:ZNM'IIJG7L]D57RAR=%,QXON"1L$ZR]RF(
M\9$;W<S/<^[=)$<X_>.R=U,R0I:B[]_O%'W?T7M=?8';ZD:-6HAT
M  $WORCO4+2U6>97LP_/C-6,7&YUUZNJR4ETT7FZ6"PVO\@]SE$GG5(+17?G
MS>P7:-(XTQ"9CCE8^C-0
M           "(GYK6K=D=-=5(2R9I18;=MFLDD9$9YCDBM->8NW4:U_G/=$^
M<=E7F,E@              MG/+;9HWD'3;.JFU$91;3/IG*F1WI%S9/1-&?)
MW#>G[)VZG\X;>R/QB?E,>6$EP8J                             %<SY
MOG^7.%?;O"OB_P Q&MOYQW1'G](-HR6          "75X4'E\L?Z]>GRLW=D
MY7DE=)L,5PN^=C0K+"8T9M>22<O8Y&T7.+V4KD26/<-7#46O$SX::[:16)M,
M\4;IF9B.39LKRAE1SKTS;*=.=7+_ +>VS^AU/37_ ,#]N@;?7UDS?I#^?HA=
M1_YVRC_?VV?O&#;Z^LF;_!^B%U'_ )VRC_?VV?O&#;Z^LF;_  ?HA=1_YVRC
M_?VV?O&#;Z^LF;_#\U^4*J3-O_QQE22YT\QIO]M->77C_P# _'@.[?7'.3-^
MD.;5'E"<(,FBFYWF1$?*2S1;;7N']/KIS8(>OH'/_..'$C?SP[[PWRC_ $]5
MDEJ1>9WGKW*PIM32D[2RVC6II!<QI7M\K525D>ACF:\G?R9Q85Y9WHEQ1UIY
MWW3M5MNI<(K/#-G)1'ROMO$1F6WJ3T^IZ?.,<W_$&WY9W;6^#GT8[8KCNQML
ML(NEQCB*25SM?M1()1Q?6M.;NL+9/ZIZT?-IV\I#L^S/*'(KUF6=6-=-.P.)
M,L,T&S&U-5W#*&"77;;X77K4E#+;&JCA4;'ME-MD1_,X"-T]58AW-#KJ^N;[
MFO@PX+)&:B:AQF(S9*4>JCY&4(3JHRX\.(XZ]P
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MR/VRUI['%*67T/I,Q%N$NQHY8..@
M                  B?>:E(_P#A6@GZ"N=N/RMR$:5\)[HGSCLJR!FL
M          %GWY4O)';G9S*(SBE&3,3/'N)NGQ^_7%T?]HM1?3#:\Y]<=T1Y
MSV2_1BL                             5S/F^?Y<X5]N\*^+_,1K;^<=
MT1Y_2#:,E@          M@/*QG__ *%XZ7L;8[-_W['=H:7\*_:*^4I/ S6
M                                       K(O-M?GXQGZYM[^1.4C6_
MC'=%=4.09+          !;8^6#_L[-L/@GVJ^Z>YPNWC5%?*4D<0L
M   %;AYMSIW@UNY&+;VG%GIG0L:BT+<A3D[U/N;S=/.YJTFVJ,40UJ5(/E/O
M-=.PC&MN-8E%=9A"6&2P          <^VHRM.![H[;9PM"G$89GV'96MM!-J
M6M..Y%76ZD(2\MIE2E%#T(EJ2DS[3(N([$XG+D\8PN0/!BZK:?JCZ/-M,CB/
ML,R(N X;+<@NNU")K"KR=EZ$-/1ZVPF\CFE,? S+YFO'2KQG\NKE>G1MZ$*
M                                                 !$7\UI;/1^F
MBKC(6V1+L=NW-%$DSU+,,D3[.OH&M?YSW1/G]*N\9+              !9/>
M4*M&)FV6;,MD>J:7/%]J#X'GN(I^E49]IC6W\X[HCSGLFM#)8
M                  KF?-\_RYPK[=X5\7^8C6W\X[HCS^D&T9+
M !:_^5C^07CWP8[-_='=H:7\*_:*^4I/(S6
M               K(O-M?GXQGZYM[^1.4C6_C'=%=4.09+          !;8^
M6#_L[-L/@GVJ^Z>YPNWC5%?*4D<0L          $4'S3?2K-WRZ3X]AC:'&+
MF'D&W$,GHE*5I(-I.69!-D%JNXK4I2HI/$M#]G7T#2N;5V_*)B(ME5BC-8
M         ";YY5_Q$OO5RR[Z?,P?]SJMN=L=BN,JGY5R,S664;RR; X=4C&5
MJ;2T;K/.@Y1_1%[8:U_*LQT3/"<K'&!,9L8,*PCJ2N/.B1IC"TGS)4S*90^T
MI*C))J2I"R,CT+49*>V
M         (8OFTK_ -3V5QV!S>U=1@;QI[SE+5&<94C7E[M6OT/;J-8Q^J>Z
M/]QV5H(R6              "QV\GAI_-WG7L_>_G?#TZ?S@X<-)_G'=/'=\8
M3@AFH                             5S/F^?Y<X5]N\*^+_,1K;^<=T1
MY_2#:,E@          M?_*Q_(+Q[X,=F_NCNT-+^%?M%?*4GD9K
M                               5D7FVOS\8S]<V]_(G*1K?QCNBNJ'(
M,E@          ML?+!_V=FV'P3[5?=/<X7;QJBOE*2.(6          #$7K0
MV1J]]-GY6)6+33G/>4,Q)N-5[FA0)+[Q%K819;1>V<_6_.%^N<6RFT9C@I)-
M]=GKK8W/I&!7ZFU6$>KK;-1M2V9J.ZLFUN-?5V&F6S/1'9RZD)F,3AV)RZ<'
M'0          9!]+V^^1=.6]N ;JT%M9UY8GD4.[F18,^VAQK'U*/-9CHG,U
M$V"_+0SZZOD+G(T\QZ&6IZU6=LYY.3&8PN(O":ZTJKJ_Z9\,R(N_3;U>-X/5
MRB5$M&D./%MSBEM+<4]:39S[JC=L3]MS>V]/'4QV\<X<KT;4Q"@
M                                       !!"\X3EBX&(873MFHE/T6
M&2]"-TD_4]Q,S;/BE:4_2>QJ--/7,?*?]Y^%>(,U               LD_*!
M4Y0-L\W?YE*-='GC?$TGV9]B"O0DC^E&DQCUQW3_ *^DV49J
M                 %<SYOG^7.%?;O"OB_S$:V_G'=$>?T@VC)8
M +7_ ,K'\@O'O@QV;^Z.[0TOX5^T5\I2>1FL
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MC6_C'=%=4.09+          !;8^6#_L[-L/@GVJ^Z>YPNWC5%?*4D<0L
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ML,9S$Q.)5$Y<U''0
M!Z\IXH\=YX^!-H-7;I['IT/0!5&^9\W&1F'6#7UY.$LZJ@R:MT*5W^A0=X-P
M"TY/5F.337LU/3V3&GLX8CX13/'/5&!&:P              6OGEI<*+&^GR
MTL$)(D29F>1-2C]R1F654#IES=^[K^Q]FA#6_"D1\ICR2?!DH
M                  5S/F^?Y<X5]N\*^+_,1K;^<=T1Y_2#:,E@
M  M?_*Q_(+Q[X,=F_NCNT-+^%?M%?*4GD9K
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M([3,R/AVD(FLUU=B8EW8..@
M      .-9A8-U6,75@]J3<2$MU?*1J/E)2"X$1D9GQ'8XRY/"%-9XVNYY;E=
M;VY3S;CJVL?S+=2@(G2DIT]4W=SEQ)$F0\[P(G2^AT3[!"KSF2(:?Q#H
M          +AWP \&?QKHVA6;_+SRLUW#AZI6TL]"NJQTN*$)7IHWZ3T&GLU
M175O;&:P                            !7,^;Y_ESA7V[PKXO\Q&MOYQ
MW1'G](-HR6          "U_\K'\@O'O@QV;^Z.[0TOX5^T5\I2>1FL
M                                 !61>;:_/QC/US;W\B<I&M_&.Z*Z
MH<@R6          "VQ\L'_9V;8?!/M5]T]SA=O&J*^4I(XA8
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M[:!;Q%M/&X33B)-?(D,*0Z;2B29*,C-)Z=AC.8PI]X
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M^I;?6Y;,C1+WBW3D),N[T-,O/LAE$9&TMQ!D9/>@]/8'+^3L:,<!+H
M       Y=A.+OY?>MTT<C-Q<:3((B2\H]&$DH^#"''/3[&@1&1=4>%1BBL,Z
M2*>D42DFWG6;2=%=[K_E$V,K_MD-K]'L:#3VQBZ:3F&R(9J
M                %<SYOG^7.%?;O"OB_P Q&MOYQW1'G](-HR6
M "U_\K'\@O'O@QV;^Z.[0TOX5^T5\I2>1FL
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MRW*,B=2:7+[(KNZ<2;O?&E=I9R9RTF]W;7>F2G_HN1/-VZ%V")U4XZ.
M         R^Z'\?;R;?>OJW6"D(7C.1O=VIOO",V8[*B/EYV^S7V1=/)R5U_
MTW82G;_;&+CJ6B9)NXMY?(3'JW[J>;5KW7?R-->7MYN(Y>=ULN5X0[[$J
M                          %<SYOG^7.%?;O"OB_S$:V_G'=$>?T@VC)8
M          +7_P K'\@O'O@QV;^Z.[0TOX5^T5\I2>1FL
M                        !61>;:_/QC/US;W\B<I&M_&.Z*ZH<@R6
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MA[8UXR<6S)1&2DBL>!N(47L%VC2)VU[IQQRK;S/4S,^TS,S_ +O$9J?P
M          ;@?!AV@>W*ZJ8<HR;5$B8EG$1Q#CD4B-U%5 D)/NI+#Q'H3Q<1
MIZHS9%YQ5<Y,L-1T=VRVAM!&9\J$I0G4^T]$DDM3&:WZ@
M              "N9\WS_+G"OMWA7Q?YB-;?SCNB//Z0;1DL          %K
M_P"5C^07CWP8[-_='=H:7\*_:*^4I/(S6
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MM1%J7,9:EKK/XUQSE&MNR:<A!-H2A/T*$I0G7CP21$7'YQ#);R
M         !Z%K*3"J[*8HR2F) F2E*49$E*6([CIF9J,DD1$CTF1!&HJJ_--
M[Y5^['5ABV+PIT&6YMKG&^<.2W$?KGG(YWT+9E;924PI<AULU^XZN7O4H,^4
M]-=#TTO/XQ'.$5UF46H9K              !,$\J%L_)W&WNR64IMU,.,]GT
M5;G+,0CO$X5B\A!=ZQ'=;(S)[L,]3&E9Q69^4SQG"ST&:@
M            >*E)3Q49$7S0'](R,B,CU(^PP'] 5S/F^?Y<X5]N\*^+_,1K
M;^<=T1Y_2#:,E@          M?\ RL?R"\>^#'9O[H[M#2_A7[17RE)Y&:P
M                                      %9%YMK\_&,_7-O?R)RD:W\
M8[HKJAR#)8          +;'RP?\ 9V;8?!/M5]T]SA=O&J*^4I(XA8
M           ZGWDV8P/?/#+7"<^HJR[K+.OF5Q)M(KDQF.S.<B.2B]7;E0S=
M2\<)OF+O$Z\A<1V)F-')C*NF\:_RZ.9;79C/WFZ;JJPL\8NK"5)M<8Q':MNN
MAG;Y5G&2RR??N96YL];C\.M=83PBI)U!$?M-=!IMB_&->B<S&NB&WE.(Y+A-
MLNBRNGF4=NVPS)7 G)0E]+$@C4PZ9(6M/*XDC,N(RF,:K<<
M                 &Z[P1^@3(^L[JDQA<BCEKP["+?"LQ=M5XZC(($I5-N?
MAL*PA&V5_1.1#1&F+-;NKO*1&7(>NI72N>/1-IF.$+?393:^CV>VUQ/ :&%&
MAP\<IX]6A,6*J$VIN.[(<;(HRI,PV20<A6A=XOM[1RTYG+L1B':PET
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M_D%X]\&.S?W1W:&E_"OVBOE*3R,U@
M        *R+S;7Y^,9^N;>_D3E(UOXQW175#D&2P          6V/E@_[.S;
M#X)]JONGN<+MXU17RE)'$+                  !\6\QO'<GB'7Y+04N0P#
M6VX<*\JH-M$-QHS4TX<:>Q(9-;:E&:3Y=4F? ,S&AC.J(=XO?ELMO.HRBE;C
M[%NJQG),<@N6LZ)6M;;87!DU^-8A?J;9>=C8:F7(0_8*9[QOO"(R+F+0R(QI
MF+SQX2GC6/A7A=5G2)N3TH9[9X;G3=9RL6=O @/0KB-:NO%2M5+DU3ZXK##2
M5%[L-<NB2)7'V!-J[9=B<QEB>)=                          !]2HJ)E
MY,3 @);5(4VXZ1.N$VCD;(C5[8R/CQ 6V_@"^&7C?15T_JFVC+%IEUA=YG">
MLYC.+V4SU)_(Z:VAH*TKZ2%+,F7*\N5)K-*/06NAC2T[8V0BOY?DD6C-8
M                  T/>/IU$+V;Z-<^JX;K\:=DV*[D8^R_&]T&W6W+;:#.
MU,K3(@RXQMJ0XV1D9ZDDRUT&E,8F?A%NGRI^+6TG75C+M;.3(FSYSIORI4I]
MZ3(?=,B2:WI$A;CSJS))<5*,QFM\\              <MP3$YF=9?08C -)3
M+Z>B#'-3J&4DXI#B^+KB5H06C9\3(QV(S.!<(^ SLL6SG17CE;*9C>Z%C!V^
ML7'F_4W5\R]I<%BO$3\:.PHR4Y'/774S[=1?LX8QT369G.>K=T,U
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MQC=.J9XSM6F<"!'K8Y18I+)HEJ61+4:U<RSU5[8QFI[H
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M=A[I1D3*R!+C/*1).OKE&XE+QD9=WPU[3%>R8FW#1RL3$<6L(0H
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MWU...U-?71N=?WQEJ9((CT+0BT/7EYB8B(T@K$YF9U;7QFL
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MNF-'9B1X\2,VAF/%9:CL,M(0VTTRRVEMIMMMLDH;0A"2(DI(B(BT(9K?L
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M:DW'9:8;(SU/D90EM&I^D^5/:,5OV
M
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MLZQ#H
M
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M"2DB27;Z"&2]'[@
M
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M$W;6D&;KRVL*#((C5&+0^73V-0OC.(T*SF,MLPA0
M
M
M         Z/ZC-TJ7:#9O<3-+F?"@>Y>$9G.KU39<"(AZ?5XM;VK+*/=&3%9
M?<5ZD?U,E:J(O8U,56)F>')RTXA3C^+IU8V/53U79Y:S$M'$QO-\N?KWF8M>
MPT\WD<+$TNJ0[72YC4@B.A3QUT+T:ZGIWV3F<='*QB/EJO$*
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M/4^',H9NQ&'N Z
M
M                                           (DOF:^OVHV7V:5LM4
MY''I<CN/=%E$AC(3B2Y"<JVMSB-$C%6JH):5:R%I-/\ E!<YEI[7M&M?QKNY
MIGC.%7C;6UC>6,NWMY;L^RGNF_,F/F1O2'C(DFXX:221J,DEZ!DI\\
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M<@VXN4[38"^^VF3&K69S:.]4KVANG[*M0M^,;>KD3F<]$L49K
M
M
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M3''+DH([?FI>HALM$TD?L+7_ -/<//L__$GS16^KFV'G^E4]17\21OZO</\
M?(.;J_)MAXGYJ?J*-2%>XL?5"TJ_-[A_TIZ_^9 WP;89);.>;UWKI;.#491C
M3KU7)>A,..1, P2+W3#*9BG3<D2,M:)',;J-#^889I.L23$XX)2_0-X^/3#U
M;.5N*7F05F)YG*I_=1UW(\PVLHX9)A459/L4>I1\UDS$K5,E.)3]3T29&DS+
M0)I$QFNAF<XEOSB38<]DI$&7&FL&I2"?B/M2&34GZ)).LK6@U)]):ZD,U/9
M  !I7\:OKNN>A_IJO<^Q9MI^[CXAGUHPRY JK3GD8[*P9MI*8EC/A)7[6_5J
MG7CZ=-"UTI'"9GDBT\8A""1YJ;J(01DFDC\3U/7;W#^W\9!W?5W:_I>:FZAU
M.QUN4C!H:?:=42=O</(S2A1&9%_XE[3+L'-]3:GA^#YUI6?6]TF8!NS?$S'N
M+?!L.O)L0HE77.LR+Z9EK*D+A5LZ:VPKEHR]KS:%Z->.G+Z1;J5G6.C;"(4
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MF>:;3QB%H34P&ZJKK:QK7NJ^!#@MZJ-1\D2.W'3JI1$:CY6RX^D9SQXJ?0
M                    '7>Z&XM/M=BCV5WCD=J S-A05+DRE0VN]FK4ALN^
M3&EF2C-/ N3C[)#M:S:<0Y,XC*G#\8KK8MNL/J1>O(V2/W.&P\;PU<",B[3=
M5[-O755A DO-/'34Z^_[N6I)ZHT(CTX]HJ\YGAHY6,1QU;7O*X=(CVX_4TSN
ME=5BIU/B68[,73"Y%*4AAEBUB;NLO&F8FXCJ92M5<G57<KUY2X%IQ[6,5F29
MXQ"T9A1&8$.)!CH2W'A1F(C#:"T2AF.TAEI"2,U&24H01$6I\!FI[(
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M@R6L$_)@?R+WG^%S*?BOP :1_.>Z9\X[)\HS4AQ>:J^3G8?@EO3]D[0#:O\
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MIX5!4P:>N89C0X#!1X[##+,=IMM*E*)*&6$-M(21J/@E)$(F<SE6CZPX
M                 #BV;93!PG%+S*[-:6X-'!7-DK6ZPRE+:%H09FY)=981
MQ67%2DE\T=B,SB"9QQ5)WF$^M*5U%]4MKBM!94\W$L>?RVGG(B%3RY3=I1[K
M9PN.A<ZIGSDM&B.ZCF0LTK/M,B(R%^R=(CHFL:]VFOI2VXM=SM^]K,?JF'I#
MG\XF +DI9CS)"DQI&9T<):C*$Q(<06LDO;&6A?/$TC-G9T72?AW[8Q]J^D+8
M_'4MOM3H^!U<2P2^J09DY$FVJVR)N4TR\UH4L]24DC,=O/Y3#E=,LVQ"@
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MO9^>;=SX3L]_*JU$V\I[D:-MO@'_ "X<=_SO;KXW<$%4Y]G+:+A?#?Y+TO\
MF2/_ )2Q#L:.3 Z    CY>8]^0?<_.W$^)C<,73GV3;6%0H(4EU^54_/;DGU
MW/?R,Q@:T\9[HLM#1DMK:\6:OC6/0EU#M25$E!;:7A<QN=V1$NQH=3-7_P"J
M0NFJ;:*6[=MM#.ZVYK+9ZH:W"S1M!D?,1H1DEDE)DKTZD7:)G678T;H/+U.N
M-=<,<V]-50<%2>I:\#W=P(:>K6>R;\EOAAIF>+TIGVG"3K_^VL9SJJ-')AQU
MQ#<&Q;J,#S6S=4E"*_$LDFF:E(21E$IIL@RU<4E'8WZ3(AV(S.')X0IM_&]W
MSD;O]>N^-0IOEAX)N=E[$%PF(C:76[RNQ%3AI>BR'_6"2=07%6FFO#74Q5]<
M='*Z99(^7AV:;WBZM4TSC;RR3BVX+GU)4M'[EH*AXB,XC#ZO^U]@=]6(MF2^
M<<'7'CK[6JVPZH%U:FW6S5C>#+T=]:YO\HI+1W_ZTRRK_L_8'?;JY33BY?Y>
M+>NLVKZU,4QZ<\RR_N%N'ME$A]Z[ ;YU4<#<=3O*4R5'=7H5NG7NDK,M>.G#
M7GKG&8ZNVCFMW<1E)G8IC$U)D:9F/4LI)I,C(TR*V,\1D:3-)D9+]!F0B=78
MT<A''7I6/[AD_6E?]0"I(\S3\O&K_!3,_CDW$&GL_P _]44TGNCUXE_*K&?P
M@IONC&$1JM<8> M_9Y;"?!3A?W3S(5=-=9;J!"D8/S,55">Z4I\YQ7^4<N5E
MR]]R\&MH,_-!]W\\O[HUIXS")\E4&,EIJ7D_Y+S&]F7$WIH<W<(SU3KQ^\3$
MB_4(:5\)CEE,^2RF&:D7/S0'R.;CX/\ >'[-VG&OK\;(MY0JG9W[MF?YU(_;
M5C.=5I=/E*OE7YY\'$'XW]O!=-)3;6%H*,U     "!UYNK^#,2^W])\6F<#7
M_P"7VC_<]E>8,EK!/R8'\B]Y_A<RGXK\ &D?SGNF?..R?*,U(<7FJODYV'X)
M;T_9.T VK_.>R/\ 2LD&*U@%Y-KZ+<C\!LM^,S!Q?^/L3]A   "L+\WS\IW:
M#\,>HW[#V#&E_"OVBOE*'V,UK6/RSGYD;SY^<_E;CHW]G\X[HCSGLE*C!8
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MD0R"Q3;C&<,+2D:F-EH9?Y3+7([6D,G]$DOI&R$3:9U5$1#G@XZ
M     #77XF?6)BO1WTQ[A9U<3H?NG*P[/X-56^NT*)K]E&V[RF\@MMPKFSKO
M652'*OE0A!J4X9D1%H9BZ1QS/+BFTXX0IK.K3J"L.I_?O<C>FPCKB.9WD\W(
M4Q7HD6$^P<R-!CK0\Q"D2HR%?Y$7!"U$7LCEK;IR[$8AC<)=
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M>\_PN93\5^ #2/YSW3/G'9/E&:D.+S57R<[#\$MZ?LG: ;5_G/9'^E9(,5K
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M*M,CN[?(+-;3;*[&[LIEK.4RR1DRTJ7/>?D*::(]$I-6B2[!FM\@
M       &4_1]TYY#U,[UX;MW2%&*/:9%5U5DX]-BPW&T6D>T=CFP<QB3'69^
MYB]>9!D7#AQ%5KNER9Q&5QYX972#BO2)TQ;>XA308965OAVW]U;32A43<KW2
M+;O%J><E,NGK*_OFW'*[4U+)2UZZF>@[><SCIP(C#8J(=
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MCWB"/YY"9M:=9=VQ&CLIMM#2$MMI)"$%HE)=A%[!#CKS  $7/S0'R.;CX/\
M>'[-VG&OK\;(MY0JG9W[MF?YU(_;5C.=5I=WE*733U69XC34OYN(7I]G=_;S
MT:"Z:2FW): #-0     @=>;J_@S$OM_2?%IG U_^7VC_ '/97F#):P3\F!_(
MO>?X7,I^*_ !I'\Y[IGSCLGRC-2'%YJKY.=A^"6]/V3M -J_SGLC_2LD&*U@
M%Y-KZ+<C\!LM^,S!Q?\ C[$_80   K"_-\_*=V@_#'J-^P]@QI?PK]HKY2A]
MC-:UC\LY^9&\^?G/Y6XZ-_9_..Z(\Y[)2HP6  "!)YK+^"U_6-[OU=G1M/\
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M"DJYM%>V+3C<SMC;&O-$<9S*&LM2EJ4M9FI:U&I2C[5*49FHS^:9F,UO$
M            &YOP8.@G)>LKJ7QMF3C<N1AF.VV'7SETO'T7]?WD#<K$*ZP;
M-GW>HW&3CQIRU+7SJ]J1ER\=2ND<YT<G1;W=/&RN-[ [38;MIC<2&Q'QFCB4
M[DB) 56HEHAO2W65G"5-L3CD@YB]$]\YIJ?$<M.9^"(Q'R[O$N@
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MIDLDW:998D2ZS+L<JVCUR:]N5I/N9ZN)&1EV%H6I'RV+4BV,3DK$Q.$H09+
M           =*[^[LP-E=O).<62T-QF+6KK34MR&VGGL75MH+FGR(L?4S1^O
MU]@C%4KNMARTXC*E%Z]MU"W=W]GY4W(BR67,8QJ&3L4XJF^>%%?;-/-#?D,Z
MES\?;:^R.WG-LD<&%8AULW\)'&G\IZP:>L9;<7S8%G+IFA#RB(V8,56AFRVX
MHCT/V!IZO--^$+K&LKF*N*F)'YB;2M:_;*-9ZK/4^)D1C-6CZ
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M!^&/4;]A[!C2_A7[17RE#[&:UK'Y9S\R-Y\_.?RMQT;^S^<=T1YSV2E1@L
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M.#)8                               #^&DC[2 ?SD3[']\_\(#R
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M<P]MIAMK7D(^.G:>O9K_ (0=?L      /X9$?: _G(GV/[Y_X0'D1:<"
M ?PR(^T!_.1/L?WS_P (#R(M.!      #\76&WM.<C/3V#T#0>J59%(^;1>I
M?^V?SQW+F(>XVTAHC)!&1'IVGKV:Z?JCCK]      !XK0E:32KL,M/8[0'HG
M6Q34:C2O4]?IS])Z@YB'LMQVFCU01^QQ,S].H.OW            T[3]GM
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
2                    '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>lg_morganlewis-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_morganlewis-bw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!! 9R P$1  (1 0,1 ?_$ ,T  0 " @(# 0$
M       *"P@)!@<#! 4! @$! 0$!                  $" Q    8" 0($
M @0$"0\5#@,)  $" P0%!@<($1(A$PD*,11!(A4747$R%F%"([6V-W<8.5(S
MD[/3)#4V5G:7M]<X&H&1H4-S-%1TM"5UE2;6)U<HB,@926)R8Y1%EJ9'9X>G
M2%@I4V6&@I)$U%751F;&$0$!  $# P,% 0$! 0$!     1$A,0)!41)A<3*!
M(D(#,Q-2H9'QL?_:  P# 0 "$0,1 #\ G\
M
M
M
M
M
M
M
M
M               .&[!V#A>J<+R+8NQ<BKL2PC$JY=MDF26RW&ZZGKFW&VES
M)BVFW7$LI<=21F23/J8"))ZB7NV./?&7+&\%XV:QQ7EBA#3JKC+<0Y"R<!*B
MMH&27%++H)%9*T5F7G/E#KFI:EE(21)D$CM/M[E:Q)KNFM:1+7WBO(&=?PK2
M%QWRFLK(\B"[(HV^3<9YF8U&=2N2PN2?'AHVTS4$:3/RU=O7KT,:\^'_ "SX
M\N[;3P1]X9IS=V?T.N^2VA,?XRXN_:8_4V>W\PY+OYE#C0[!N]=M+YZ@B\?,
M66MNI7 C(6T4TN_YI)DM/;T5C2YNS6R89J#=VJ-^XA#S[3>=4>PL.L&*^5"R
M#'W7GJ^3'MJR'=5SK:WV6%FF75V#+Z/JE]1P@LLW)9=G:8B@
M
M
M
M
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M1=#.>-\?+IDSKAN(&5
M
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M6+!">AH\%$?7H70SEXXF=#.N&X(94
M                                       &)7/++).&\+^5UW7FVBVC
M<;=\/4SSZ&W8S%K%U3ELN ]+:<6GS8S<EA)K274U)(R%GH51^;4RC(LUV'EF
M5Y;)@R\DO+5R=;R:R.46 ]+6TTA2XL<O!EKL07A^$+<W-'7X@    NC?11V5
MDFU^#5#EV5R($JW>V3L. MVMBMPXQL0;"(AA),MK6DEDE1]3Z^(W^RYY,\9B
M-M8PT                      "N4]ZG 5%V-PAE'.^9*=;<MUIC^5Y?R?E
M-<8B-'F>8OS?,\SX]$].T;Y?&)-Z@Y#"@#G&M=E9WIW.\8V=K')[/#,^PRS1
M<XME-,MMJTI+1IMQEN;"<>;>;2\EMY1$9I4710;"V?\ ;]^LSC7J:\<J[$<W
MQF'K#>6EV,:U+(I['92]A9)NAC!-7X7)R3=*TMZ^P:/C"<@N9TA3U;UL/EW$
MJZ2G"/PNNYZ)$(@                T%>N_ZN>,^FUQ].FQ^=#7N?;^*[,C
MZV<BYPK$,AI\AUY)UVJ4=0TK#,K8M)3S&<M]Q+5&)DDE_'._ZFI)O?\ ]2WI
M%2MN_=&<[^V;F.T=@75E=7V7Y1DV2ONVDMN=*C+R;(++(I494QJ)!3*-,VS<
M-3GE-]ZC-7:GKVE+<JZE$ !.^]F96R',FV5:)MU-1F,RSF*NE^7)2)+B]<X2
MI,TY/G$:#;)73M[#Z]/B.D_G?=G\_HL.AS:
M
M                                               5.7NE*:=7<_<N
ML).1.6\:WVAM]V%4KB%'1CZ(];J@G&&WRDO'**4;R3,S0WV^7\#Z^&N7QB3>
MHR@RH  )H_LY*]2^5MW9?.&A+%?M",<'RNI.FO",55YWG>87;V]W3IVGUZ?$
M;GPONG598C"@
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M $6VA_7UFW]K?!QTG\K[L7^GT6%@YM@
M
M                                          *HKW4?]_=<?NE[F_6[
M40WR^,9F]1?!AH  $UCV<']\UD7^8;,_8-B@U/A?=/R^BR@&5
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MD1D9&8LTU%K5'C1HC9,Q([$5DC-1-1VFV6R4K\I1(;2E/4_I/H(/.
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MO@XZ3^5]V+_3Z+"P<VP
M
M                              %49[J7^_MMOW2]S_K=J(;Y?&)-ZB]#
M"@  FL>S@_OFLB_S'9G[!L4&I\+[I^7T64 RH
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MM'7V:)[\5RNJNT].O6$XXLNGE(>_3M(_RIQ*OQ&,WC9NLLNSGPB@
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MA_GS['EQ[N\*VTK[B*4VLEM38JEK;)]DS-!K;/HM/4R(^J3,8:W>^
M            "J+]U(73G=;G^'9>YOUNU$-\OC&9O47L8:  !-7]G ?_ "F\
MB+_P&S/V#8H-3X7W3\EE",J                    ^7;7=511ES+><Q BH
M0MQ;T@S2A*&S02U&9$H^B3<+K^,,9V2V1TS<\H>/^//?+W6U,6KGS(S\N3(D
MI5T2XIHS^K%5\'$&7XR&O#GV3RX]WS5\N.-C?EDO<.()\UQ+3?63*^NXK\E)
M?SI\3%_SY]CRX]W9.-;8USF)QBQC+JFZ.9Y?RQ0W'5>=YOF>7V=[2/R_*5T_
M$,WC9NN9788B@                                        #^26E2E
M)2HC4CH2B+XIZ]>G7\?0!_0                  _#,DD:E'T(OB?X '764
M[<UKA*>_*\QIZ-)&E/6<XZDNY3BV4E]1I?Q<;47XR&IQY7:);)NZZ+EOQM4D
MUEN'$#277J92973P^/\ _"?0+X<^U3RX]WOUW*/C[;/(8K=K8K,><4E*&V9$
MDU*4ON-)$1QB\3[#_P 83PY]CRX]W<M3?4]ZPW*J+"//CNH0XVZP:C2I#C:7
M4*+N2D^BFUD?XC&<+F5]<%        5T?O7?Z?>"?^R?+S^5<7AJ[1)O4&,9
M4     ?2I[FXQVSA7>/VUE1W-:\4FNMZ>=*K+.!(21I2_"GPG6)45XDJ,B4A
M:5=#^("TS]MQZRM!S2U/0<7MD?.Q]W:XHJ?%<35!K<GG5M]@FL=785!GWV1Y
M+D%W;=,EF6*'U.(:)MMT_K$DC48U=9E$K,94       !%K]QEZRE1P>TA(T-
M@"IK>U=XXYMC&:VX^0RF!)Q^[P.1K"2S(I<EQR\J'*M;S.9+);RN\S[2)/;]
M;KN3QGE?HSG-Q%5]F&46N;Y;E.:7K[LJ[R_([O*+F4_(DRWY-K?V<JVL'WI<
MQU^7)=>ERUJ4XZM;BS/JI1J,S&&G'      !/,]F3_1;:']?6;?VM\''2?RO
MNQ?Z?186#FV      #P29#<2-(E/&9-1F'9#II+N43;+:G%FE/TGVI/H0".'
MZD?N0^*/!3*+#5\)O(KW:M5-RNFG5EUKW))F/)N\>1C#S3+5I475<;D1UF^4
M:U]?$TIZ=/'KN<9/DS;>B'KRX]V!S=Y$6%A5XS@VM-78Y7V+\6AM=<7VY,3N
M;&E@7-A)JIMJEO8ZVTV$^"^V4DDI2GZI)(B(@G+&F)5QG5HHV;ZB/-?:5ZN\
MN^4G(B+W1HT<JR'O;;*ZULXS:VB?1'EY?([7G4+,E'U\1+RN<S1<.IE\J^4+
MBS=<Y([[6XH^JG%[AV&I:C_":SR(U&8GER[U,1^?OJN4'<2_WR&^N\B[25]\
M&PNXD_@)7YQ=2(/+EWIB=G/<4Y[<UL0O*J\JN6O)A+E790+%4/[_ #;+,.P3
M F,3?D9[<;+F5/PI*V"2ZCK]9)F&:K>5QA]U9SPX[(9@S</UUM>*94[3\O:6
M3[FR:8E%3]K&;B#/8[1&Y/.T_5_#Z_DM_P 2-7EF8Q(F-<YJ77P2]T=PXY*8
MQ#K]M(RC$ML_*1'K*CPC6>4/XLR]'QZIFWZ(]C;7ME(6B-=2I#3'59]["$&?
M4S,S>,OQ,]THP84       !'2]Q?SCSSA-QTQ2\US83*_*<MQ/<<FK7%L\DJ
M4*FXG*U0E@WIN-6]/*9)",F7T4:S474^TRZJZ].&)+6>6\048GN5N?45AEGS
MJU_R66VO,>V!NA;CGEH2CO<5]XGUEJ[>IG^$Q?\ 3TB>'K7G+W+G/HBZ=U3_
M .?VZ/[H@?Z^D/#UK^D>Y>Y](5W?ZSJ\2/HK/MSFG_&^\03_ $](>'K6[#V]
MOK1\F^6?.Z/I/;-@J=6WN$;0S%#+N5[(O&8YTM372(S##61Y=;0&F6GG%=J3
M:-22_),CZAY3E,62'C>ZPB'-L 5^GN /<I62,JO.('"F18U<'#,AEU.V-DS&
MMB:XV-0[5UIL+*\9R'%L3NL;RZIB6.%3(E6PI3QLJ5(4I7UB21$6IIN(+.?;
MBVYM5UI_:&T]C[(>86TXR]GV;Y-F#K+C+3C#*VG,AL[%;:VF'5H29&1I0HR+
MP,Q,T=<"#LK"MS[AUM(*7KK:^RL!EI;6TF5A6=91BTA+3C2&7&R>H[6"X3;C
M+:4*+KT-*2(_ B%S1.O]#/W0DVUV'CO%+G!#)FKV!D-3C&G\^QF!L78.>WVW
M=E[!Q7&,=QC+;7(\PMXE9A4>):OK)\F4J86A/4S29D:W*283_P 10    !A?
MSDYVZ,]/[4C.W]\S<BA8Y8SK2EJ#QO')62R7KJOQFYR<F9,.(_'=:BJ@4CW5
M?=^5T27B?463*6H1?./WC>?VZ+?".(6KM;7N&9 5_72LPSBCVEB&;5%>C["<
MQ^?3KJ<]@,LV,EQ4Y+YF@R0EMOH1=Q];I+F:FMF*BZ\@_5HYS\@[URYL^0NZ
M<(8<6^O[$PC=VX*ZE0IZSFV:>R%(S:2@OESF>4W_ !+3:2^@2\LW,T,,3YG*
MGE!8H)JPY(;ZGMD?4FYFX-A2D$9I-)F2'\B6GJ:5&7XC#RY=Z8G9ZD7DUR1@
MGUA<@MWQ#/MZG%VOGD<S[>O;XM7Z/R>X^GX.H>7+O3$<QJ^;W-&D+MI>7O*"
MH3^"KW]M> 7Y*4?")EC1?D)(OQ$1!;;N8B3/PP]W9RSTHWBNO-L:RU1F6 JR
MZ-*RG.LBD[@R_8,3'K>]KCOSKG)6Q5L2'JBE)]<)I3:D^824F1D9D+;.5UT,
M8B?[P ]0G1_J'ZH9V?I:3?O18U'C%S=-7>-S<<3'1EKV2,U*8C$Z3*>=)9XO
M*[R-1FCHGK^40<N.->E)?_J,'[F[U9>1/ ?DCIC6&J7V89YEI"/G!MMY'GM.
MRZ7WDYQ0J=>/%<HI(QO_ "U.@OKH4OZ.[MZ$5G*<9B26I9;<HR[7N6.?3326
MO,JU]JC5WKS_ '.:SZ_09_>)XD0U_IZ1/#UKR?X2[SZZ&7=4^/\ _OVZ/[H@
M?Z>D/#UKTI_N4.?4]GR?F8$7Q2?F1M@[G;<^J?7IW?>(?@?TB?Z>D/#UJP.]
MNOR\V=S?]-C&-[[<-@\QL-N[7QEXX]GD%NW]GXY:P8T'^?,FM;FT4?8\?5)O
MFA/Z4B&.5\KEJ3$PWIB*      #7AZA7J:<:O35PS&LPY%6&6P8V:5^93\83
MBV)3<K\]&".8FB^*<W"DQEQ?+_/.%Y1=>KO<OI^0?6R9UZ"$)SD]X/NW.)\[
M!>,.L=9%KERP<G1LVN(6U\.S\DUU[9IJHQ_9NP(D=$>PHBC.24DW_'EK270B
M(BLLXW,U9Q;,71&5W;ZH?./=]Z=S;\EM]8VQY$1DJ/&MY[>C4J516'8YOIA2
M<TDH)^0AX_,5^F$MMN5PQV=Y5\H7W3?>Y([[>>4HU&\[N'8;CIJ/IU4;B\B-
M9J/I\>H>7+O3$?R?*?DZ:B6?([?)K(NTEGM_8)J(OP$K\X>I$'ER[TQ'9.%>
MH%S:P;):#(ZOEIR7>517=5<G5/[]VVBKM2J["-8?9MI'CY>R<FNG*C$V^WU+
MO;49!FKA*,X3>\&Y%:\M=::WY$:KU/-U+6/UM1F>Q([.V\OV>=$PFS=EVK!6
M&PY,6PN5//LI^NRI*D%\/ 7,Y7-T3%BP!X@<O-4\TM0U&X-1R+F1C\Z%C[DK
M[:I)-$^U,O<8I\H;:9B2GGW393"N6O$U&9'U2?4RZARXWB2Y0[?<B>L3OOA3
MS%=TCIFQ?8>AXAKG()K#F1; HXJ(>18]<R'7&E8OE5+#6^<IEOJ7E]3+Q/J9
M$8U.4G':6Y2\<W.J/$Q[EGGTS&C1_,JW/ET&CS7,_P!T&Z[U_3.J^\3ZRA?]
M/2)X:[UY#]R[SZ,NG6I+\6?;G_NB"?Z>D6\<]:].P]RCSZGH2CYF!%[5=>Z+
ML'=#9G]4T]#/[Q#ZEXA_IZ1/#UJRJ]';D'D_)STX>)VX<Y=-[-LTU)37^3NG
M+M; EV,ZTO&#45A=S;&SF?J<$OKO/.+_  G\!CEK<]VIIHV;"*  #27[@/F'
MG/!CT[,DWWKPT)R.OVOJ[&&S<FWT!/RF26DV-*_GC'+2HLR/M9+P)XD'^F(Q
M>-Q<XE2S,PKP,5]Q_P ^L7H&:'[5;NO)F2)?VI<[&W/*LW/F#Z^0Y(^\-/<P
MU^E+IX#<_9CI&;PSUK[_ /A+O/K^*J/_ #^W1_=%%_T](>%[UYF/<Q<^F'2=
M[:5WHDT]CF>[H4CQ^GI]XOQ(/]?2'AZU)3]K#ZIN_P#F_P @]Y:<W-;R[EC!
M]$V.P84N=D^=Y'*.8YLK!J%I"G,LR:[BI;;BV[A%Y;:'"^'=VF9'B\LS&(LF
M+E(H]4KU9^.OI88)AEUNV1D?YU;9K-@2-5UU1B%GE%393=;.80G(VL@>JYT!
M^J8;1GT$VC[^KIJ7T,NP^LDF==EN>FZ"!SR]V!RFY"IE89J#$L)U[A[5@EZ#
MEF'66WL'S)Z-5WED]6ID+B;"2RG[1JW6?FDD@B-75)="(:S)\=?<QE'7SOGU
MS/V#9*L;SE/R,4E3#+/R);UVM(A)\EM;7F)9F9;((EN(69*/Z2/H,YO30Q'7
M1\J.3Q_'D?OD_P >W]A?[X0\N7>F)VCSL<L>4\57?%Y+<@(R^AEWL;EV*RKH
M?@9=S>1I/H9!Y<N],3LS7XW>LMSPXY6]3:0]Z;8V4S56L.U*HV1NG<=W4S51
M;>#;*BS(C6=1D.Q97R7D.I\.YAQ:?I"7!A*FX;>\G?D6^(T',36>!X9A<=^I
MBY'D.L,3V9E&3HKUIM57$J.BVSFQ9E36'$Q":[D&2B6OJ1]"Z7[;,]37Z)O7
M&ODQJ[E?K&DVYJ&7=3,.R"MH;:N>OJ=ZDL%0\CQ^KR:L-V"^XZMIQ57;LFM)
MG]19FGZ Y<;QW)9=F0(RH               "J+]U(9?O[;<OP;+W/U_VNU$
M-\OC&9O47L8:  !-7]G#T_?-Y%^'R-F?XWYC8H-SX7W9_)90C#0
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M%9*S[9E^]DN4R*:N;J*MVT?88CN+A5K2W&X;/EQD]$$HR(PMS<K-'40@
M  #8UZ77J"9=Z:G*2LY*8="^?M*[#,QQ(HQ4]9=K-G+84:&^LH5M/KHADE,8
MOK&X2D_01BS'79+GHWR^Y[Y!:5Y>QM<\DM17M?-CWF<XUA+]4C)\<O+..WC.
M"Y:A^6]&QJUMX+,9<@T)2OS35U,B41&8Z<IX\),YN69<\KV1 !R;  !<\>@,
M9GZ-WI\%^#0%/^OE\ W     C=>ZP>6QZ2&8.-].XMZ:3+Q+J70[JR(_ 6;B
MI,$   2\/;R\\=/<#=&\I=F764T%1MISCONJ+@$&XR;$(A2,QKYU3DN&M*QW
M(KRJD6R9%K3-?SNRE;LDNJ$I/J.DDO#>:,VV5&8Y:<D<XY?\D-O<F-E+@.9W
MN3+9&89.NLK(]- 59R8L2(LXM7%>?CPFO+B)^HA:B(_I'-ICL       #,7A
MYSIWYP9S=>P="6&+U^1+BVT13F3XU&R2)Y-U#C09Q%%DO,I[E1XB"2?7ZI]3
M^D6<K-DLRM=O21]:70OJ4ZM1=KR&GP#8Z;:_CN8+G&3ZZH<N=@P+RLHZMUG%
M*K++.Q-%I*LT%'7V='S/HGJHR(]62Z\=DEQIR;O1AH              %47[
MJ3I^_MM^GQ^\O<_7_:[40WR^,9F]1>QAH  $UCV<']\UD7^8;,_8-B@U/A?=
M/R^BR@&5              !_#CC;+:W75H:::0IQQQQ24-MMH2:EK6M1DE"$
M)(S,S/H1 (V7KB^X%T_Z;&O/NVTY;5FS>46R*K9%1A<G![G6NP,?TEF> NZ^
M=:7O+%',PC7]-%R2)FR_L]@XJW9!P9)]I$WU.X%7+RCY2[4Y>;3N=N[>E4LO
M++JPOI\EVBIF:.%YF0Y%:Y/.[8,=UUM!'97#QI(CZ)09)+P(+;4DPQQ$4
M   'E8>7'>9?;Z>8PZV\CJ74N]M9+3U+Z2[D@)I7H5>YERWCK38#PYY9U[=Y
MI['(^ X!HNYPS'L'Q=G!:" K.9V:R-F97DV4TJIR;%^=4E#?2E?E>0\2NWO3
MW:F+<7=*L9-5;4PC<V"8UL+ ,AI<AH,FH:*^8=I;NHO4PF[^GA7<6%-E4LV?
M"1-;A3VS4E+AD?4C(S29&<LQ<++EV*(   I=?6@].E/IG<R;;CU3D_98O$P+
M LFB9''>OK6FDV.55LV=)@,7EU5U:WY;"8AFMDD_4(O#J74:Y8SGCLDSC7=J
M1&5 'T:>TET=M5W<!2$SJ>QA6D)3J"<;3+KY+4N,IQL^A.()YE/5/TEX +;W
MVUO.2IY8\$\-UH4R#*S+C=K35=/FZ(+U#V,6&=V.S789'!JK2=85Y+;P]SHF
M:U'6KH?82NBNW?*3$O6I-ZD5#"@    "$+[P7FWA^"ZMT=QUQ7(*+)[_ &C2
M\E,3SJKQ^UQN\LL(E4KO'Z56,Y9"8MCM\8>LDVL@V$NL$X\3#G0NB#&I<<;.
MZ69LO97 C*@  L9?9R<UL9NM0[8XH9;/@JVA;[4MLRP^'&F4$)Q6"XEJK7]6
M\X[3N6B<AGN(DP7"5):B+CETZ*61D9%K&9E,ZX3DQE0    !'E]Q'ZAN-<)N
M)IPFTJG; N\FU]<5=5'<QV7,>H9>06]5,DHI;2X@3Y#33U>KJ\VVIM'P[NO4
MBWP^W[V>4S]JHA&&@  ;<O11X6["YF\ZM20,!<C-MZ1V#J+=>7_,P<@F&K$L
M7W#@K-HEA5!4VIQ'S3,+H[)\F,G],XGP&N,REN%S=C].Q04U=31NOD5\=,=K
MJM2S[4J4KQ6HB4KQ5])#-W79]@  0OO>0K4G1/&<BZ=%8SR@)7X?"1QTZ=/\
M<;X_&I8K2!A0  3=O9M.++?&7-$9>6J5L=1ET\>XL"Q OC^#H0W/A9ZL_DL@
MAAH   !Q_*LLQ7!<=MLOS?)L?PW$Z"(J?>Y1E5S78]CM+!0I*%S;:ZMY,.MK
MHB5K21N/.H01F1=?$!7!^X/]Q#E.[LSF<6N*4BF8TAC$^1#SNROZG"<O7E6Q
M]>[#RRLCY/AV5XUDMPE.'6M+&B.1FUDA;R3\PTD2BZZE\=9NEF4*,94
M    3./:9<C^>4K?EQQGU)45T+C'DD7/LZS;/[O5ES;8W5[+Q["<6KZ:AE[)
MA0I-;3V4RFAQ5MUSBTNO=W>1=%D-<<9^[.$N>FZS &5    5TGO7OZ?."?\
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M%T4DS2HC^)*2?0R/\1D _  !/,]F3_1;:']?6;?VM\''2?RONQ?Z?186#FV
M   Q)YI\Q=7<(]%9MNS9=I2M,XMC5MD57C]Q=O8ZG)4TLBICV$5FX:IK\X)1
MCN6#6X<5[IWD7:?7PLEOLEN/=3[^I[ZDV\O4'W]F^6[ SO)+[!:S*\RJ]<T%
MID4?)*VEP0\_R;(,3JJF<UCV/.+K*R%;I0P:F24I)=Q].O:2WI-E:Q1
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M[^@-_ W>GS^X!3_KY?@-P(   (VGNMOX(S,?W==)?KW9"S<5*0@
M     #(CB_R;VEQ-V]B6W=5Y'=4-G09%BUK<1*2Q9J7LFIL<R>HR9W')%B]7
MVI0H]E(J&TFZ4=TVCZ*[%].T[QY7C=$LRM_/1M]2O7_J1\6,5S*HOZN3MO$,
M*PBPW9A[&4N99>X/>YS,S-ND@9%9*QG%V7),YG#I2FUML$2R:5U2GM+NO+&\
MV)G:MN@RH             JBO=2'_P NZX\/ALO<WC^'_6[40WR^,9F]1?!A
MH  $U?V<)?\ *;R$_P#P&S"_]!L4&Y\+[L_DLH1AH              $=/W
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M:U=Q$G6DXZS=-ZKBG77'W7'G5FXZ\XMUU:OREN.*-:UG^BI1F8RKQ@
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M^!;+*4Y-D0$DE#41LU(^8C*+K^#H8M_7RDST2<Y;B-50PT      "U[]H=_
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ME\8S-ZB]C#0  )J_LX2_Y3>0G_X#9GA]'](V*#<^%]V?R64(PT
M   .GMY[SP'CO@,C9.R9%G%QB+9UM0Z[45KEK,*9:N+:B)3$:6A:FU+0?<KK
M]462\KB;I;A23\T>8VU.:FVY&U-G9#<6DYVEHJE$&9D&3W4%C[#BOQ&)#*,F
MN+B2W(-F0I)J)?0B,R+H1F+RN;IL31B ,J  "1UZ1'MZ-V>I"_2;"RNU8Q+C
M\ZK";6_R3$LTQF+G$3%LM_/%KYN!27U%<,.V34G%B)+:D&1)49F1]2Z;\<27
MEU3.=)O$VO0WM>^!>DXM>E^WR[8S\:N9B/?>%ANF+XG'2KHD)QY:CURT:W>^
M,;G=]+BU'](3GCI$LRR:SCT". N:U,RK^[O%L<^<BRHOSV/:GTO!FQ_F8C\3
MSF'?N_5V/,^=YB#^A:2/Z!?]/2)X>M1\/47]H5BSF&R\SX69YF.19Y'K\JL'
ML9V#=ZQPS$DV:EXRC'(:%TN"UD@X+S:; WC\SJVI".AEWGUSF<M]VKI[( FR
ML R+4^QL_P!6Y>W$9RS6N:Y5@&4,P)29T%K(L-O9^.W3<*:A*43(B+*N=)MT
MB(G$$2B+Q&5<*  'D:>>87YC#KC+A$9=[2U-KZ'\2[D&1]# 6R_MKO4FS7G1
MQ>E4^UW5RMG8_=;!O[&6J7E-PE5#%R:CJ*QLKS*+NZEOFG[2_C/?T1]'0NI'
MOEK/+9F:7"2Z,- #H;D_I2EY#\?-T::N*VOG+V1JC9."5<J;#K9+]/9YKA-[
MBL:WJWK2)-C5]E#.W[FI'8?EGXF1EU([+_\ $NJDWYX<97.&G,#?W%UV?+M'
M-*9[+PQ=A.E09LR4<:#!F>;(EUL6#!?</YSIW---I\/@%QG38F<:[L2!% '9
M6G=IY/I'9V&;8PQ]<;*,%N6[RD?;F6%>MJ:TR\RE29M5*A6,<^Q]7UF74+_1
M%EQ<EF5SMZ2?+1_E[PUU9FT]AMJYQG ]6XM?N(:LTJEW:=5X;;V4IV1;39\J
M<Z[+LE&;QKZN?$^I]3/7.8LO>)&S@84  $9'W.7/F)Q,X:IP:KF63%]NFSR[
M4=HW':NVXJZ?.].["8)"Y-/95Z724XVGN0^3K'3\I!C?'29NU2ZZ*G484
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MLNJB:)2OTQF'+EY7))B8=T#*@  A=^\C_:+XR?HXURB_U1QT^ WQ^-%:6,
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M/1)?$!:W>W)]%W'/3@UAD6[]BMV4KEEL.+F.L\SN(-EE$3"W]8HRS'LEQN+
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M1#?+XQF;U%[&&@  35_9PE_RF\B/Z?(V87_H-B@W/A?=/R64(PH
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M2-+K7F.I(CZ),68ZI5P TZT^VAYAUMYIPNYMUI:7&UI_BD+09I47Z)&(KR
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M.I6VDS\"073J=Y7-]DDPVCC*@   (7?O(_VC.,G];7*+_5''0;X_&BM+&
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M)FW[HJN!S:  !*2]I2:?^M HD]"-9ZDW,9=2Z^!8[3?2-<1:S#(
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MRL>7[EY*CP(T61/>9;XME&7+DLM(>FJ:)USM-Q2C3W'TZ=3&K=(S-Z@L#+0
M )]/LPY]LB+MNN;D.IIGME9C(D1BDO):7,1K/!$MN*BDX3"UI0DOK&DU%^$=
M)_.^[%^<]E@>.;8           "J*]U)_?W7'[I>YOUNU$-\OC&9O47P8:
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M1V8E?4U\.L@18S+4:/&A0([<6+'8CL(;88998:2E*$)2A*2(B(B+H,M/H
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M\WGUPR^?=0U\ORLXXR(O<^ECOE(W/A/EH+N,O,,^OY)>)BS'47C(@
M J2/<\'#/GU7_*$LNF+YOY_>M*^K_P!]&QN\T]IGVI_0\!U_9T]F.'7W1OAR
M;  !:]^T._@;<*_=_P![?K[6 )/H  TH>O;DU[C? 79?V'!DSOM?$-MU%E\O
M 7.^6KI6E]@>?)>["_G9IOM+JX?@D=/U]?9CET]U-L.;8  -OGH%(2YZR'I\
M(5U[5;^J"/IX'T^PK[Z0%SVDB2DDE\$D1%^(BZ$ _0       4T?KST%-C?J
M"9%644A$FO1JW6;R76Y:9J3=>K9INI\]/4C,C+X?0.G[?FSPV:8QS:  !<[^
M@-_ W>GS^X!3_KY?@-P(   (VGNMOX(S,?W==)?KW9"S<5*0@  #?I[=#I^_
MZQ_K_P#C:UZ?C^^?7HZ?KZ^S/+I[K@0<V@      5V?O9_Z<^ O^R',#^5\6
MAJ[1)O4%,94  $X_V:LR0G;><0D]/E7;C8+R_J=3\U.O\.)/1?T%T+X#<_G?
M=G\EC2,-            *HSW4O\ ?VVW[I>Y_P!;M0C?+XQ)O47H84  $UCV
M<']\UD7^8;,_8-B@U/A?=/R^BR@&5            8>\_P!2D\,^0RD^*BU]
M,Z>'7Q^>@?1](UP^<3ELI)^09F>^]WF?Q/;VRC/Z/$\SNNHG+Y7W)LZA$4
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M^9<J=@S]=S]J,Q&EU-O70/L92F\X<_4VS<[^GUNG1/77+$Q.L29^B2(,J
M  (7GO(OVB^,OP_I:Y0_C_SQQT^ WQ^-%:4,   )N?LV_P!OO+/],['_ &!X
MB-3X7W3\OHLA1E0   ''\JQFKS+';;%[M#SE5=1%0IR([QQWU,*4E9DV\DC4
MVKN07CT%EQ<Q+,S"OE]>'VQ$S$\BG<J^!T>RLL4R>T=F;8U;9R-C[/VID&V=
MA9WD]Y<99B57CF'VL.OP>#6SXR'&5/I4PXA9]II,C-O=50A-@ZBVQJ6>FJVI
MK#8>L[126%IK=@X5DF&3U)DMK>C*3#R.LK9!ID,M*6@^WZZ4F9=2(Q!UX
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MO9O6[NL+Z\Q'(+JLNZ_#Y6.GG^Q&$0*.55MFATIQJ>41'VHZ=#9TPK<P(
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M2GCFT  #*3@Y3)R/FMP_QY;Q1D7W*3C]3*D&UYY,)M-LXE!4\;'FL^<31/\
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M)-Z@IC*@  G$^S64?WQ9JGKX':[#,R_1_,##AN?SONS^2QO&&@
M %49[J7^_MMOW2]S_K=J$;Y?&)-ZB]#"@  FK^SA_OF\B\/\HV9X_P#Z&Q3P
M&Y\+[L_DLH1AH           !C1S'HEY-Q@W30-D9KM,,E14D3?G&9JEPU>#
M7F-=_P"3\.XAKA\XSR^-4B/*" JKY+\B*Q1=%5V\]MP%$:>PR5$S_((YD:.Y
M?9XM_#J?3\)B<OE?=9LZ,$4 =FZDUC:[<S!G#J9Q]J<] G6"51X2;!SRX*$K
M<+Y=4R"1D9*\3\PNGX#%DS1)DM/:>\T8-) LH5EL*SL95FJ'*IF]%P&78,,F
MW%E8KD'NATG6U*22>SL3^5\1N\./_3/E>SX9^U0YQ]?\[[(/_P!R=?\ W80\
M./\ T9O9^?X*ASC_ -#[(_L*5_\ =A#PX?\ 1F]C_!4.<?\ H?9']A2O_NPA
MX</^C-['^"H<X_\ 0^R/["E?_=A#PX?]&;V/\%0YQ_Z'V1_84K_[L(>'#_HS
M>Q_@J'./_0^R/["E?_=A#PX?]&;V/\%0YQ_Z'V1_84K_ .["'AP_Z,WL?X*A
MSC_T/LC^PI7_ -V$/#A_T9O9Z,GVK/.QEPTLU6RY*221DM.F*Y!&9E^3T^]Y
M7P$\>/<S>R>IZ('!W8_!?B3BFN]FWMM/R![!<!J9-%<8JUB\K&I6,S<Y=EQE
MMLY+DB9*Y2<B:-1=Z/+\LO%7=]5RY9DX]CC-;>[<\,-   ^1>4%/DD!59>U\
M>S@+=;>5%DI4IHW63,VEF25)/N09^'B$N-A3+^M+P$=]/;F%9Z:K(*OS5:P;
M KJ':LXU^:L%^SR*LG3I,5NJ/(LF6EYM$4S-?S)DOIU[4_ :Y29TV2-0PRH
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M8W'C1*+%*QNJK(\2.J)&9C-N..)0S&7(E*91W.GX&XO\8EN;DDQ,.<B*
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MS3^T)'S3L)ORV,>W1@/>XQ\[&D][Z?.\";['#^A1#?"9SZ1+<?\ U<O#"@
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MN/N8OV=+9U;DK+,%T[@2KF3\S9S9J[7SG9G=\T@T(=,S,DD8MQT26[5O $4
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MEB6S1R&HI8KGN)73,N.DZPKIF2E55X+7)4T7Z5)'T,:S/'$W37/HF]C*@
M   A=^\C_:,XR?UM<HO]4<=!OC\:*TL8   3=/9MD?W]9:?T?,['+_T"Q$:G
MPONGY?19"#*@        #IW8/'?C_MIA47:NC-.[-BJ<0\J-L'66%9FPIUMY
MR0VZIG(Z2R;-QN0\MQ*NG4EK-1>)F8N;MT&AWGQ[9G@SS/JDO4?VKQ]NJ7_7
M6GBZ'PC36!P;>TKZ&TKJ^MN7$:\?6JKG2YR')'0TGWMI41EVB^69BLR8U0:?
M5 ]N_P I_3SJ\FV@I>.W>BZIG*[JKOK7/\>L<PDXUC)XNR[)ETM/35K:9ZI&
M1I+RTI(E)+J73H?5XYS>/QAG&)=ZCPC+0  /=@6-A52"EUD^;72B0I!28$I^
M'()"RZ+03T=;;A(61>)=>A@+Q?@)R$;Y.<>:W:;2G5)EY5D]+U>;G-KZT\IE
MD_JV,F7)Z?JGTKZ?@(AOG).6)LSQSC5FH,-   KH_>N_T^\$_P#9/EY_*N+P
MU=HDWJ#&,J  ">Y[,7^.;6_=#S/^UK@HZ3^=]V;\Y[+!P<V@
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ME]&.7RBJW'-L  $I'VE*.OJA42C,O#4>YB[>OB?^YVF\2(:XBUG&0
M   %9_[OSA>>M>1N.\L:V%8MX_L%O6^IH\J1]LO1ES:/",JN'VT27J]NF4XE
M-89FEN0MXB+Q01=3+=UX^5W2:7"&.,*  #(+BIR0S_B%R)U+R7U6]6Q]AZ<R
MN/F&)O7%6Q=5C=K&BRHC:IE5)=98G,^5+7U0I:2,_I 6JWI/^X7XL^H9A=!0
MY7.+2VVL;H:RFSY_;F5ZJP:KRK,:/#,?LLPR;#:AK.)=@C$K2\L'TPN]I"D$
M@T*2DT]!9,S*9UPD,1I<6:T3\.3'ELFHTD]&>;?:-2?!22<:4M!J3])=? 17
ML  #65SD]5OB1PCUM>9=E6UM?9?E$.JNY4/7V'[.UA)SI3L+%[G(:Y[\V[?+
MZV8ZQ9N511X_U>CS[J$E\1J<;UT3/;54]^JUZDN8>I5R1R;:=C .EUU!R[+[
MK5M!8TM359135.91<39M(N3/TUC9P9\PW<2CF@T/+2@NO0S[CZ.7+.G2$F->
MM:P!E0   %KW[0[^!MPK]W_>WZ^U@"3Z  /7F16IT25"?)1L3([\5XDJ[5&U
M(:4TX25%XI4:%GT/Z %3S[HC@](XN\XK3=B6I#=1RPV/N+(J8Y!W2S4QK^OU
M+'=[7;*MAP'.BLS3U.&[(3_%FGZO77*3$O6I.R,J,J  #8YZ7OJ%YOZ:G)JO
MY%X/%;FV<'$<OQ;Y=5+67BU-Y7!BPGUE#M9U?$,DHBE]8W.Y/T$8LLZ[)<]%
MMMZ?GJH\5/43U?'V%JG,\?Q.^=N;NK?U'F>?:X7M6!%I[&'5-WT[$\;RN[FQ
MZ.WFSFT1'U%VNK422^L9$;%5LF$  ,R(C,SZ$7B9GX$1%\3,P&N7GAZHW%/@
M!JK.-D;1SW%<FN\*I+JW5J3$]A:X:VKD,FB>IFIM%08ID65TTN;=DF\97Y'0
ME)1XJZ=4];A,JBSU+_4'V3ZCO)3)MUYVW"B4%=;9G2:GJFZ*OH[>DU=9Y[DV
M68K3Y057,GPK')*^%?DW+D-NK0MU)]JE)Z&:VW=<->@@    N=_0%+_[-_I\
MG^'0%-U_V\OP&X$   $;3W6W\$9F/[NNDOU[LA9N*E(0  !OT]NAT_?]8_U_
M_&UKT_']\^O1T_7U]F>73W7 @YM       KL_>S_ -.? 7_9#F!_*^+0U=HD
MWJ"F,J  "<3[-8_^&+-2_P#S78?[ ,.'2?SONS^2QO'-H           !5&>
MZE_O[;;]TO<_ZW:A&^7QB3>HO0PH  )M7LW:=YWD-E-V5G6-L1G-DPE53CIE
M:ON.X)B2RE1V>G145LE=%'U\#(QN?"^Z=5D;W%U[>I=Q%U,NI=>GX>GQZ#"O
MT            !6X>\.X:Y3BV^-4\E,:J[)>M&-4PJ'*K=<#()L%C-,KVQL*
MQ9B'=IJSH(#CD:6V:8SDE+QD?5*3(R,]6WE,WHDF$)894  $R[VN?JWZ[XI9
M0]Q?W"3D#%,L4[7XK=.3,-H:^%EVQ-F89";E65UDF15#S]?#BNNN/--(6XE"
M34E*NAC<N>/BSC%RLMJ2\I,EJH-]CEQ5Y!1VC!2:VYI+"):U5C&4I24R(-C
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M)\O/Y5Q>&KM$F]08QE0  3WO9B_E;7/_ -HF9?VM<%'2?RONQ?G/98-#FV
M              @!^^<_[+O_ )[/_1' 0 P   3S/9D_T6VA_7UFW]K?!QTG
M\K[L7^GT6%@YM@  Z3Y%ZAQ_>ND=JZLR&LBV<;-]<YYB3")<14]#$C*L1N,=
M)],-,J"<I26[-1>7YS7F$?;WIZ]Q67%2J8KU1.%>;<(.7&V-876&V.-X+&SK
M(:;6UO(J&Z.MR:MQV%CSUH_45J;:Z<BLP7+^.2T+?<,C>3T4?7PO*8N>A/\
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MD^ULL7-L[)=[E+\9^<J=<HKF[22:XT:*CS)J*B,2_J]#)E/3H,YM:=$"
M  N=_0&_@;O3Y_< I_U\OP&X$   $;3W6W\$9F/[NNDOU[LA9N*E(0  !OT]
MN@77GUC_ .@_K4__ (SZ]'3]?7V9Y=/=<"#FT      "NS][/_3GP%_V0Y@?
MROBT-7:)-Z@IC*@  G$>S7_;CS4O_P TV'^P##ATG\[[L_DL<!S:
M    51?NI.O[^ZWZ_#[R]S=/]KM1=1OE\8S-ZB]C#0  ,Y>$GJ ;\X&9F]FV
MC<NR?&+.0S;M/'C=_&H7G#N8$2NE*5(D45Z7UX\)"5%Y?UB(B\.G467'L-H$
MSW,GJ32+%R;'W9MV&PMAMHH:-E53B4*09&ITG3UPCJ:^GP[2%S.P\?\ A,?J
M5_\ 'EM_^R35?W.@S.P?X3'ZE?\ QY;?_LDU7]SH,SL/Z3[F3U*BZ]=X;?5U
M+H7_  E51=/T?VN0S.P_G_"8_4K_ ./+;_\ 9)JO[G09G8/\)C]2O_CRV_\
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MEO+,FM<F<JRL&X-:F<423:K2;WD,^:?578CKVEFW-:CID0  !<L^@UI%W0O
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M;OW-5^$_FU J*.#9Y4X:T6WFIDOO+C_5[#3YBNNK;RGLFR >,J
M      M>_:'?P-N%?N_[V_7VL 2?0   >K-@PK**_!L8<6?"DH-N3#FQVI46
M0V9D9MOQWT.,NH,R+P41D K.O=1>DC9\<=C0.8FGZ3&8.B<@B']Y;Z',6H+Q
MG;6RMHYQ:,L5^-8_2U;EG5_9\J.1S'U.O)/JE2U=HMMNJ331#6$4
M       !<[^@-_ W>GS^X!3_ *^7X#<"   "-I[K;^",S']W727Z]V0LW%2D
M(   WZ>W0/ISZQ_]%[6I?_&?7HZ?KZ^S/+I[K@0<V@      5V?O9_Z<^ O^
MR',#^5\6AJ[1)O4%,94  $XGV:W3[XLU_#]J[#_8!APZ3^=]V?R6-XYM
M        *HOW4G7]_;;_  Z?>7N?I_M=J+XC?+XQF;U%[&&@
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M89QE^5K>=4^\O)<ENKU;KRG5OJ>=5:391N.J?<4LU'U,UJ,_B9AFW<<0$
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MY+ L'R#R*[[,^6+[>A2G^XOLF' A]ZO*\>C9*_"9C?[))RTV9XVV:[M9XPT
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M3(P'9%?O#=507;4[?VC6)^';7[ RR$7Y)(^$:V:+\A)%^(N@OER[T?27R)Y
MN(6VYO3<:VW$J0XA>S<U4A:%D:5(6E5V:5)4D^AD?@9!Y<N]3$[.KK6XM[V:
M_97=K97-C*<4])GVLZ3839#RR22G7Y4MUY]YQ1((C4I1F?0A%?-   !L3]+G
M@)D_J4\KJGC#B$Y5?<VN$9GF2)*+:LI3*/B$.-+?1\];0;&&GO3(+ZIM&I7T
M&0LQG79+GHNR<>QRDQ6M148_5UU/7(==?3"JX$2NBI=?,E.N%&A,L,$MPR^L
M?;U/Z1,YW5]P   %='[UTS_/W@GX*+I9\N_$RZ$?ZEQ>^!_2-7:)-Z@QC*@
M GN^S%(^_:Y]#Z?>'F9=>GAU^[7!?#J.D_G?=B_.>RP;'-L
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M3T=95.LB)+2D)Z=#/N(R+7/C..D)<M9HPH  +7OVAW\#;A7[O^]OU]K $GT
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M'7(;?I,PQZWQFW8<B2GH4IMZMNH<*:VN--CN,N$I!&AUM2#Z*29%EIQ0
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MMLT,V<+&:?5^ZJ2\63;?R<7(4T52@HLE?F=Z9:2Z%T(C+P^(LE^B79:TC*@
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MMN]_@T?F&G^+,:YS&/9GC<Y]T8<8:  !:]^T._@;<*_=_P![?K[6 )/H
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M.0U$7YQ^=YG>@SZDCIVD.G+/CQ2;U&_+4>R32M18?;]K:_+6?EM=$K+XI/\
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MA>&2I,VQ;;:F//R,9I*MV0[(:92E:W#4M:4D2C,B(,W9,.[Q%
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M4B,2G/XI1GU&;RMN=EDPS.989CH\MAEIALC,R;9;0V@C/XGVH)*>IB*\H
M
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MM&>&S9@.;0
M
M
M
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MUXR4ZLB4I1]RS+Q\1+;=U?9$
M
M
M
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MKHLX!EH
M
M
M
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M)'ZUFTAP9M97.3:=1MQEMI6V7@HB5U(G+?V6-B0@
M
M
M
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MX_Y+@#NS8]G!3=Q]B9='RJ9D<?-8YK<^4KBC%!27:[YO5NYQI-E2?QD
M
M
M
M
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M93.FAC5MK$4
M
M
M
M                                ?*OJ:%D='<X]9I<56WU58TU@EEPV
MGE0K2&]!EI:=(C-IPV'U=JB_)/Q":7)==&B?E9[<_P!/#E=\W;YQ0[1_.I/V
MR_53(>T[BJK6)MY]D)FN2HT6N?4XR:*9GM(B/M,C_"-7E>5^Y),31H6Y!>S'
MB7;#Q<:]IZ_PR0<I"F%[(S395RVF(4Z2M;:RKL'G&;IUZFD$?P\Q*C^!]1;>
M'25)Y=6M'-O9N\^L,;;<_? \:\B\QQ+?9CT7=$Y2.YEQWN67W8IZ)+R^T_\
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M^(RKS
M
M
M
M
M
M
M
M
M
M
M
/                 __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>lh_morganlewis-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lh_morganlewis-bw.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@!U@@J P$1  (1 0,1 ?_$ ,0  0 # 0$! 0$! 0$
M       )"@L(!P8%! ," 0$!  ,! 0                $" P0%$   !@(!
M 04#!0D)"@@* A,  @,$!08!!P@)$1(3% HA%18B%[=X.3$CMG<8.+@9&C*U
MU3=7E]=8B$$D5G:6F*CH66E1,].4-=;(26%"8D,T)94F)]ADA<4V1D=G*%)H
M<=%C1%2TU%5U2'D1 0 " 0,$ P$! 0$        !$0(A,0-!88$243(3<9$B
MH?_:  P# 0 "$0,1 #\ O\ (L-A=;GI/ZHO]XU;L;G/I"H["UK<+-0+W5):4
MFDY6L7*FS3VNVBO2::4(JD20A9N.7;+8*8Q<*)9QC.<>T!\?^OXZ-O\ M"=
M?^UYW^ 0'47%KJ2<$^;-GLM*XI<G]6[QMM.@4K19:Y2I9RO,15<6D$(DLVLQ
M?LF*ZL:23=(H**IX.1)59(I\ERH3O!VZ   "*2Y=<KI'Z_M]JH5PY[:$A;;2
M+).5&TPRL[)N58FQUN3=0TW&*N6,0Z9.%&$FR52,=%51(^2=I#&+G&<A\W^O
MXZ-O^T)T!_[7G?X! =:<5>H9PIYP2%SBN)G(W7>]I#7;.$D+LTH[Q^Z5K;*Q
MK23:#<2.'L>RP1.27AW)4^[DW;E$W;V .RP
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MMRR.'$78:S,1\]!R3?.<XPO'RT4X=L'B.<X_=)J&+_X0'[P
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MR#+,<WG',;#KR29,,L&\0S9'.>]V=WV .RP
M
M
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MC^$>WP&AX
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M6X1+RD(K<646QEHB]5A@HZ=.F55O\"^3<I)*&[&DDB^9D,HFU*LH$U(
M  *87K:/S!>*/UOV_P!#&T0&:(     [1X7]0SF/T^[^TV%Q/WM=M7.RR3:0
MGZDSDUI'6UY*@9OA1A?==21G-2M;5RV;E1R=RU,Z0)\INLBH4BA0UHNBAU9:
M5U<N([;<:$)&T3=^NY9"A<A]8Q2SM>(K-WRS\]&6*HJR*SB36H-]BBY>QGF5
M%EV:Q'4>HNY49'=+!,*                  ,D3U7_VVO([_$#CO]!U' 5P
M@&OUZ7'["C@S_:9_3#Y! )_@    &(-U8OM3>I9]?_F1^D5L8!P  V>>@/\
M8V]/;\0$1^_L\ E_
M
M
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M@@P;I.YB&I]G;?&E<;.#G3;+VO7TMB-O=33='2-A+,E&M?%[N>YV]F0'7@
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M8)H*3"%%M#)]8JWAS@N6Z=MISDS2WU!PO@^,D2DV+10V,^PH#J@
M
M
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M3.9D*HG"J6)"/,;.#N"Q6+$S*JI@OA^(MW,&R<BA2A\Z O>>AT_C4ZB7XO\
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M1AC=WO$*2-*4ISE+@Y@RM.M9]K?U&OK@;Q_#B5 1@@-OGI._99=-/Z@'#?\
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MP
M
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MRUKN5RGI:T6NSSSY>3F[#8YY^O*34W+R+HZCE])2DBZ46754-DZBA\FSGMR
MZ5X-\*=Z=0?DQKGBUQZ@4Y>^7^0SEW+2.7"%7HE2CS)*V?8-VDFS=TI%U.JQ
MY_&<*$34774RFV;)+.UT$% V6.G/T^]%=,_BS1.+VB(PIHVOHXF+[>GC)%K9
M]M;+DFC1*U;(MADUG1O>4VLS(FV:^,JC%QJ#9B@;P&R8#ND!C"]??[9+J$_6
M F/WC@0$0(#;YZ3OV6733^H!PW_1UUR C ]6!]B5R-_&!QW^F^D ,D4!9]](
M=]LE2OQ ;V_>*, :O8"D%ZWG\UG@]^/_ &)]'3<!G" +WGH=/XU.HE^+_CC^
M$>WP$F_K2=AV>L]-/1U&A'ZC"$V9R[J+.Y)HFS@TQ$536&TK)&PKG&>TAH_-
ME;LGYL=F#^8CT,X-@N#8,&88 L5^F3U7TZMN=0MS7>H477LI'--8R<KQ]IVY
MI".8:>N6XVUBKQ,1-L;S+IM7[+-)5-5^K$0TKXL9(K%5P9)5VFS2.&KK%:%T
M9!0C6M0FF-3PU<8L_=S* BM=4^/A&<?DIB98M8II#HL6[/)3YQX1$\$[,Y]G
MM 14<UO3W=*GF] S25LXPTO2^Q9%NYS'[CXW1,1IJ\QDJX[<^^I)A6(Y&BWI
MYDWL/\10\KVD]A<D-@IRA&9T+.@QR,Z0G40Y,W2SW.G[?XTW[CFI3-6[;A5T
M:_:'LXZVE3)].L7;6SQX[DZ_8&,-7%UE7#-Q)1"J9DLD=X6.HV0"W$     I
M!>MY_-9X/?C_ -B?1TW 9P@#9YZ _P!C;T]OQ 1'[^SP"7\  40O7%_Q6].S
M_'_D?^#NG@&>( VN>BE]D?TY?J@:/_ F+ 2?@ "H%ZU;[++0?U_]6?HZ\J@&
M8( U^O2X_84<&?[3/Z8?((!_3ZD;A=H[E)TLN3U_V#4(57:/&?5UDW=I[92<
M<ABWU&6HB.)^8K[*83PD]4K-VA&KF.?L%3J,SF72=>%ERU;*)AC^ - +T-MI
MGE6_4GI2F'SBL,EN*=I9FQE'W;$3TF3D)$R6#%[N'&7UCCXAKV9[<DPG%Y]F
M,Y]H7]@
M
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M33>G8Z5K=*L"GB]QYAK,W6SVI1F50A4U6.$':)CI.BFR%O@
M
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MQ#Y.3AI+EINR(A)- J)6\E!U"[RM-AI!KEO\A1F]BX!)5%3/8=1(Q3'Q@^3
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M:Y>Z39HQ3*L=8*G;8AG/5Z:8G-@IC-9.)?I+$[<8-W3X[<8S[ 'V0#!&VO\
MQI;*_P ?[C^$4B ^  ;_   QN_4-\P+=S#ZLW+*9F9Y:3I>C-C6'C-J>)2=>
M8A("F:1FY&FR)X')5G"1VMOO3*8GU5BG-A=>5,8G=2PDF0(2P&AKT>/27<8+
MWQMTWR=ZA4S?ME7/<])JVT8305+M4AKO7U-I-VAVMBK,/>YZ!0C]CV"[+P3]
MJL^+'RD(VC'"JK/NN\I8=&"=[;'0IZ0^D>-N^9[7O ?0R$Y6=([3F8&8ML/,
M[,E(R6AZ3,2<9)-I#9DW;W>'S)^Q2435,?)\9+G';V&-C(8]@#O_ *3OVIO3
M3^O_ ,-_TBM<@-OD!G!^MY_.GX/_ %?]A?2*@ I!@-/OT5/V66_/K_[3_1UX
MJ@+?H#)$]5_]MKR._P 0.._T'4<!7" :_7I<?L*.#/\ :9_3#Y! )_@$:T]U
MD.E/5YV:K-AZA/$J'GZ[+2,%.1+[==)1>Q<Q$/%H^3CGB693M2=,GK<Z2A?_
M !3ES@!^3^NMZ1_^T:X@?SX4G^% $CM0MM9O]3J][I4Y&V>FW6NPEMJ5EAG*
M;V'L-9LD:VF8&<BGB6<I.XV6BGJ3A!4N<E424*;'LR ^B   !Q_U"OS!.<7U
M/^2_T+W4!AC@ #?X   !#]U^Z!*;*Z-?4(KL.58[N.T%*7];""!G!\1>I[!7
M]ISAC)D]I420E-<&44^XDG@Q\^PN0&,0 DBZ0VDN-G)7J/<6./?+<LQG1.ZK
MQ*:UL1J]87-5G/BFU4ZRQNJ4(V=;&[62DAME6#:J]XBA5&ZZA.[WC%,4-%C]
MD-Z-O^!?(#^?:<_@L _9#>C;_@7R _GVG/X+ /V0WHV_X%\@/Y]IS^"P'ZD)
MZ23H]5^:B)Z.IN_"R$)*1\NP,MO*;52*\C7:3UJ95+,7C"B>%T2]XO\ =Q[
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M.CKFG(,Y<*2$YHTJBWAY46\5[6\8+YI5=F;+EL%.D  28=([IX7;J;\Y-/\
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MQ+/]WL :R("D%ZWG\UG@]^/_ &)]'3<!G" +WGH=/XU.HE^+_CC^$>WP&AX
MJ_\ 5)]+)PIZ@=SLN\=06.2X=\B+:^>35QL5'K#*V:GV+8'QSN']AN.J%I:M
M%C[5+.NP[F3@Y.+PZ646=/6KYVJ97(5%N0?I"^KKJ%Q)KZOK^DN3T&U,HLQ7
MU7M>(J=A<L"GSV'>5[=2&LD$))-#'?4:M'TAVY^0BHL?.,9"!WDSP7YC\-)-
MO%\IN,^YM&&?.CLHJ6V!19R(JL\Z2*<RB-:N>6JM1LQDRIFR;,>]<XQC&<]H
M#E(!.5Z<KEG<N)_5TXF+5^7<-*KR$V!"<7-E06#J^0L]=W=+QU3KK9\BD;&<
MJ0.R%X.6;']F2.&!<&SE(ZA3!L7     *07K>?S6>#WX_P#8GT=-P&<( V>>
M@/\ 8V]/;\0$1^_L\ E_  %$+UQ?\5O3L_Q_Y'_@[IX!GB -KGHI?9'].7ZH
M&C_P)BP$GX  J!>M6^RRT']?_5GZ.O*H!F" /KXO7M^G&"$I"T>WS$8Z\7RT
MC%UJ:D&#CP%E&ZW@.VC)9NMX+A$Z9NZ;/=.7)<^W&< /9-7\->7>[95"#T[Q
M;Y#[2EG#@[5-CK_3&Q;:L59+RN5\+^XZZ](U3:D>HG6.KDA$2*E,?)2YQD!;
MAZ1'I&MZ;!O=2W=U/HQOJ'34#(-YM'C-'6!E*[5VD9FLFX91-^FJG)/(C6M'
MD<X+EXDW?KV)PAA1MX48H<KM,-&BL5FN4JM5ZFTZ!AZK4:E!Q-9JU8KT:TAX
M"N5R!8-XJ#@8.(CT6["*AX>,:)-VS9!,B*"*92$+@I<8P'[@
M
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MHK)'(HDH3!BYP;&,@-#/IC>L;U KK.HZKZF]1OE?VE6X]K"N>2>KJPSME,V
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MV$];W:0S0Y]X@JDE=M4SJF9K6=U9+&+A!R6>J#QJ9UA$ZI&DB1RT,?*K=3&
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M?U_]6?HZ\J@&8( U^O2X_84<&?[3/Z8?((!/\
M
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M(]5I7*Q7FJR$FEJG5Y9!).8+36DPB1P^D')6[J?>MD'"S=JF@U:MPGY
M4@O6\_FL\'OQ_P"Q/HZ;@,X0   $OW0(^V2Z>WU@(?\ >.> 6O?7%_Q6].S_
M !_Y'_@[IX!GB    F^]-[]MKP(_&!L'Z$-H +GOK5OLLM!_7_U9^CKRJ 9@
M@#7Z]+C]A1P9_M,_IA\@@$_P
M
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MSVJP3MXZ<*FR95=RY78*++K*&SVF,8V39S]W(#^7YIM5_P FFO\ _(VN?P:
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M"Y(HDJF?!B*)J$-G!BYQG&<9[,@/@_FFU7_)IK__ "-KG\&@'S3:K_DTU_\
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M<@/T
M
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M-#.?"<&P<+W8
M
M
M
M
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MYSD!^X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                            /Q[#8(:IP$Y:;'(MXBO5J'D[!/2SO)BM
M8N&AF2\C*2+DQ2G,5NR8MCJ'SC&<X*7/L 1P:AZS72XWYLNFZ<TYS7TQL'9^
MP9A*OTNEP$G,+3-BF5DEETHZ/37AFZ)W!T4#FQ@QRX["Y]H"3<
M
M
M
M
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M?-CJMLJMCWS08>PUJRUZ8OSR(G:_.Q#Q9J]9.D56SILJ=)4AB&,7(;#0
M       .?^67YK')?ZO^Y?HZL8#(%Z!'VR73V^L!#_O'/ -GH          <
MP<W=UVKC7POY=\BZ+'U^6NV@>,&_=UTZ+MC61?562M6J]4VR]5Z/LK&'E8*7
M>5]Y+P2*;U)J^9N5&QCE271/DJA0IQ=&?U0'/KJ)=2;CAPZW7J+B!5]9;@^>
M#XEG=6T'=$)>V/S?Z%VCM*&]Q2=LW_=J^V\S8*2T1=>8BW7?9J*D)X:AB*IA
M>\      %1GKZ>I;B.GC99CB+PVCJGLOERVCREV5=[,DK,:]X\9EF#=W%1AX
M9NJV2O&U%HYZ1X5BJN6+A\&0R^(\.=5@0*$-DY/]6[J=[&DF2FS^:O+Z].#9
MDEZ%K3YS[M&0J"[A1WXL-J?5C+-3I\3APW,H4C"*9M"92SG!<8)[ _L7Z8G6
M%T1'KVYGPCYZZ]CV:R;]]/5#3.Z&>(X\>FJLC*23NHPRBL:BQ+WLE=+Y332R
M;LP?&38QD/NN.'7-ZN?#B>3:47F=O"38P$@JSD-:[VF76ZJFAY1SDDE7U*QM
M].T.*JF9PF<BY8L\8[25R<Q%$U<F, U(^BGSRV7U)^G;IKEIN"JTNG;%NLIL
M*NV6(U\C,M:DJ\H%YG:9[VB6,_*SDI')S*<-AR9LH\<^ =3)"J&+C&0$,OJ(
M>OWS&Z27)W26EN..M>,]UJVR=#H[0G'^[:=M*QS[2?4V#<ZGEG$NJ)N76\<A
M#XCJZ@?":S5=;QCGSXO=R4A0EFZ%'4+W1U/. E?Y4;[K&KZCL*6VALJDN(?4
M,+:X"FDBJ=(LF<8X1C[G=;_-ED%TG!LKG-(F3,;&.XF3'LR$QX
M         *2777]27SEZ8G/RP\5]":JXH6[7L3K#6MU;3&WJ-M^?N1Y6Y1KQ
MY)MUY"F;UH$(:/05;EP@0L<50I<Y[ZA\^W 65NDKR[V3SSZ=W&7EOM^$H]<V
M/N>L6F:M$)K>-GH>D,'4'L:Y5!HG 1MGLMPGFK=2-KJ!U,.))T;*YCFP8I,E
M(4)%P
M
M
M
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MB4/6HN:MS.KLU6V"8C8^U7^1B*\V0350.TC'"AV^<>6P4!S3TG?M3>FG]?\
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M<W9K++JIJK)QL-$LI!5V^>'21.;":9<FS@N?^ !(&
M
M
M
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M/N44#N<HJI1[3QWJQ?+ME<X#)\N&PNISZCCG:TKS=26VGL2P+24C4M>M))U
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M.Z<:;[9HB!VW5+4HWQ[TBX.$DUF#C8M=1>%-Y29A4W+5= Z7CE:N3*-4@EM
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M7:UP] V'O"4N4A%-8Z29J-Z]'V+CK581W(95>%R4CF1:)]W&>U3&>S&0T#
M
M
M
M
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MAG"^MG_/[XH_4_;?31M(!8^](;]C;2_K ;V_?R+ 6?@%4'UDGV2%:^N!IO\
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MQ38P%)SU>/VR5U_$!HG]XI,!>\]-Y]B5P(_Q V%]..T0$WX
M
M
M
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MTX[1 3?@
M
M
M
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MC#?O=_.3Y*0+B(  RA/5X_;)77\0&B?WBDP%WWTN/V%'!G^TS^F'R" 3_
M  //]L_Q5[+_ !?W+\')(!C"]%/[6_IR_7 T=^'$4 VN@'./(SB!Q:Y>1%:@
M.4/'[4N_(:FR3V8J<?M6D05R;UR3DFJ;*1>0N)EHY-'+2#5%,B^4LEPJ5,G>
M[>X7L#TS5.IM9:+U[5]3:;H=5UCK*E,58VHT2DPK*O5:N,%WCF17:1$-')(,
MF2*[]ZLN?!"X[ZJISY[3&SG(? \LOS6.2_U?]R_1U8P&,-TG?M3>FG]?_AO^
MD5KD!M\@,(FXK1;?E5:E]MIRBT*AR"G%MFHJX4S-*Q:>QW1[HFKA1L\5S*':
M%<X-WD53>+GVD-GY.0W6JP[KC^M5Y]3EX=S47L'$NZLXKQFAX!Q7'#!NM!KP
M9X_^\#0ZL8=(S;*'WG*.2]SY/8 _6<.&[-NN[=KHM6K5%5PY<N%2(-V[= AE
M5EUUE3%31113+DQC&S@I2XSG.>P!C=^HJW5J?D+UEN:>U](WZM[/UK-3&F(*
M$O-0?DE:S-2.O^..GM=VTL-+)8\K+,XJY52098=-S*-7.6^5$%%43$4,&H7T
M4OLC^G+]4#1_X$Q8"@'ZR3[7"N?5 TU^&VW@%SWTN/V%'!G^TS^F'R" 3_ .
M?^67YK')?ZO^Y?HZL8#(%Z!'VR73V^L!#_O'/ -2/K!]++5?5BXD6+1EN]UU
MK:]7]X7#COMETV5.YUMLTC R#?$@LS26D'-#MZ:9&%@8D*KA9KX;E-/+QFS4
M2#)JTMN#F/T9.?1;5#LI+5')/C-?I*H[!H-BPLK7[5$I+)H6K7UQ9LG"3>U:
MYV!!Y(=)RV6R1=JLUDXUPFNFS=IAL!].?J":*ZF'%FB<H=$292QM@1Q#WVBO
M'J+JSZEV7&M&BMJUO;"IHM3>\H19X11LZ\%)&4C5VSY O@.4P%//UMW%.>=I
M\-N;,'&N'E?BF]NXT[(D$TN\G"NGCM;9.ILJY)WCX;RQS6U-10^"IIJHH$[V
M3KEP _L]&?U)-?QE1VKTSMGV9G 7A]>)?>G&_,T_;M4+FRF8*'CMHZS@C.3M
MR'L%?<5Q&PLF*>5G+]L_E5RX*FP/VA?I  '-]SY>\:-?<AM/<3;;N.GQO)+?
M:=J<ZKTRW<NYB]6"-I=,LVP+#.2$1"-)$U0K;:JTZ360DYHT='OEVAFK999W
MDB!@\8ZJ[1T_Z7G4C8L6SAZ]>\".831FS:(J.73MTYX\[$1;MFS=$IUEW"ZQ
M\$(0F,F,;.,8QG.0&5IZ<:WM:/UL. TT\F6\$B]V1=:@1ZY,F1-=UL+36RJ"
MQABY5(<N7%C?65./1QC'>,JZ+@N<&SC. V0@    '*7.GD;)<0N'')CE%#U=
MC=I306F;UM5C4).1<0["RN*;".IDD*[E6K9ZXCD9#RWAY7(BJ9+O=[N&[.[D
M.8>F7U@N%_50UTTL?'[8#.)VG&0Z+_9'':Z/645M_7;HN&R<@LK!F5+\74]%
MXZ3(A8(CS48KXJ::IV[OQ6B02E@ #.U]:]RUU==MD\2N'=/F(6P;&THCL3:>
MWR,3,WCVBJ;)C*2PU[5'SM-)1Q&RTU!Q#R5=L<JIF\DK&N%$S%60/@.C_1"Z
M!M$+K#G5R<EV+IM4MA7+4&EZ.[/W4D)*4UA%76X;!4(D?[ZY1:$V9 ))+%P5
M+"N'">,G.4^$@X@];C6WK7F=PWMZG>]W3G&&?K;7M05*3SM4VM8Y1_W7.<>
MJ;P+DV[2%SDZ>.S)NS!R=H3T>CGND;9>D=(5QJNS-(:[Y4;BK<HV1=85=I&E
MH+7MU9N'K;)2':>8;6CNI_NB'*EVX-V]XI0M9 *H/K)/LD*U]<#3?X#[@ 1
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M=+G&35UARI&25?Y"[62;(/L8*0S9Y(0*S*0\+..TJ3PG9G.,X-D)\@
M
M
M
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MH:3P
M
M
M
M    #Y69HM(L;S$A8:=59Y^5$C?#Z9KT1*/,-TS',FAAR^9KK813,H;)2][N
MXR;/9CVY ?D_--JO^337_P#D;7/X- /FFU7_ "::_P#\C:Y_!H#]*)U_0X!\
MG)P5)J,+)(E4(C(1-;AHY\D19,R2Q4W;-DBN0JJ1LE-C!L8,7.<9]@#ZX!\S
M-TJFV9PD[LE2K-@=-T?+H.9N!BI5PBW[YU? 26?M7"B:/B*&-W<9P7O9SGL[
M<@/ZH.L5JL)+H5NO0=>0=*%6<HP<2PB4G"I"]PBJZ;!NW(LH4GLP8V,YQCV
M/W     'C^Z./>A>1U8+2N0>E-3[RJ!%%%T:QMS7E2V+!-G"N$\'=M(RW1,N
MS9O/O),X62(14IB%S@V,EQG <*0?1$Z15=L"EFCNG7Q04DU7"+K*4OJ2N6&$
M36;J%52RVK%@;R=::)]\N.\1)H0A\>PV,X]@"2FI5"IT&N1%.HM7KM+J, UP
MQ@JM4H2-KE<A&6%#JX9Q$'#MF<9&M<*JF-X:*1"=XV<]G;G(#Z(  ?!K:LUB
MX5577UQ0UUUU#K+++5"OJ*K*J&R=1550\<8ZBBAS9R8V<YSG.>W(#_/YIM5_
MR::__P C:Y_!H!\TVJ_Y--?_ .1M<_@T!]%!U6L5@CE.M5R!KQ'ADSNR0</'
MQ)'1T<'*B9R5@W;X7,EA0V"Y-VY+@V>S[N0'[P   /\ DY"*$,FH4IR'*8AR
M'+@Q#D-C)3%,4V,X,4V,]F<9]F< /BV6M-<1CQM(1M I,>_9K)N&;YE58)H\
M:N$C8,DNV<H,$UD%DS8[2F*;!L9^YD!]L   #_-9%)PDJ@NDFN@NF=%9%8A5
M$EDE"Y(HDJF?!B*)J$-G!BYQG&<9[,@/BVFL=;,'39\QU[1V3YDX1=LWC2IP
M+9TT=-E"K-W+9PBP(L@X06)@Y#DS@Q38QG&<9P ^X ?QR,='R\>^B99BSE(N
M49N8Z2C9%LB]CY&/>HG;/&+YFY(JW=LW;=4R:J2A3$4(;)38SC.< (SK=T5N
MDQ>;<>\63IY\4E[&NZ4?.UHS458KL7(/5^PSAY*5RN-(FMRCITIVJ+*.&BIU
M53&4/DQS&-D.W=*\>]#<;JF6A\>]+ZKT?2RJ$7-5M34&K:^@G#HA,I^>>1M5
MBXMJ^D#ESG)W"Q3KJ&-DQCYSG.<A]A*Z\H$X_7E9NCT^8DW7A>9D96LPL@_<
M> BFW1\=X[9+.%O!;HD3+WC9[I"X+CV8Q@!],R8LHQFVCXUFUCV#-%-NS8LF
MZ31FU;I%P5)!LV0(FB@BF7'84I2X+C'W, /GYFBTBQO,2%AIU5GGY42-\/IF
MO1$H\PW3,<R:&'+YFNMA%,RALE+WN[C)L]F/;D!^U%1,5!L$(J$C(^'C&OB^
M6CHIDVCV#?QUE'"W@,VB:+='QG"QU#=TN.\<V39]N<Y ?H /\UD4G"2J"Z2:
MZ"Z9T5D5B%42624+DBB2J9\&(HFH0V<&+G&<9QGLR ^/C];Z[B7K>2BJ%2XR
M09J86:/X^K0;-ZU5QC.,*MW39BFN@IC&<X[Q38S[0'V@  ^#6U9K%PJJNOKB
MAKKKJ'6666J%?45654-DZBJJAXXQU%%#FSDQLYSG.<]N0'UT;&1L,Q;QD/'L
M8J-:%,1K'QK1NQ8MB'4.J<K=HU3201*94YC9P4N,9-G.?NY ?V'(10ADU"E.
M0Y3$.0Y<&(<AL9*8IBFQG!BFQGLSC/LS@!PWLWIB].+<TB[FMI\#N(-XL#];
M"[VS3W';5#FU.U<*&5SEQ:2U5.P*E44/DQRY<Y*?.?E8R _9U%TY>G_H*293
MFE>$O%'5]CCC=]G:Z7H#5L%<$CX<+.2&S;F573LJID%7!O"R=T;*1<X*3NEQ
MC& [-  'R=WH5&V;69*E;(I=3V#3IE,J,Q4KO7(>UUF52(?"A$I*!GF;^+?)
MD4+@V"JI'QC..T!QPPZ5W3!BGC>1B^G#P,C9!HIA9H_8<0./;-XU5QC.,*MW
M3?7B:Z*F,9S\HIL9]H#M>MUBM4Z&95RHUZ#JM>C4\HQT#6XEA!PT>EDV3929
M1<8W:L6J>3&SGNID+CMR _<   !_*^8LI-D\C9)FUD(Z0:N&+]@^;I.V3YD[
M2.W=,WC5P11!RU<H*&(HF<IB'(;.,XSC(#@R_=*7ID;0?K2]\Z??#:PS3ET9
MZ\G5^.&IFD^_<G\7)SR,['55G+R!3G7,;)%UE"9/GO9QWNS(#^&C=)/I>:VF
M4;%2NGMPXA9]LHFLQFOR=]6R,I&+I%5(5Q$/I:LOW,0XR1<Q3*-C)'.7/8;.
M<8QC 2 L6+*,9,XV-9M8^.CVK=BP8,6Z31DQ9-$B-VK-FU;D30;-6R"92)ID
M*4A"%QC&,8P _J  ',.X^$G#'D3/)VKD#Q&XP[TLZ2*#=*Q[CT'JK9T\FW;(
MX;MD$YB[52;D"(MVY<$(7"G=(3'=QC&/8 _ZU+PGX::"DBS.BN)'&/2LP13*
MQ)74NA=5ZXDB*FRF8RI7U.JD,Z*IDR),Y-@W;VEQ_P & '0TS 05C9XC[#"Q
M,\P*L1QAC,QS.49X<)E.5-?#9\BNCA9,JAL%-W>]C!L]F?;D!_'!U"IU@[E2
MM5>NUX[PJ9'9X.$C8D[HB.3F1*Y,P;-\KE2RH;)<&[<%R;/9]W(#Z(   'A>
MX^+W&CD2@W:\@>.^B]Z-FB>$FK?<>I*!LY!LD4_B82;HW:OS::*>%/E8*7&,
M=[V_= <K071[Z4U;ES3L3TY.%2<GDV3IJO>-NIY=NU6\TB\(XCX^7J[Z/CG2
M#A N4E4$DU$2]I2&*4QL9#ONJU"IT2#9UBD5>NTVMQQ<DCZ]582-KT&Q(;/:
M8K.)B&S-@U*;/W<$3+C(#Z(  >0[=X^Z$Y PZ=>WSI'4.[8!(JA$H/;NM:9L
MF'3*KC.%2IQERA9ID0JN,_*Q@F,&_N@..FW1SZ3S694GDNF[PD,^54<*F0<\
M:=2/(;!G)3%4PG7'=57KR*9<'SX9"-2D2SV9)@N<8[ [OH6M]=ZKK[>IZPH5
M+UQ56?=\I6:%5H.GU]KW4R(E\O#5YC'1R'=23*7'=3QV%+C'W,8 ?:  #DK:
M? /@EO.T.KQNWA5Q*W%=7QC'>W#:?'#3NP;0\.<J93F=6"VTV7EG!C%1)C.3
MK9SG!<?\& 'V.G^)'%/CRKYC0/&3CWHY?PU4?&T_I?7&LU?"7,Y.NEXE+K<(
M?PUCO%LG+V]ALJGSG]T;M#H0
M
M
M
M
M
M
M
M
M
M
M
M
M
M       'AV[M_P!.T)2;/?+A&V:2AZI[E]XMJTSBWDDM[]EHF&:>21E)F':J
M>&ZF$C*=]9/L3*;)>]G&"FFCK2!O>?J;.#6LU).'?ZOY>^?@KD]J[YQ"4G4'
MA+.XLTNU<F;JK;[8+*,E%F&3$R<I#9QW<Y)C/LQ%ZK_GE.U(.-[>HQJMWE+
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MK27>0(
M
M
M
M
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M']X
M
M
M
M
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M,X^Z"C_H
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M#=M)S8<??S64U_C[:_1<MEF%2JF(PL9BJ&*8IBK95RMC.,E[N<9"<$
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M.K&;P];K$ R5D9B8D5B$54*U8LT#'-W2F/GL["XSG.,9"IORI]9CT\]1OI2
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MXNGV1^PDYN$2@KC8Z<J@_?192L'"B[FN'6+E/'9A-0N,^W&0'8@
M                                                       !G/9[
M<^S&/;G.?[@"F%ZESDK(:ZW*]U S=47#*^\('&'"<RLOBR'S:+5OBL*XB")3
MS%(V3),<8;]YLMVK][M[^/D8AMQ8WKW4/@=+H/BQN><X][XHFWZVC7%YJH_$
M_DDK8F\5KY_?]-L-8<>\$V$I"NS=UI-*92[CE+L7P3M[V.TAHE$Q<4M/4CU/
M7*VITNH55G6N%1V=9J\!7VIW\/L@SXS:&B6D<@9Z9+?S9(SLR3;&5,E33+D_
M;V%+CV87+">/7JF,Z.76@WEU%^3=ZTELR'XYQ\#5M$6?:;1;4,?;VEE-+PFP
M-85)!)\I8-IW=F:#,SN[C*I2M$U<N"HYPL4N#$4F)4RP]8O58/O=N>57W5Y0
ML>;S_GO$\]A7/9Y7R?<\+PW+?_\ B,][M[?[GW/[MHBV:D9^U-<MO\&.#_\
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MB3NJVB/P4Z9S]XV%"D2"X[P0ZB/$KJ2:A-N?B7M%G?:_&O&T1<:X^9.J[?\
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MN<UY'T U:-0(^VL$6S9%A;;7B3+)XM9C&,8R.4LHXQC!N]G. G!
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M[3<&4,9T?;6L%G&NMC/'B*IC.&IIZT5EQ)H$4R8V6;Y$^#'(<IS!)J
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MPGIO/L2N!'^(&POIQVB F_
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M8H[=NOXS97^]EE.YW3]TY0O&?L2_ 7^M=R__ .<:8_HN /V)?@+_ %KN7_\
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M?>+#7M3U#<]?KL*JV7*8K?,PYE9!7M,H=8F#%01"#'U"?IFM-\-] 6#F_P
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M?9ZW)E)@Q\%*_AI1%7&.W/9@_P!W(#[H  80W$_\Z;C5^/\ TW](M< ;O(
MRKO6(ZSI=!ZN[:QU1.-2E]Q\5M-[,V&2/3135^-&=DV9JI%24PBNKDTDO2-8
M0JF3'*D<R)D\Y+G'8H<+5?H[9Z6F.D&>/D7:CEG5>5&ZX&!1/^YCXEQ#Z\M"
MS1'_ ($SSED>KY_\M<P"I5ZO'[9*Z_B T3^\4F [RT'ZG&A].7H_<,^)O%NC
MQ^Y.7L!K2[)7><NS>59:AT@[F]M[#FHAM+,VBT7-;)N"T+)(.\1[%RRC6J;A
M(R[Y14JK(!!)M7U!G61V[9G=GG.>VZJJHX?*O&T'JI]#:EK,8D90YF\<TA-=
MQ%=;.&+-(V$R^;\RLJ4N#+**J=X^0D[Z;/JT>>/'79M9KW-RU+<N..,K+,V-
MO<R]>K49O"AP[A7"3NPT.VP#.MM[:ZC?$RY4B[$5YA\1/RZ#R/R?QBAIVZNV
M=0MU:WHFW=6V>+NFN-F5.!O%'MD*OAQ%V"KV6-;RT-*,U.PIL)NF+HALD/@J
MB9NTARE.7)<!%AUY.:F\>GWTT]P\H>.C^MQNUJ7;-10\&[ME>;VF$397+9M9
MJTV5S#.E4$7"BD3**X3-DV/#/G!L>W "!WTVG77Y^=3OG+M70G*BPZPEM>U'
MBA>=O0[:E:UC:;*DN4!M_15,CUW$FS>.%5X\L)?Y$IT,EP4RADS]O:3':%RW
M;/\ %7LO\7]R_!R2 8HW2=^U-Z:?U_\ AO\ I%:Y ;?(#._ZY/J4>IGQ6Y^<
ME>''&JPZ;T_0]*V"K0%<O$?JB,NNS)0DYKFHV]Z\GGFSWUWHRSA.2LBJ:)6T
M V3*@DF4Y3GP<YPK[)=>'KB[#D924AN;_(Z;<D,U-))4N%KK6.8Y52,BTQ[G
MJ-+:Q$45R1F?)<)H)85.0YNS)N_D!]CKKU'O6WT;;<.'?,>]699DZ0--4G=%
M UW=8U^CC+=SF-D&EHI6;'"(NDR$[RD:\CG?AFSW%BX.;.0O)=![U'5+ZI\T
MIQJWW2:_I3F-$5MY88AI5W[D^K]YPT$T*ZLDAKUG./7EAK%L@6A57;RO.7,G
MGW:BH];O5DTW2+,+0P"#KK0]<KC]T@M>0K*:AC;AY.[*B7TCJ;0\3+I1.,Q3
M5SY!:_[,GRMY!:G4%L^PHBVR5LN^FGB"C9FG@B+UVR#.YY,>I@ZQ/)&TRTPC
MRHF-!59ZX44B==\<H:+UG UQL=4JA6C*SI(2>SY7N]PN,JR4^]4^[@N2E-DH
M#\#0?J1NLIH">CI5AS)N&V(=HIVOZ=OR'KNW(&=;9<F=G9R,I9(TUY9)G5/V
M>-&S#!V5+&$R+%3Q@@#A#J.<WK5U'.9&V>9EXH]?US;]PQ^JT[%4*I(R,G6X
M^5UOIO7VIG3V%<2Y?>:,?/'HGO%-LN=PHRPZ\OE=QX7CJ!KM=%+[(_IR_5 T
M?^!,6 [KW?NW5?&[4FP-[;ONL/KO4^KJV^M=XN4ZHJ2/AH9C@I3&PBV2</9"
M0>N54VS-FU26>/GBR3=NDJNJFF8,Z/J0^L3Y5;1N%EH?3HKT'QST\P>.HZ'W
M%=JO"7K>EW:I&50Q.MX*S-YK76MXN12/G*3 T?,R:7<(M[P1.8S=((I'/45]
M1Q+,2[B-NWJ3YJI$R2&+9&U':C#6GE\D\4C@R$746VOS,SIKX-[4<I&+DN?;
MCN@.]^GMZO/GMH.[UZO\VE8OE_HMR\:LK%)'K=5I&]JG%*+E(M+U&S56/K=9
MMSB/05.L=A/LE5I Q"(EDV.,Y5 :5W'KD%J'E5I;7?(30MTC=@ZEVG76UFIM
MJC,+I)O6"YE$'#5ZQ=I(2$1-1$@@LS?L7223MB]05063(JF<N JT>M6^RRT'
M]?\ U9^CKRJ 1@>AT_C4ZB7XO^./X1[? 6A?4#\[-_=.CIUV3DIQJD:O%[/C
M-L:NJ#5W;ZTVMD-B&MDF^:RY#Q#M9!$[@Z+<OAJ=[M)GVX 57>G'ZO?=,3.[
M]M?4MG*Y<J35]-Y>Z2UQI34T;6[ML+=+JXUQG&P&)LC[,1#P:=85D7+Y[(JH
MMFJ".3)X<.LMVC@(N^97JM.JYR:M<N;4>RXGAYJI1\N>"UYI6%@9"S(1Y%L&
MC<6?;]L@9"[3$TV1QDKA:*S7XYV8V39CR8P0I Y*TQZA[K):1L3*?A.=&V+T
MBW>>9>5S<YH/<5=ET3X0(XCGK;8,3.OV;-PFWP7O,'+-PCDQC(JI*',?(:)G
M0HZ[NLNKOKJ;IML@X?4W,754&A,[0U5&.G:]9MM6\VTBL;6U6M)*KR2M34EG
MR#:1C7*KA[ O'*"2JSA%=LZ7"P, PQNH3^?USA^M_P EOIGNH"Y9U8_6%65I
M9['I/I61,&WAH9XYBI/EQL:LHSZT\Y;Y625<Z8UC9&QH9M#IKD(9&7L[1[YT
MG?*6)1+X3E0*P3WKR=8E_9\6Y?J&\D$Y7"BRN&C*W(1M8[R^7.3XS2(Z.:TP
MR9<NC=PF6'<3Q@G<P7PT^Z%HWH:>JOVYL;=- XC=327J]D:;-F(ZFZQY4L(*
M"H\M#WB9>H,*Y7=TQ, E"TE6KSKE8C-"?8,(]:.=F3-(D<H++/607_0%4+U/
MG5YYD]*K\B#\DF;U_#_/Q^4K\X'QU1&%V\Q\U_S ?"GNOSKIM[L\'YQ)+Q^[
MWO&[R?;V>'CM#H/TU'4RY2=4+BGOC;G*R6I<O<=?\@U=<5U>DT]G3(]*LDUQ
M1[,5)VQ9N'";IY[TGG&?&SG&>YDI>SY("27JT<N]B\#>G;R>Y:ZE@Z;8]C::
MJ5=F*I#;!8S,G37<C/; J%-.:>CZ].UF9>-6C2QJ+%30?M3&53+C)^[VXR&9
M#N/U0G6HV^]='0Y7H:FA7/>\.M:<U5JZI,F7?QC!O*V&0JD_?\^S'L\695[O
MW<=F<Y >3O\ K=]<Z$8&FY7FGRKBXIMY=563E&*+6+2*NLDBV,NZ>U,C+PW"
MZQ"%P?/=4,?!?;VXQD)'N#OJ]^H[HBZ0C/EPM5>8^GE72#6QM)2K5#66W(>+
M.MC"S^G72@0%?K\A),DSF4\O.Q3_  ]P3"/F6G>\P0-*7B?RFTOS6X]:OY/<
M?;/\6:HVS7\3M<D5F_DI1@NV>.HF?K5AC?%6S%6BIV&/=1LDU[ZA4'K50I3J
M$P4Y@Z(       !7!]6!]B5R-_&!QW^F^D *87I#OMDJ5^(#>W[Q1@#5[ ?Q
MR,='R\>^B99BSE(N49N8Z2C9%LB]CY&/>HG;/&+YFY(JW=LW;=4R:J2A3$4(
M;)38SC.< ,);EM0*[JCE7R:U;4">'4]:\@]ST"KI]_*GAUVG;'LE=A">(8ZI
ME.Y&QR6.]DQLY^[VY^Z V[^(MGL-VXH<8;G;DG2%KMW'G2UGLZ#XV3O4;#/:
MVK4K-)/#F20,9TG).U<*9R0F<GQGY./N /4MD;!JFI==WW:M\E$X2CZSI=IV
M#<YI;&3)1%4ID&^L=BE%2XSC)DV$1&K*FQ_=P0!BCP[;9G5EZG[-%X1\38'.
MCESA>2PRSEUFHQNV-BY=2BK8RB3DJ,#K:I/E#ER8ATVT=&^TN2$[ %Q/UF7!
M*LUKC_PCY6:PK3.$A=&*$X>6-E'IG-ECK:1@G%GTFT+C/;Y>#I4A4YYD4V<Y
M[5IU$OW<X ?\>B8YA>=KG+?@=8I7O.(*0A>4.K(Y=UXJQHJ8)$:TW"@U16SW
MVT?%R;.I+D32R9/*\FX4R4AS&,H%]P          1P;[Z0O31Y1;8M>].0/#
MG4&U=NWGW%\6WVTQTLO.SWPS6H>GP/GE6TNU0/[KK-?9,DNZF7L1;DQGMSVY
MR%&+U=_ /AMP;_5[_DD\>]?Z'^=#\K#YP/@5H_:_%7P3^33\*>]/.OWWB>X_
MBZ2\#N]WL\XIV]O;CL"3_P!$-^:SSA_'_KOZ.G "[Z A^Z_6PYS6'1MZ@MFK
MRJR$B_T-(4%15!QALJ6(VO8Z[JRPXPKE%?Y)Z_<G6#%P7&5"YR7!B9S@Y0S2
M/3=:YKVTNMMP(K-G;(NXV,OVP]C-DET,."$L.G]&[1VW47)4S'3P59E:Z0R6
M3/V]J2B93XQG)>S(;'   QL_42Z"A..764YOTFKL$8ZL6G84!N>';MBMT6Q5
MMYT*J;:LZ;5HW54PQ:M+M;Y-NDEDJ78FCC)"%3R3M#3EZ$V[9#D)TA. FR9=
M\I)RI-"0NMY227<%=NI"1TA+S6DWKUZY*=0SB0=.=>F.X.?.53+F-E3Y?> 2
M#[[T#IKE%J>UZ+Y Z]K^U=17GW%\6T*THKKP4]\,V6'N$#YY)LX:KG]UV:OL
MGJ7=4+V+-R9SVX[<9".#]0/T;?\ 9[: _P#9$[_#P#)%Z>WY_7![ZW_&GZ9Z
M4 W.0 !GE^N W2^>;)X&<=FKQ1&-KU'V_NF<8$R?PI%]<IZKT:JO')3%\/*D
M,WHLR1#)<XSC#];O8SC).P.V_1+:485_AARYY!J1Z:$WM+DG$:J(^5;K)NW=
M<TSK6O65B9NLJ@5)6+]][HD$\&24/@SA!4I\8,G@!=9 5B_5SZ7B]G=&S8U_
M>)(^\>.FZM&;8B'!B%\P16R71#0SULDKWR*81<,]RF.H3'?*8R)#9+VD*8@5
M6/1J[Q=Z]ZH=ZU N[4Q!<@N-%\AR1V%DDTE[EKB>J^PH&2.110AG"D?58RP(
ME(3!CXP\,;LP4ILX#4;   !5M]71RBUGJ+I,WSCU.SL7G:/+"^:HJE J!7R'
MQ K"ZPVG2MS7&YXBL*8=FK<&E06L:X==S*2;V8:)YSWE2@*L_HZN-5VVAU/Y
M?D(QCWR.NN,.E;V_LEBPGG$6I<=LQJVN*;3E%O 5P:2EX:2FY1(F,IXPC"JY
M,?'R4U U*@        $"WJ<)JLPW1 YO$LZC7PIF*TO"PK5P5-0[ZS.>1&I7
M$$FS0/G&573)ZTP\[2]ID4VQU?N)Y 4!O2OP,K,=<KAU(1S-1RSJL/R3GIY8
MG[F/BG'%O<U81>+?\"9YRQLF^/\ RUR@--/JX7B>UOTNNH1=*NY\E887AYR#
MS#R&/^-C7\AK*Q1:$HV_\7SD89]XZ'>P8GC)E[Q3%[2Y#)@Z(]"KFR^K=T]J
MG;&2<E!'Y0:UL3F/7(15J]<TB5Q=XIJ];J8,B[CUY:NH%<(J8,FNADR9\9*;
M.,AM7  #(@]4CQ^A-!]9?D8O6HQO#P&\H377(%JP:HE11S-WZL-X^_2?84A,
M*N+%LNM34DN?VY,X>'[<YSV@- STU^[)+>?1<X53,XY4=3FOZI<M)OLJ+Y<>
M!&Z<V-;:%2FQ%#JJ*E30UY#1&,$-@F$OW!"^&4F<A.F   #(:]4U-5F;ZW_+
ML]<4:N%8V*T!"V5TT*GW%[-%\=]6MWJ:JZ><X<.HUEANS5SGY2:C;*6>S*8#
M0 ],?"3%?Z&W!)A.-EFCUQ#;VFT$E\YR<\/9N46[K)7G)<YSG[R]@)9LLG_P
M)J% 3R@(F+#T)ND-;)^<M-CX#Z(E[#99B3GYV6=Q4V9U)S,R]7D920<F).$*
M9P]?.3J'SC&,9,;/LP S<_4R<8M \1>J/:].<:M65?3NL&6F-/S[2EU!!RWA
MD)F=AWZ\O($2=NG:V'#]9(IE,]_LSG'LQ@!H:>F\^Q*X$?X@;"^G':(";\
M
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M5S+ND">]*S8'K)7O)F[47!\8[,]F<!7A]&W]KA8_J@;E_#;4(#4[
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MTSK2TIO#DSMBU03?+O#CL96_8LTI4X-FZ<&3)Y&,B'+1DU[V2D(W1)CV%Q[
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M/4/5@?8E<C?Q@<=_IOI "J%Z*G[4W?GU -I_I%<50&EWMG^*O9?XO[E^#DD
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M;*KT:X.Y6Q"XW?4K9"2J+(ZR/@-X]Z\TKA?#=%7)2N3KJF3(9;)U0O @
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M4[:4<N<LHY'6>WDU=<VN3F\&R4JK&F%GTI["9NS'F8E(WW2X ;3
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M->VC>:-TRM.3S68@],69IM/DO-Q3G#AF?:WN5Y'T/5B3QHZ\!=:BP$^\D)U
MQ%4R2;]DADR3N.<I%#V7T7/3ZGF"^]>I1?(=1E"S,&_XX<?LOFOMFTLS</8-
MR7B.PO@N2,XV0K\5 LGB.#X66S,-LF)E%0IPNA\^-$R?)_@_R[X[01"GL>ZN
M-NZ-:U7OK8;IDMULU]/Q%2655.NV3PBWLCEJ<^#J$3,4N<'SW<Y 8O'"3D++
M\(N;7'#D=(04H=YQWWO2+I;*FJW.PG'D-5;.V)>JF9L^RU483$C7R/F&"K=S
M*"ZGR\8[N< -N'0^]]2<F]04'?.B;S!['U/LVOM;+3;?7W.'#&2CW/?36;KI
MFP1S&3$2]25:2#!R1)Y'OD%6SA--=)0A0]< 927J\MBZ_P!B=6[)Z!>*C>$Z
M;QJU91;<I4;'$6-.L76'MNSWLO49]2'>/"1%FBFDJV4<L5\IN4"N$\G(7O8[
M0MW^D-^QMI?U@-[?OY%@+/P  X\Y[\U]0]/3BEMOE=NF131K&MJ^LM"UU)VW
M;3FP[U(%,TI>N:LDX-CS5@MLX=-N3.,&(T;^,[7[C9LNH0,9Z$A>1G50YZ$C
MHYN6X<D.:6_9&1<803<I0[6S;&L;N9FY)4O>>*PM%I$:NNZ6-G)THR%CS&SG
MPT0&UEQDT)4.+/'71W&V@]Y2G:*U31-50#M5NFU=2C*D5N/@,3DBBD=0GO:>
M68F>O#]\YE'2ZAS&,8V39#W(  90GJ\?MDKK^(#1/[Q28"]YZ;S[$K@1_B!L
M+Z<=H@)OP
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MN&V%8+CMI.&4PRP;#/"D7K6LLCX:8,D@;#;!D,^'VD)GN=GR<?<$N2=W1((
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M>ZQ8:^VJY74(9^MM74ZZ^N+U*2*13&RV6M,Q6S3*1,^WRDDB;[AL )20
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M71$&$MO2PJJM28-E(];XQ[IG6>%S&34(FU<R+!%!3.>S.<*]A<X-DN0&P@
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MQB*C)HIG4XY:JFL,I#X0,@HF8S;:UNRW25L;CO>)'-RIQ*6$LEDCO0M@
MRA/5X_;)77\0&B?WBDP%[STWGV)7 C_$#87TX[1 3?@
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M&(IRYUC=G81(IC9SC&.W 9NWIC=GP>K>MEPT>V-=%I%71]M?6!7:ILXRC.;
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ML9RIU4U4/G!\'QF UAN1F4ZRN<&*8N:@Y;-T2XSCL>JF[>W.<!?_
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M+KNGJR;ZT76U2!$<V*_7F:(@V-.W"S.D"J.5_#2023(DV:I-V;=NW2#K
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M$]7C]LE=?Q :)_>*3 7O/3>?8E<"/\0-A?3CM$!-^
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MD$B&.<Q$7M@>HE>O2IE39,F 3F@    ,(;EA^=-R5_'_ +D^D6Q@-WD
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MWOC)UJ1YLV_W"DKVE(I)--':)1L#YN0Q"Y.BLGEDCE4N3%,HV,3V&3, N+@
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M=G,-?[5<KJ'*P1U5MA!QKB]2<@D4Q<.4:M#64\RD3/L\W&HF^Z7 #:P
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MWY=[O.?.TBXLMTLKA'"KUZKC';V$11(BV1002#IS]LDZ2'^#7,#^9NC_ -,
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M9:.-+1['R>U:-1I"1\Q'DRIXK1)=$G[DQ\&]@#M\
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M;O$$        ,\/UQ?\ &IT[?Q?\COPCU  L?>EQ^PHX,_VF?TP^00"?X
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M^)WHUOR7^4_&GDO^L<^./R=^0&F]Z?!7Y(/PS\8?-)L6N7_X6^(_RH;!\/\
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MT[K[4_\ ]N7Y15$]\>^/@3WA_P!%-?+^:\#[[X7C*!P!^PQ_[T3_ $)O];@
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MYOQ/%\?QVOA]G=\,W[H!-\
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MUEWU7:B*!W[IZHV;J)!,*
M       *P/J\OL;;I]8#1/[^2@"N#Z)C\_OE=]3]S]-&K0&EX
M          K0^K'Y/?D^=(78U&C7OE+3RHV1KS0,3E _]^HP:KYULZ]N2I84
M+G,>\J.N7,2Y/DIR%Q+$+[#*$S@()_1:<",SUZW_ -1J[0QC1=$:K\<M%+NT
MR915N-@91=CV_:&139(X2=5ZI.8B(;N"X,@LG/2"7;XB)NZ&AL
M
M
M
M
M
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M$*4/:@
M
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MW;W5$CE4(;NYR7/=.3.2Y[#8SC/_ (< A_H
M
M
M
M
M
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M^9*KM5_ <H'3/W39[JA#%SV9QG */TP
M
M
M
M
M
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M9P;&#8]N#8QG&?\ AQG';C[O_@$LW_H
M
M             _'L-A@*C 3EKM<Y#UBK5B'D[#9;+89-E"P%>@(5DO)3,Y.3
M,DNVCHF'B8YLHX<N7"B:*"*9CG,4I<YP'(%*ZE?3FV5;JYK_ %SS]X47^^7&
M88UZHTFE<J=%6JW6J?E%R-8V#KE;@KV_F9R8D7*A4T&S5%598YL%(7.<]@#M
M<  ?SNW;5@U<OGSENR8LFZSMX\=K)MFK1JV3,LX<N7"QB(H-T$29.<Y\X*4N
M,YSG&, .(*]U0>FC;I^#JE4ZB'!BSVFSS$97JU6J]RVT%-3]AGYIZA&PT'!P
MT;L!S(RTQ+2+E-NV;-TU%EUE"D(4QC8QD.YP       <Y\B^7G%[B)"URQ\H
M-^:KT) V^4=PE6E]IW&'IT?/R[%IA\\C8IS,.6R;QXV9FPJ<A,Y,4F>W/L ?
M'<=^?_"7EO9YNE<8N5&C=\VVM0.;1/US5NPJ_<)B'KA9!E$FFY!C$/'*[:-Q
M)R*"'BFQ@GBK$+V]IL .O0               51>?OJM^/O /E_NSB#;^)^X
M]@6/2<Y!P<I<*W=:3&0DVK.4ZN7%)=@QDT3/VZ:#:QD1-A3/;DZ9LX]F< +,
MVBMJ1^]-(Z<W;$Q3R"B]Q:KU[M2-@Y%9%S(0T?L*I1%M9Q3YPVQANN\CF\N5
M%4Z?R#')G)?9G #U0    !\/L;9VMM/5"5V#MO85'U;0H%,BTY=]C6R!I%0A
MDCF[A%96RV9_&0T<F<^>S!EEB8SGV (?+[ZC[HF:W>KL+#SXUY(KMWGD5%*%
M0]U[59&6['&>^A):OUE<(YTS_O8W]\)*G;^TGR_OB?>#T#6_7SZ.&U9)**JW
M4'T!'NUU$4DL[#F)S4+(RB^4RIES)[9@J3&%[<JXQG.5L8+[>WL[INP)4Z;=
MZ7L:NQ]OU];ZO>ZE+IY6B;139^)L]=DTL9[N58^;A';Z->IX-[,F35-CM ?4
M
M
M
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MXV9LWBJ]KIT-/*JNF<=G,>U<J*/\Y.FAGP2&SDI/DXP)<SUH
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M/?RS:B:AY%:@V5<G$5%)E5DY-"KTRX34VK'QR1RF76*AE-$N<9/G&,@.KP
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M#;%XL^Q;O*M8?<5PC(EM)6NX2DQ//F\7&M4V[<BK@Q4$$RIDP4A<8P$^P
M
M
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M4^?$7633QV=G;VYP G2_90.MK_5QH'^<1H[_ *\ '[*!UM?ZN- _SB-'?]>
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M5) QODY"PH
M
M                                            /*]ZKJ-M([C<HG.D
MLWU7L)=)1(YDU$U$JC+J$.FH3.#)G(8N,X-CVXS[0(W8_G+FRS=JV1"2$]*R
MLP\1I$:S3<R\D[E')&R<]95R($</%%%2(%5<'-@F,]W!C&S]W.1&[MPJM'+
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M%$*Q<ZT]Z66+173K=_J[=PJ@164A\M'Q%7'WR)2;I'=9"^2
M
M
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MXU.HE^+_ (X_A'M\!=\ZA7Y@G.+ZG_)?Z%[J R1>@1]LET]OK 0_[QSP#9Z
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MP7!T'C"09*KM'C58F>TBB9S$-CVXSD!^D
M
M
M        "DGZG;BQ(;2Y#-]VMZWLR2::YX/I>/,5J'7>4UA\(W??MM5^() E
M>D$VOE4Y#"KOM=H=QJ8IL]S&>_DUXZN/FU&T0Z@!:@](E]I)NWZC^R?IYXU!
M#+F^GEH);5_^UYG_ /YEO_\ R,B-,-W%R;>6*:,WI    )&^F-H25Y"[XMM.
MC*]>[$K&ZBG[.9I08ES+RR:3*YT*),Y<(-X>:,2-3/,X(<_A%QA4Z>._CM[#
M(B]V?)-8^6K#Q*JZU(XJ\9J6X:R;%Q4./NF:NNRFD#-9EFM :YK<2JUEFQV[
M0[>3;G:9(N3*262*X-C)"]G9B7+.[H($   SH^;OJZ^I)QKYH<N^.E%TEP@E
MJ3H'D_OW2E.E+9K;?+ZU255U7M:V46O2%E?0_)2"B'E@>1$$BH]5:L6;91R8
MYDD$29*F4.8/VU;JF_R!\ /YK.17_P U0"&CJJ=9#DYU>Y_3%CY*470](?:,
MA[K"5)+1U8V#6FLBUO;VMOY=2Q$ONS]EK.W#9:KM\-LMCM"D*=3OE4SDN2!V
MQP*]4!SZZ=O$[5/#K2FHN(%HUEI_XY^&IW:5!W1-WM]\X&R;CM*9]^R=3W_2
M:^Y\M8+L[1:^7BVO<9II$/XBA3JJ!U_^VK=4W^0/@!_-9R*_^:H!8&].]U^^
M8W5MY.[MTMR.UKQGI56UMH=;:$&_TE3MI5R?=SZ>P:94\,Y9U>]R[(CEX?,=
M8ESY31:H+>,0F?%[N#$,%O4  0 ^J.^PHYS?V9OTP^/H"F%Z-O[7"Q_5 W+^
M&VH0&IV       #YFZ7.I:XI]JV#?K)"TZC4>NS5NN-MLDBVB*_6*O78YQ+S
MT_.2KU1%G'1,1%M%7#A=4Q4TDDS&-G&, ,CKU!?6:G.K!R;;U_6#N8C>'6AY
M27A-$5MTU6C7E\FG?A1]BW39XLY2O"REN\J5*&9N<85BH7"9,I(.W4@50+C?
MI>>B?,< ].R?,/DO5S1'+7D356D;7J;+M\IS&A])/7#690K,FV/C&8_86Q7K
M-I(SB)^\M&-6K)AG#=R6224"V@   #"&Y8?G3<E?Q_[D^D6Q@-WD  >4[WU6
MRWKH_<ND9*7=0$=N/5.Q-5OYYBV2>/81EL*H3%1=2[-HX.D@Z=1J$N99-,YB
MD.<F"YSC&>T!5WU7Z,[I9TUF7.Q=A<L-Q2ZC<J;I27V-2J; )KXSVY<Q412M
M<1<PT[V/9W',H^+_ , #V:^>D2Z-5OB7$;7Z'OK5CQ9JLW3GZ'OBR2,LT55.
MD8CYNCLYEL:",Z;E3R4F%62J.<'-WTS9[N2A26ZYW0)VITA9^K['JMQ?;LXC
M;+GOA6H;0D(QI#6ZDWI1A(S#?7.RXE@JI''DI&&B73F,EF6$VDFFS<X,W9JI
M824"?CT;?4VOULD-E],K;EFD+'7ZC1Y'<_&9[-/%'3FJP\3.1,7LK5$>X<**
M+&@SJV5K.Q+,N,)LO"E<XSW%$B$"_2   #B[J&\*J!U#.&^].(NQ5BQD7MFH
MG9U^T%:%>.J-L"#>-;%KV\-$.^BJN:L7&*9N5VY%4<OF9%FICE37. QRMXZ&
MYK](OF*UKUU973C_ ,B]'W!.TZWV# '=-6$XC$2+A"#V+K6R*MB1UOH]B20/
M@INXH@X;J*LGR!3X<M2A:DT7ZWC?-4HL="<AN"FN=T7MBU9-'%ZUQN^:T7'S
M.6K;"#B1E*=+:KW0@26DE2866RR>LV95#'PDV23R4A \/Y1^L?Z@/(-CG6_$
M#C]KGB](7%9"OQ<TP>RO(G='O.74/&L6%+?2]8J5,++/W+Q-- IJF^=9<8)X
M)BGSC "H/?Y>[6"^7:>V4ZGGNQINW627O[VTD=)V=W=I*9>O;4ZL:;XB3U.>
M<3JRYWA5BE5PXR?!\8-VX ;8W("'F]2=*O=E?(Y40LFLNGWLB'(\69H)JHS=
M,XY3+(KE6/7._;$43?QO>,B<RR>,X[N<GQ]T,8CBCHT_)[E)QLXU)V0M-4Y#
M;]TYHTEO/%YG"54^V=B5R@ELAH4K^*-,%@S3_FLM<.FV7&$O#\5/O=_ :I_$
MKTMG2+XRUJ'0N6C77*C8;0J"TML7D)8)>?0D7A/!5719:R@GL'JZ/A<.TLY1
M07BGSPJ)O"7=N,=IC![/R']./T>.0U)G*FXX<T+34S)1JC.'V'Q^PYU1<:F]
M[#^7FHA""4-395\U,?.?"F8B49*^S"J!^PO=#+9ZEG S:W2QYM;$XPV^PK2<
MC0)*'N.J]GPF%8)2ZZ^FS9EJ!?XU%L\7=5Z:P5N9%XW(NH:/F&3A))98B1%U
M U7.@GSNL74.Z8F@-X;!D%)7<%9;S.EMSRJQ\*KSNPM6NDX8]L>+8R7"DI>Z
MDM$SS[&")$3?2:R:9?#(0Q@F/ 1*=7[I+:\ZOFDM9Z2V/MNZ:?B]9[4)M-C.
M4F$@YV0DY E2L=2Q%.V\Z<C=%GEO8SK=\F>_WTRX^YG("K3OCT0*J%:E)+C)
MSOQ)6YLW,>&I^\]1XBJ_,.<(D[$)#8E#M$J_@$S+E-G"A*S(_)/C&2X[N3'"
M /C_ -3+JU]!GE;/\?+U<[T\8:;M36 VGQ)W#;Y2[ZBG8)1)I(%6HRB[Z7:T
MHMGKSMN^B+'63H8<(J-E5B/&N#-5 U6>%7+C57.[BWIKEAI=TX6H&Y*FE8&+
M!^9N:8K,TS>.X2VTN?PU45;$L%+M<8]BWOA&.D9PU,9,QDS$-D.I    <W\P
M>.<5R\XM;]XO3EFD*9#;\U7<-62MKB6#:4DZ]'W")<1#N5CXYXNV:NWC1%QD
MR9%#E)DV,=OL]@"M_J_T:W2GIC%'%^N7*[<,L9'NO5[#L^HU2'\QE1 V58R*
MH6N:[(LD<$1R7";B0>F^^GSD^<^'X8>F;&](5T<[I#N(^JU'?VH9%1JJBWGJ
M)O&<F'S=P;!LI.\M-I1VQ(E8R1LX[290P0Q<=GLSGO *-?6[Z%NXNCW?ZC+Y
MN)=T<8MN24E&:MW E#9@9J,L<8T))/=<[+@$7+]E"VY".,=PP<MG"C*<9-UG
M"!4%4';-H%I_T=/4WV%O37FVNGCNBUREQFN/%/BMH<?)B<>GD9ECI#WQ&4RV
M:\5>.#9=J5_6]GFX7,-A0RV6S.;,S(9)JS:(E#WSUJWV66@_K_ZL_1UY5 (0
M/1,?G]\KOJ?N?IHU: TO  !A#<L/SIN2OX_]R?2+8P&QUU"?L7N</_\ S Y+
M?HI74!E"=%/[6_IR_7 T=^'$4 VN@ !E">KQ^V2NOX@-$_O%)@+GOI/_ +$K
MCE^,#D1]-]W 6/@' '5B^RRZEGU .9'Z.NQ@&6)Z;W[;7@1^,#8/T(;0 ;'0
M   .7^;U;D+CPNY>5")+WI2U<7]_5N-+X:RW>D)S5%LC&9?!;)K.%>UPZ+\E
M,ACF^X7&<]F &--TH;26E=4'IU69:13B649S?XLYEY%9)-9)K /-VTIA83JD
M417[$S0;IP4QBERH3&>\3.#X+G ;?(  \9Y&VF.HW'K?%VES%)$T[3.T+3*&
M.LFW(6.K](G)9Z8RZO8D@7#9H;M.;Y)<>W/LP Q/NF[$OI_J(\"8*,3*M)37
M-'BW$QZ)U$T2*OI'>-%9M$S+*F*DD4ZZQ<9,;."EQGMSGL ;DX#'%]2%]MKS
MW_&!K[Z$-7@-3OI._99=-/Z@'#?]'77(#O\  9H?K9_S^^*/U/VWTT;2 6/O
M2&_8VTOZP&]OW\BP'@'K5OLLM!_7_P!6?HZ\J@$8'H=/XU.HE^+_ (X_A'M\
M!=\ZA7Y@G.+ZG_)?Z%[J R1>@1]LET]OK 0_[QSP#9Z 0K>HJ@Y.P=%;GZPB
M6QG;IOJJN3BJ1<XQDD96=J4"R33G.39QCNLH:)76SC[N<)Y[/: S1.@KP]XT
M<]>I+J[BORI1LSK7>RJ5M=:)95*SJ5&8>W.FT27O,4@G,(E47*B6*K;Y0R1"
M'RIW,8[.SMS@+\W[(;T;?\"^0'\^TY_!8!^R&]&W_ OD!_/M.?P6 ?LAO1M_
MP+Y ?S[3G\%@/S>MCPQU1PB],YRBXC\;HJQ-]4ZE8ZIDJM'V>?4L<^W96#G=
MK#;]Q</YQZ1LJ^*A*V*27)C)<&(A@J1<&R7':%1;TAEG8P'61ID4[Q&Y7N_'
M[>U8C//-U%G6'S2$BKFIF&4(;!6DE[MJ+C!E#=I<L_')V=X^,X#5Y  &.+ZD
M+[;7GO\ C U]]"&KP&KUT]?S!.#OU/\ C1]"]* =@        YMY7\1>/'-S
M2MKT!R9UE7=GZWMC%RW48S+) TM7)-9JNU9VNE3WAYE*A<H;QS'92;%1%TW/
M]PV2&,4P8CG*_14GQ8Y2\BN-\D_<2,CQ_P!Y[3U :;4;JL5)K&M[Q-U1I8D$
M3IHG3;SK:)(]0-@N"F26*8OR<XR VO> &S[)N[@?PGW/<7+A[;]N\1^-^S[4
M\=NCOG3NR7[3E,M<XY<O5$TCO'"\G+*G.KDI<J&SDV<8[>P!C>\3?M3.-'U_
MM-?I$UP!M] /A=H;#KVHM9[$VO;E%D:IK"BV[8=G6;DPHX2KU+@)"R32B"9C
M$*HLG&QJN2ESG&,FQC';@!BA\C]]\G^KWS\?7N=Q*7K>/*';D%0-44+$EA2+
MJ;"U69.NZMU)55'7E6$-4ZFA*(-"K'PB0YO'?NSF<+N5SAH <#O1\< M,T2K
MS'-MU;.6NZG$>U>V^&97*V:ST;7YI5%)=2(J,11)"JW^Q,X5V8R/GY>7PE+%
M3*J:,9E.9K@)N:)T5>DEKI))*N].?B$\PBB9!-6ZZ1I6S'12F4;J^)YS9$9:
MW9G1#MB]U;)\K$QDV"FQ@Y\&#(KZH%>@*CU+NHA5*I!P]8JU8YS\M:]6JU7H
MQE"P%>@(7?NP(V&@X.&C4&T=$P\3'-DV[9LW331013*0A2E+C& W$0&8)ZU;
M[4W0?U -6?I%<J@%KWTG_P!B5QR_&!R(^F^[@+'P#$LZQU6D:?U8>I%$RA3%
M<N^;/)2TI8,BHCG,=>=LVFZQ!L$5[#&*>)L"&<'Q\E3&<&+\G. %_/COZ5[H
MQ[QX_P"C-U,:CO9PRW!IW66T6:['?,\HR7:[ I4);&ZS-0\&T.HU52EL&3-E
M)/.29QG)"_<P'L7[(;T;?\"^0'\^TY_!8!^R&]&W_ OD!_/M.?P6 [OZ>G0H
MX"=,/=%GWWQ7K^T(G85NU?-:AF'%VV5(W&*/39^UTJYR"+>,>,FZ2$@:;H$<
M8B^#9,5,JA.SL/GL#OOEEQ"XY\XM+63C]RAU=7]JZPLOAN%(F936;R<%--DU
MDXZTT^Q1ZK6>J%LBBN%,-Y&.<-W1$U5$LG,BJJF<*77*'T1M7D928G.&O-*4
MK,:NHJK#ZWY%T-*RX:943[Y6ZNV=>.X1QY-)SVD3P:I+K%1-COJJG)DRH5V^
M:GIGNK#PFJ-CV38=.UG>^K:DU<2-DOO&VV'V(G"1;;QE%Y:0HDO$5+;&(EHS
M0,X=/$J^LS8H%R=PJD7&<@/S>A3UF]Z],KD[K6JR]^G)SACLF\0E7WAJ.>E'
MDA5*M"VF9:,93;="C73LK.JWBH>9\^N=MX*4RU14:N\&R9!=L&P>
M
M
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M?),IE,3!>S)<=G8 W70
M
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M6,2V(6#][3,WY'$U.25BDO\ UG8)*7EG/F9>676^^N%.YXG<+W2%*7!B]-
M     !GA^N+_ (U.G;^+_D=^$>H %C[TN/V%'!G^TS^F'R" 3_     ( ?5'
M?84<YO[,WZ8?'T!3"]&W]KA8_J@;E_#;4(#4[  %7GKZ=?3;W1\V]H'6VMM
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MCY/MQVAUL<Y$R&44,4A"%,<YSFP4A"%QDQC&,;.,%*7&.W.<^S& &<?ZN/K
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M?4EEIO7>AGLFR=,GMIE+"Y2:H7[:18Q\9LV,BVQ$0"F5EFJL@Y,T>LPN#@
M
M
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M&E5EPG/U#CK#6-DHSL:J-E,D1O9]K3<.Y/&/'S N(V,9*NVK-P^3='=9"VP
MKL^IFXT<XN5' _4VO> =:V1:=Q0_+>AW*RQ^K[]'ZZGT=:1^G-]0DP\>3<E:
MZ>@ZAT[3888BC7#DYSK*)*82-A+)R!1:ENBOZD:?BI."G=%\KYJ$FH]Y$S$/
M+<F*9(Q4M%2+91G(1DG'O-WK-'\>_:+'2615(=-5,^2FQDN<X >65OT\?79I
MLVPLU0X4;<JMCBE%%HNP5O:VGX.;C55D%6JJK"5C-L-7[-15LN=,QDU"Y,0Y
MBY]F<X >Q_J;?4M?R.\O_P#.DJG].8#6[
M
M
M
M
M
5                        !__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
